Search Within

NEURODEGENERATIVE DISEASES
Results 1 - 952 of 952
Nanoneuromedicines for Neurodegenerative Diseases

Journal: Nanoscience & Nanotechnology-Asia
Volume: 8,Issue: 0
Page: 1-8
Authors: Ram Singh * and Geetanjali

Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 8,Issue: 4
Page: 393-409
Authors: P. H. Reddy and T. P. Reddy

Aquaporins and Neurodegenerative Diseases

Journal: Current Neuropharmacology
Volume: 8,Issue: 2
Page: 112-121
Authors: Eleonora Foglio and Rodella Luigi Fabrizio

Coenzyme Q10 in Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1917-1921
Authors: Clifford W. Shults

Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 5
Page: 621-634
Authors: Vincenzo Pizza, Anella Agresta, Cosimo W. D'Acunto, Michela Festa and Anna Capasso

RNAi Silencing in Mouse Models of Neurodegenerative Diseases

Journal: Current Drug Delivery
Volume: 4,Issue: 2
Page: 161-167
Authors: Mohamed H. Farah

Oxidation of Potassium Channels in Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17,Issue: 0
Page: 1-4
Authors: Junsheng Yang* and Xueni Yan

Advanced Tools of Regenerative Medicine for Neurodegenerative Diseases

Journal: Recent Patents on Regenerative Medicine
Volume: 2,Issue: 3
Page: 208-223
Authors: Martino Sabata, Tiribuzi Roberto, D'Angelo Francesco and Orlacchio Aldo

Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 230-245
Authors: Francesc X. Sureda, Felix Junyent, Ester Verdaguer, Carme Auladell, Carme Pelegri, Jordi Vilaplana, Jaume Folch, Anna Maria Canudas, Carlos Beas Zarate, Merce Pallas and Antoni Camins

Retromer Dysfunction and Neurodegenerative Disease

Journal: Current Genomics
Volume: 19,Issue: 4
Page: 279-288
Authors: Christiane Reitz*

Molecular Imaging of Stem Cell Transplantation for Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 2
Page: 4426-4440
Authors: Ping Wang and Anna Moore

Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 2152-2174
Authors: Rosa Ana Gonzalez-Polo, Elisa Pizarro-Estrella, Sokhna M.S. Yakhine-Diop, Mario Rodríguez-Arribas, Ruben Gomez-Sanchez, Jose M. Bravo-San Pedro and Jose M. Fuentes

The Ubiquitin Proteasome System as a Potential Target for the Treatment of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 1
Page: 3305-3314
Authors: Zheng Ying, Hongfeng Wang and Guanghui Wang

Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 2
Page: 4335-4343
Authors: Z. Zhang, J. Yan, Y. Chang, S. ShiDu Yan and H. Shi

The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review

Journal: Protein & Peptide Letters
Volume: 24,Issue: 9
Page: 841-853
Authors: Ana Flavia Almeida-Santos , Lucas M. Kangussu * and Maria Jose Campagnole-Santos*

Potentials of ES Cell Therapy in Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 3
Page: 3873-3879
Authors: Anand S. Srivastava, Rakesh Malhotra, Jason Sharp and Travis Berggren

Type 2 Transglutaminase in Neurodegenerative Diseases: The Mitochondrial Connection

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 3
Page: 278-288
Authors: Mauro Piacentini, Walter Malorni, Maria Grazia Farrace and Carlo Rodolfo

The Importance of Steroidomics in the Study of Neurodegenerative Disease and Ageing

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 12,Issue: 2
Page: 212-228
Authors: William J. Griffiths and Yuqin Wang

Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 1
Page: 962-972
Authors: D. Reglodi, P. Kiss, A. Lubics and A. Tamas

The Protective Effects of Green Tea Catechins in the Management of Neurodegenerative Diseases: A Review

Journal: Current Drug Discovery Technologies
Volume: 15,Issue: 0
Page: 1-11
Authors: Tahereh Farkhondeh, Hanieh Shaterzadeh Yazdi and Saeed Samarghandian*

Oxidative Stress, Antioxidants and Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 1
Page: 2033-2052
Authors: I. Casetta, V. Govoni and E. Granieri

Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 2193-2210
Authors: Antonio J. Herrera, Ana M. Espinosa-Oliva, Maria J. Oliva-Martin, Alejandro Carrillo-Jimenez, Jose L. Venero and Rocio M. de Pablos

Development of Novel Genomic Blood Biomarkers for Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 6
Page: 669-678
Authors: Fran Borovecki and Mario Habek

Aggresome Formation and Neurodegenerative Diseases: Therapeutic Implications

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 1
Page: 47-60
Authors: L. S. Chin, J. A. Olzmann and L. Li

Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 5,Issue: 3
Page: 195-202
Authors: Antonio Martin, Giulia De Vivo, Mariangela Ricotta, Maura Iannuzzi and Vittorio Gentile

Cell-Replacement Therapy with Stem Cells in Neurodegenerative Diseases

Journal: Current Neurovascular Research
Volume: 1,Issue: 3
Page: 283-289
Authors: Vincenzo Silani and Massimo Corbo

Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 3
Page: 4311-4327
Authors: Carlos Fernandes, Catarina Oliveira, Sofia Benfeito, Pedro Soares, Jorge Garrido and Fernanda Borges

The ASK1-MAP Kinase Signaling in ER Stress and Neurodegenerative Diseases

Journal: Current Molecular Medicine
Volume: 6,Issue: 1
Page: 87-97
Authors: Yusuke Sekine, Kohsuke Takeda and Hidenori Ichijo

Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 2
Page: 2036-2055
Authors: Gaetano Serviddio, Antonino Davide Romano, Tommaso Cassano, Francesco Bellanti, Emanuele Altomare and Gianluigi Vendemiale

Alkaloids Pharmacological Activities - Prospects for the Development of Phytopharmaceuticals for Neurodegenerative Diseases

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 7
Page: 629-635
Authors: Soane K.M. Chaves, Chistiane M. Feitosa and Lidiane da S. Araújo

Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 6
Page: 679-692
Authors: Ricardo J.S. Viana, Maria B. Fonseca, Rita M. Ramalho, Ana F. Nunes and Cecilia M.P. Rodrigues

Implication of Rho GTPases in Neurodegenerative Diseases

Journal: Current Drug Targets
Volume: 12,Issue: 8
Page: 1202-1215
Authors: Judith Antoine-Bertrand, Josee-France Villemure and Nathalie Lamarche-Vane

Protein Aggregation in Neurodegenerative Diseases: Insights from Computational Analyses

Journal: Current Bioinformatics
Volume: 7,Issue: 1
Page: 87-95
Authors: Anita Sarkar, Sonu Kumar, Abhinav Grover and Durai Sundar

The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3,Issue: 6
Page: 515-533
Authors: G. Benitez-King, G. Ramirez-Rodriguez, L. Ortiz and I. Meza

Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 2
Page: 3509-3519
Authors: Yossi Gilgun-Sherki, Eldad Melamed and Daniel Offen

Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 1281-1292
Authors: Wenzhen Duan and Christopher A. Ross

Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 3356-3373
Authors: Russell H. Swerdlow

Molecular Pathology in Neurodegenerative Diseases

Journal: Current Drug Targets
Volume: 13,Issue: 1
Page: 1548-1559
Authors: Alexander H. Peden and James W. Ironside

Cannabinoids and Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 6
Page: 440-450
Authors: Julian Romero and Jose Martinez-Orgado

RNA Metabolism in Neurodegenerative Disease

Journal: Current Chemical Biology
Volume: 5,Issue: 2
Page: 90-98
Authors: Kathryn Volkening and Michael J. Strong

Midkine and Pleiotrophin in the Treatment of Neurodegenerative Diseases and Drug Addiction

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 10,Issue: 1
Page: 28-33
Authors: Luis F. Alguacil and Gonzalo Herradón

P-gp Transporter and its Role in Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 209-217
Authors: Simona Rapposelli, Maria Digiacomo and Aldo Balsamo

Flavonoids in the Treatment of Alzheimer s and Other Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 0
Page: 1-19
Authors: Cristina Airoldi , Barbara La Ferla*, Giuseppe D’Orazio , Carlotta Ciaramelli and Alessandro Palmioli

Conformation as the Therapeutic Target for Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 14,Issue: 4
Page: 393-402
Authors: Rajaraman Krishnan, Franz Hefti, Haim Tsubery, Michal Lulu, Ming Proschitsky and Richard Fisher

α-Synuclein Misfolding and Neurodegenerative Diseases

Journal: Current Protein & Peptide Science
Volume: 9,Issue: 5
Page: 507-540
Authors: Vladimir N. Uversky

Systemic Redox Biomarkers in Neurodegenerative Diseases

Journal: Current Drug Metabolism
Volume: 16,Issue: 1
Page: 46-70
Authors: Anna Pastore, Sara Petrillo, Emanuela Piermarini and Fiorella Piemonte

Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 4
Page: 525-539
Authors: Valeria Lanza, Danilo Milardi, Giuseppe Di Natale and Giuseppe Pappalardo*

The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 2
Page: 187-210
Authors: Andrea Abdipranoto, Sara Wu, Sandy Stayte and Bryce Vissel

Peptides and their Metal Complexes in Neurodegenerative Diseases: from Structural Studies to Nanomedicine Prospects

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 6
Page: 715-747
Authors: Giuseppe Trapani, Cristina Satriano* and Diego La Mendola*

Docking of Natural Products against Neurodegenerative Diseases: General Concepts

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21,Issue: 0
Page: 1-9
Authors: Frederico F. Ribeiro, Francisco J.B. Mendonca Junior, Jahan B. Ghasemi, Hamilton M. Ishiki, Marcus T. Scotti and Luciana Scotti*

Therapeutic Implications for Immunophilin Ligands in the Treatment of Neurodegenerative Diseases

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 6
Page: 349-356
Authors: Kevin Pong and Margaret M. Zaleska

Environment and Neurodegenerative Diseases: An Update on miRNA Role

Journal: MicroRNA
Volume: 6,Issue: 3
Page: 157-165
Authors: Margherita Ferrante* and Gea Oliveri Conti

Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach

Journal: Current Drug Targets
Volume: 16,Issue: 1
Page: 20-30
Authors: Carme Espinet, Hugo Gonzalo, Catherine Fleitas, Maria Jose Menal and Joaquim Egea

Redox Chemistry of Green Tea Polyphenols: Therapeutic Benefits in Neurodegenerative Diseases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 5
Page: 380-387
Authors: H. M. Hugel and N. Jackson

Contribution of Analytical Microscopies to Human Neurodegenerative Diseases Research (PSP and AD)

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 9
Page: 961-975
Authors: Carmen Quintana

Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases

Journal: Current Protein & Peptide Science
Volume: 18,Issue: 0
Page: 1-8
Authors: Athanasios Alexiou*, Bilal Nizami, Faez Iqbal Khan, Georgia Soursou, Charalampos Vairaktarakis, Stylianos Chatzichronis, Vasilis Tsiamis, Vasileios Manztavinos, Nagendra Sastry Yarla and Ghulam Md Ashraf

Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 3
Page: 5574-5593
Authors: Martine Uittenbogaard and Anne Chiaramello

Neuroprotective Effects of Nonsteroidal Anti-inflammatory Drugs on Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 6
Page: 695-700
Authors: M. Asanuma, I. Miyazaki and N. Ogawa

Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases Models

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17,Issue: 0
Page: 1-10
Authors: Ana Carolina Bombardi Duarte, Maycon Giovani Santana, Guilherme di Camilo Orfali, Carlos Tadeu Parisi de Oliveira and Denise Goncalves Priolli*

Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain

Journal: Current Neuropharmacology
Volume: 16,Issue: 0
Page: 1-7
Authors: Raffaele Mancino, Alessio Martucci, Massimo Cesareo, Clarissa Giannini , Maria Tiziana Corasaniti , Giacinto Bagetta and Carlo Nucci *

Nerolidol and its Pharmacological Application in Treating Neurodegenerative Diseases: A Review

Journal: Recent Patents on Biotechnology
Volume: 12,Issue: 0
Page: 1-11
Authors: Rusbene Bruno Fonseca De Carvalho*, Antonia Amanda Cardoso De Almeida , Neylon Barbosa Campelo, Daniel Ramon Oliveira Dantas Lellis and Livio Cesar Cunha Nunes

11C-verapamil to Assess P-gp Function in Human Brain During Aging,Depression and Neurodegenerative Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1775-1784
Authors: A. L. Bartels, O. L. de Klerk, R. Kortekaas, J. J. de Vries and K. L. Leenders

Cyclin-Dependent Kinase 5 (Cdk5): A Potential Therapeutic Target for the Treatment of Neurodegenerative Diseases and Diabetes Mellitus

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 1070-1074
Authors: Fan-Yan Wei and Kazuhito Tomizawa

Heat Shock Proteins as Suppressors of Accumulation of Toxic Prefibrillar Intermediates and Misfolded Proteins in Neurodegenerative Diseases

Journal: Current Pharmaceutical Biotechnology
Volume: 11,Issue: 2
Page: 158-166
Authors: Shigeki Arawaka, Youhei Machiya and Takeo Kato

RNAi Applications in Therapy Development for Neurodegenerative Disease

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 3
Page: 3977-3991
Authors: M. M. Maxwell

The Immune System, Involvement in Neurodegenerative Diseases, Ageing and Cancer

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 4,Issue: 4
Page: 349-352
Authors: Evan P. Booy, Dina Johar, Kamran Kadkhoda, Graham H. Bay and Marek Los

Resveratrol: A Therapeutic Approach to Neurodegenerative Diseases and Aging

Journal: Mini-Reviews in Organic Chemistry
Volume: 7,Issue: 4
Page: 267-271
Authors: Pallas M., Canudas A.M., Junyent F., Jimenez A., Verdaguer E. and Camins A.

Recent Developments in Tau-Based Therapeutics for Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 6,Issue: 1
Page: 20-30
Authors: Miguel Medina

Intranasal Lipid Nanoparticles for the Treatment of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 24,Issue: 0
Page: 1-10
Authors: S. Cunha, H. Almeida, M.H. Amaral*, J.M. Sousa Lobo and A.C. Silva*

Chemistry and Biochemistry of Oxidative Stress in Neurodegenerative Disease

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 7
Page: 721-738
Authors: Lawrence M. Sayre, Mark A. Smith and George Perry

Human Embryonic Stem Cell Therapies for Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 4
Page: 440-448
Authors: Eva Tomaskovic-Crook and Jeremy M. Crook

Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery

Journal: Current Neuropharmacology
Volume: 6,Issue: 2
Page: 164-178
Authors: K.-G. Schmidt, H. Bergert and R. H.W. Funk

Single-chain Fv Antibodies for Targeting Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17,Issue: 0
Page: 1-9
Authors: Kin Yen Chia, Khuen Yen Ng, Rhun Yian Koh and Soi Moi Chye*

MAPKs as Mediators of Cell Fate Determination: an Approach to Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 6
Page: 538-548
Authors: G. Tredici, M. Miloso, A. Scuteri and D. Foudah

Nano-medicine Improving the Bioavailability of Small Molecules for the Prevention of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 1897-1908
Authors: Piera Di Martino*, Roberta Censi, Maria Rosa Gigliobianco, Luana Zerrillo, Federico Magnoni, Dimitrios Agas, Wilma Quaglia and Giulio Lupidi

Collective Roles of Molecular Chaperones in Protein Degradation Pathways Associated with Neurodegenerative Diseases

Journal: Current Pharmaceutical Biotechnology
Volume: 11,Issue: 2
Page: 180-187
Authors: Guang Rui Luo and Wei Dong Le

Neurosteroids in the Brain Neuron: Biosynthesis, Action and Medicinal Impact on Neurodegenerative Disease

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6,Issue: 1
Page: 73-82
Authors: Kazuyoshi Tsutsui and Synthia H. Mellon

Protein Conformational Pathology in Alzheimers and Other Neurodegenerative Diseases; New Targets for Therapy

Journal: Current Alzheimer Research
Volume: 7,Issue: 1
Page: 74-83
Authors: E. Zerovnik

Gastrointestinal Immune System and Brain Dialogue Implicated in Neuroinflammatory and Neurodegenerative Diseases

Journal: Current Molecular Medicine
Volume: 11,Issue: 8
Page: 696-707
Authors: G. Deretzi, J. Kountouras, S. A. Polyzos, C. Zavos, E. Giartza-Taxidou, E. Gavalas and I. Tsiptsios

Role of the Transglutaminase Enzymes in the Nervous System and their Possible Involvement in Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 3
Page: 4767-4773
Authors: G. De Vivo, R. Di Lorenzo, M. Ricotta and V. Gentile

Impaired DNA Damage Repair as a Common Feature of Neurodegenerative Diseases and Psychiatric Disorders

Journal: Current Molecular Medicine
Volume: 15,Issue: 2
Page: 119-128
Authors: H. Shiwaku and H. Okazawa

Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 2
Page: 2771-2777
Authors: A.L. Bartels

Role of Mitochondrial Protein Quality Control in Oxidative Stress-induced Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 13,Issue: 2
Page: 164-173
Authors: Giovanna Cenini and Wolfgang Voos

Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases

Journal: Protein & Peptide Letters
Volume: 17,Issue: 5
Page: 630-645
Authors: Jie Yang, Tong-Yang Zhu, Zheng-Xin Jiang, Cheng Chen, Yue-Lan Wang, Song Zhang, Xiong-Fei Jiang, Ting-Ting Wang, Lin Wang, Wen-Hao Xia, Lei Li, Ji-Jun Chen, Jia-Yue Wang, Wei-Wei Wang and Wei-Juan Zheng

Phenolic Compounds: the Role of Redox Regulation in Neurodegenerative Disease and Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 385-398
Authors: Hassan Y. Aboul-Enein, Pawel Berczynski and Irena Kruk

Perspectives on Development and Regulation of Therapeutic Products for CED-Based Therapy of Neurodegenerative Diseases

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 6
Page: 495-512
Authors: Mahadevabharath R. Somayaji

Neuroprotection: The Emerging Concept of Restorative Neural Stem Cell Biology for the Treatment of Neurodegenerative Diseases

Journal: Current Neuropharmacology
Volume: 9,Issue: 2
Page: 313-317
Authors: Fiorella Piemonte, Ferdinando Rossi and Barbara Carletti

Phenotypic Screening Strategies for Neurodegenerative Diseases: A Pathway to Discover Novel Drug Candidates and Potential Disease Targets or Mechanisms

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 6
Page: 693-700
Authors: R. M. Pruss

Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 7
Page: 810-815
Authors: Anna Lisa Iorio, Martina da Ros, Ornella Fantappiè, Maurizio Lucchesi, Ludovica Facchini, Alessia Stival, Sabrina Becciani, Milena Guidi, Claudio Favre, Maurizio de Martino, Lorenzo Genitori and Iacopo Sardi

Transglutaminase-Catalyzed Post-Translational Modifications of Proteins in the Nervous System and their Possible Involvement in Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 4
Page: 370-375
Authors: G. De Vivo and V. Gentile

Genetic Aspects of Glial Cells Regarding Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 0
Page: 1-9
Authors: Julio Cesar Martinez Lozano*, Rosa Margarita Gómez, Andres Gabriel Zarate Sanabria, Giovanny Jubiz and Sonia Del Pilar Otalora Valderrama

Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 2
Page: 3570-3581
Authors: Charles Finsterwald, Pierre J. Magistretti and Sylvain Lengacher

Enhanced α-Synuclein Expression in Human Neurodegenerative Diseases: Pathogenetic and Therapeutic Implications

Journal: Current Protein & Peptide Science
Volume: 10,Issue: 5
Page: 476-482
Authors: Alison L. McCormack and Donato A. Di Monte

The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 5
Page: 293-302
Authors: S. M. Allan and E. Pinteaux

Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 3
Page: 391-403
Authors: Kathryn A. Frankola, Nigel H. Greig, Weiming Luo and David Tweedie

Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection

Journal: Current Neurovascular Research
Volume: 6,Issue: 1
Page: 70-81
Authors: Merce Pallas, Gemma Casadesus, Mark A. Smith, Ana Coto-Montes, Carme Pelegri, Jordi Vilaplana and Antoni Camins

Use of STAT1 Inhibitors in the Treatment of Brain I/R Injury and Neurodegenerative Diseases

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11,Issue: 1
Page: 2-7
Authors: F. H. Ebner, E. Darra, S. Mariotto, H. Suzuki and E. Cavalieri

Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases

Journal: Current Drug Targets
Volume: 14,Issue: 1
Page: 47-55
Authors: Andonis Karachitos, Julian Solis Garcia del Pozo, Piet W.J. de Groot, Hanna Kmita and Joaquin Jordan

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease

Journal: Current Alzheimer Research
Volume: 2,Issue: 3
Page: 355-365
Authors: Andis Klegeris and Patrick L. McGeer

Direct Production of Reactive Oxygen Species from Aggregating Proteins and Peptides Implicated in the Pathogenesis of Neurodegenerative Diseases

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3,Issue: 4
Page: 299-308
Authors: Brian J. Tabner, Stuart Turnbull, Omar M.A. El-Agnaf and David Allsop

Recent Patents and Advances in Regenerative Medicine and Stem Cell Therapies for Diabetes, Cardiovascular and Neurodegenerative Diseases

Journal: Recent Patents on Regenerative Medicine
Volume: 5,Issue: 1
Page: 36-54
Authors: Mohamed I. Saad, Maher A. Kamel, Taha M. Abdelkhalek, Moustafa M. Saleh and Shady H. Tawfik

Fermented Grape Marc (FGM): Immunomodulating Properties and its Potential Exploitation in the Treatment of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 43-50
Authors: G. Marzulli, T. Magrone, K. Kawaguchi, Y. Kumazawa and E. Jirillo

Fluparoxan: A Comprehensive Review of its Discovery, Adrenergic and CNS Activity and Treatment of Cognitive Dysfunction in Central Neurodegenerative Diseases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17,Issue: 7
Page: 572-582
Authors: Alan D. Borthwick*

Proteomic Approaches Contributing to the Understanding of Neurodegenerative Diseases: Focus on Alzheimers Disease

Journal: Current Proteomics
Volume: 1,Issue: 3
Page: 221-229
Authors: Ephrem Engidawork and Gert Lubec

Calpains as a Target for Therapy of Neurodegenerative Diseases: Putative Role of Lithium

Journal: Current Drug Metabolism
Volume: 10,Issue: 5
Page: 433-447
Authors: Antoni Camins, Natalia Crespo-Biel, Felix Junyent, Ester Verdaguer, Anna M. Canudas and Merce Pallas

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases

Journal: Current Neuropharmacology
Volume: 16,Issue: 1
Page: 97-116
Authors: Botond Penke*, Livia Fulop , Maria Szucs and Ede Frecska

A Heterogeneous Networks Fusion Algorithm Based on Local Topological Information for Neurodegenerative Disease

Journal: Current Bioinformatics
Volume: 12,Issue: 5
Page: 387-397
Authors: Xue Jiang, Han Zhang*, Xiongwen Quan and Yanbin Yin

Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 7
Page: 849-862
Authors: V. Foti Cuzzola, R. Ciurleo, S. Giacoppo, S. Marino and P. Bramanti

Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options

Journal: Current Neuropharmacology
Volume: 7,Issue: 1
Page: 65-74
Authors: Bayani Uttara, Ajay V. Singh, Paolo Zamboni and R. T. Mahajan

Consequences of the ?-Ketoglutarate Dehydrogenase Inhibition for Neuronal Metabolism and Survival: Implications for Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 5895-5906
Authors: L. K. Trofimova, W. L. Araujo, A. A. Strokina, A. R. Fernie, L. Bettendorff and V. I. Bunik

Effect of Electromagnetic Radiations on Neurodegenerative Diseases- Technological Revolution as a Curse in Disguise

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 8
Page: 1406-1412
Authors: Gulam M. Hasan, Ishfaq A. Sheikh, Sajjad Karim, Absarul Haque, Mohammad A. Kamal, Adeel G. Chaudhary, Essam Azhar and Zeenat Mirza

Cerebrospinal Fluid Proteomes: From Neural Development to Neurodegenerative Diseases

Journal: Current Proteomics
Volume: 4,Issue: 2
Page: 89-106
Authors: Carolina Parada, Maryam Parvas and David Bueno

Medicinal Plants in Neurodegenerative Diseases: Perspective of Traditional Persian Medicine

Journal: Current Drug Metabolism
Volume: 19,Issue: 5
Page: 429-442
Authors: Mohammad Hosein Farzaei, Zahra Shahpiri, Mohammad Reza Mehri, Roodabeh Bahramsoltani, Mahdi Rezaei, Azade Raeesdana and Roja Rahimi*

Nanoparticles, Neurotoxicity and Neurodegenerative Diseases

Journal: Current Drug Metabolism
Volume: 16,Issue: 8
Page: 676-684
Authors: Gohar Mushtaq, Jalaluddin A. Khan, Ebenezer Joseph and Mohammad A. Kamal

Curcuminoids in Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 7,Issue: 3
Page: 184-204
Authors: Darrick S.H.L. Kim, Jin Y. Kim and Yesun Han

Chelating Agents for Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 1
Page: 2760-2772
Authors: R. J. Ward, D. T. Dexter and R. R. Crichton

Growth and Trophic Factors, pH and the Na+/H+ Exchanger in Alzheimers Disease, Other Neurodegenerative Diseases and Cancer: New Therapeutic Possibilities and Potential Dangers

Journal: Current Alzheimer Research
Volume: 4,Issue: 1
Page: 53-65
Authors: Salvador Harguindey, Stephan J. Reshkin, Gorka Orive, Jose Luis Arranz and Eduardo Anitua

Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 439-454
Authors: J.C. Fernandez-Checa, A. Fernandez, A. Morales, M. Mari, C. Garcia-Ruiz and A. Colell

Quinoline Fluorescent Probes for Zinc from Diagnostic to Therapeutic Molecules in Treating Neurodegenerative Diseases

Journal: Medicinal Chemistry
Volume: 14,Issue: 1
Page: 19-33
Authors: Barbara Czaplinska, Ewelina Spaczynska and Robert Musiol*

Role of Artificial Intelligence Techniques (Automatic Classifiers) in Molecular Imaging Modalities in Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 14,Issue: 2
Page: 198-207
Authors: Silvia Cascianelli, Michele Scialpi, Serena Amici, Nevio Forini, Matteo Minestrini, Mario Luca Fravolini, Helmut Sinzinger, Orazio Schillaci and Barbara Palumbo

Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview

Journal: Current Alzheimer Research
Volume: 14,Issue: 1
Page: 1190-1197
Authors: Khurshid Ahmad, Mohammad Hassan Baig*, Gohar Mushtaq, Mohammad Amjad Kamal, Nigel H. Greig and Inho Choi*

Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 3
Page: 4568-4587
Authors: L. Pisani, M. Catto, F. Leonetti, O. Nicolotti, A. Stefanachi, F. Campagna and A. Carotti

Targeting Stress Activated Protein Kinases, JNK and p38, as New Therapeutic Approach for Neurodegenerative Diseases

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6,Issue: 2
Page: 109-117
Authors: Caterina Bendotti, Massimo Tortarolo and Tiziana Borsello

Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 8
Page: 858-866
Authors: Xifei Yang, Yanling Zhang, Hua Xu, Xiaobin Luo, Jun Yu, Jianjun Liu and Raymond Chuen-Chung

Diagnosis of Neurodegenerative Diseases: The Clinical Approach

Journal: Current Alzheimer Research
Volume: 13,Issue: 5
Page: 469-474
Authors: Manuel Gómez-Río, Manuel Moreno Caballero, Juan Manuel Górriz Sáez and Adolfo Mínguez-Castellanos

Sirtuins as Possible Targets in Neurodegenerative Diseases

Journal: Current Drug Targets
Volume: 14,Issue: 6
Page: 644-647
Authors: Gizem Donmez

Peptidyl Arginine Deiminases and Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 2
Page: 104-114
Authors: R. Tu, H.M. Grover and L.P. Kotra

The Unbiased Search of Biomarkers in Neurodegenerative Diseases

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 5
Page: 471-479
Authors: Pascual Ferrara

Nitric Oxide Homeostasis in Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 13,Issue: 2
Page: 135-149
Authors: Luciana Hannibal

Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 3,Issue: 4
Page: 267-267
Authors: Mark A. Smith, K. S. Jagannathan Rao and George Perry

Catalpol: A Potential Therapeutic for Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 1
Page: 1278-1291
Authors: B. Jiang, R.F. Shen, J. Bi, X.S. Tian, T Hinchliffe and Y. Xia

Recombinant Antibody Fragments for Neurodegenerative Diseases

Journal: Current Neuropharmacology
Volume: 15,Issue: 5
Page: 779-788
Authors: Karen Manoutcharian, Roxanna Perez-Garmendia and Goar Gevorkian*

Drug Screening for Huntingtons Disease and other Neurodegenerative Disorders

Journal: Current Molecular Pharmacology
Volume: 3,Issue: 3
Page: 164-173
Authors: Hemant Varma

Production of Reactive Oxygen Species from Aggregating Proteins Implicated in Alzheimers Disease, Parkinsons Disease and Other Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 1,Issue: 6
Page: 507-517
Authors: Brian J. Tabner, Stuart Turnbull, Omar M.A. El-Agnaf and David Allsop

Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 5
Page: 776-783
Authors:

Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 8
Page: 945-964
Authors: Javier Caballero-Villarraso, Alberto Galvan, Begona Maria Escribano and Isaac Tunez*

QSAR and Pharmacophore Study of Dyrk1A Inhibitory Meridianin Analogs as Potential Agents for Treatment of Neurodegenerative Diseases

Journal: Medicinal Chemistry
Volume: 9,Issue: 1
Page: 152-161
Authors: Sandip B. Bharate, Rammohan R. Yadav and Ram A. Vishwakarma

Expression and Functions of LRP-2 in Central Nervous System: Progress in Understanding its Regulation and the Potential Use for Treatment of Neurodegenerative Diseases

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 10,Issue: 4
Page: 249-254
Authors: Carlos Spuch and Carmen Navarro

A Commentary on Neuronal Degeneration and Cell Death in Guam ALS and PD: An Evolutionary Process of Understanding

Journal: Current Alzheimer Research
Volume: 3,Issue: 4
Page: 397-401
Authors: Ralph M. Garruto

Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 1229-1241
Authors: M. Reale, N. H. Greig and M. A. Kamal

Advances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles

Journal: Recent Patents on Drug Delivery & Formulation
Volume: 6,Issue: 1
Page: 2-18
Authors: Carlos Spuch, Ortolano Saida and Carmen Navarro

Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 3
Page: 6699-6700
Authors: Antoni Camins

Microglia-Targeted Pharmacotherapy in Retinal Neurodegenerative Diseases

Journal: Current Drug Targets
Volume: 5,Issue: 7
Page: 619-627
Authors: Erik Schuetz and Solon Thanos

Promises of Nanotechnology for Drug Delivery to Brain in Neurodegenerative Diseases

Journal: Current Nanoscience
Volume: 5,Issue: 1
Page: 15-25
Authors: Sara Baratchi, Rupinder Kaur Kanwar, Khashayar Khoshmanesh, Punj Vasu, Chauhan Ashok, Matta Hittu, Andrew Parratt, Subramanian Krishnakumar, Xueying Sun, Sanjeeb K. Sahoo and Jagat Rakesh Kanwar

NOX Inhibitors as a Therapeutic Strategy for Stroke and Neurodegenerative Disease

Journal: Current Drug Targets
Volume: 13,Issue: 2
Page: 199-206
Authors: Belinda Cairns, Jong Youl Kim, Xian Nan Tang and Midori A. Yenari

Adult Neurogenesis in the Olfactory System and Neurodegenerative Disease

Journal: Current Molecular Medicine
Volume: 12,Issue: 1
Page: 1253-1260
Authors: B.W. Gallarda and P.-M. Lledo

Targeting CNS Transporters for Treatment of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 1
Page: 1523-1533
Authors: Gabriele Jedlitschky, Markus Grube, Igor Mosyagin, Heyo K. Kroemer and Silke Vogelgesang

Editorial: [Hot Topic: Therapeutic Antioxidants for Neurodegenerative Disease]

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 7,Issue: 3
Page: 183-183
Authors: Daniel A. Linseman

Infectious Agents and Neurodegenerative Diseases: Exploring the Links

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 1
Page: 1390-1399
Authors: Mohammad Zubair Alam, Qamre Alam, Mohammad Amjad Kamal, Asif Ahmad Jiman-Fatani, Esam I. Azhar, Mohammad Azhar Khan and Absarul Haque

Protective Effects of the Caffeine Against Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 0
Page: 1-13
Authors: Ester Tellone*, Antonio Galtieri, Annamaria Russo and Silvana Ficarra

Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 8,Issue: 3
Page: 235-242
Authors: Martina Iannaccone, Federica Titta, Enrica Serretiello, Giulia De Vivo, Antonio Martin and Vittorio Gentile

Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases

Journal: Current Stem Cell Research & Therapy
Volume: 9,Issue: 6
Page: 513-521
Authors: Tanmay Tanna and Vatsal Sachan

Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 1
Page: 120-127
Authors: Sarah Burgess and Valentina Echeverria

In Vivo DNA Electrotransfer for Immunotherapy of Cancer and Neurodegenerative Diseases

Journal: Current Drug Metabolism
Volume: 14,Issue: 3
Page: 279-290
Authors: Daniela Fioretti, Sandra Iurescia, Vito Michele Fazio and Monica Rinaldi

ADF/Cofilin-Actin Rods in Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 7,Issue: 3
Page: 241-250
Authors: J.R. Bamburg, B.W. Bernstein, R.C Davis, K.C. Flynn, C. Goldsbury, J.R. Jensen, M.T. Maloney, I.T. Marsden, L.S. Minamide, C.W. Pak, A.E. Shaw, I. Whiteman and O. Wiggan

Bis(thiosemicarbazone) Metal Complexes as Therapeutics for Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 3058-3068
Authors: S. Mckenzie-Nickson, A. I. Bush and K. J. Barnham

The Ins and Outs of Nanoparticle Technology in Neurodegenerative Diseases and Cancer

Journal: Current Drug Metabolism
Volume: 16,Issue: 8
Page: 609-632
Authors: Cornelia M. Wilson, Amandine Magnaudeix, Thomas Naves, François Vincent, Fabrice Lalloue and Marie-Odile Jauberteau

Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 7
Page: 1294-1303
Authors: Ada M. Tata, Lucia Velluto, Chiara D'Angelo and Marcella Reale

Recent Patents on Drugs Addressing Neurodegenerative Diseases

Journal: Recent Patents on Biomarkers
Volume: 3,Issue: 1
Page: 25-35
Authors: Manuel Van Gijsel-Bonnello, Michel Khrestchatisky, Max de Reggi and Bouchra Gharib

AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives

Journal: Current Drug Targets
Volume: 17,Issue: 8
Page: 890-907
Authors: Claudia Marinangeli, Sébastien Didier and Valérie Vingtdeux

Editorial (Hot Topic: Therapeutic Targets in Neurodegenerative Diseases)

Journal: Current Enzyme Inhibition
Volume: 9,Issue: 1
Page: 1-2
Authors: Jungsu Kim and Jason L. Eriksen

Roles and Therapeutic Potential of Metallothioneins in Neurodegenerative Diseases

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 4
Page: 408-413
Authors: Isao Hozumi

Neurodegeneration in Niemann-Pick Type C Disease and Huntingtons Disease: Impact of Defects in Membrane Trafficking

Journal: Current Drug Targets
Volume: 10,Issue: 7
Page: 653-665
Authors: J. K. Schweitzer, J. P. Krivda and C. D'Souza-Schorey

Removing Protein Aggregates: The Role of Proteolysis in Neurodegeneration

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 1
Page: 2459-2476
Authors: D. A.T. Nijholt, L. De Kimpe, H. L. Elfrink, J. J.M. Hoozemans and W. Scheper

Natural Products Based Ayurvedic Formulations: Chemical Cons tituents and Treatment in Neurodegenerative Disorders?

Journal: Mini-Reviews in Organic Chemistry
Volume: 14,Issue: 4
Page: 280-287
Authors: Ammu Muraleedharan, Gaurav Joshi and Raj Kumar*

High Dose Immunoglobulin (IVIG) May Reduce the Incidence of Langerhans Cell Histiocytosis (LCH)-Associated Central Nervous System Involvement

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 5
Page: 380-386
Authors: Shinsaku Imashuku

Role of Physical Exercise as Complementary Treatment for Epilepsy and other Brain Disorders

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 3
Page: 6720-6725
Authors: Ricardo Mario Arida, Fulvio Alexandre Scorza and Esper Abrão Cavalheiro

Transglutaminases - Possible Drug Targets in Human Diseases

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3,Issue: 2
Page: 99-104
Authors: Vittorio Gentile and Arthur J.L. Cooper

Nuclear Imaging of Inflammation in Neurologic and Psychiatric Disorders

Journal: Current Clinical Pharmacology
Volume: 1,Issue: 3
Page: 229-242
Authors: Erik F.J. de Vries, Rudi A. Dierckx and Hans C. Klein

Gender, Hormones and the Transmissible Encephalopathies

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3,Issue: 2
Page: 161-169
Authors: O. O. Abiola and S. A. Whatley

Targeting Mitochondria in Fighting Cancer

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 4034-4046
Authors: Vladimir Gogvadze



Journal: Current Stem Cell Research & Therapy
Volume: 3,Issue: 2
Page: 88-98
Authors: Philip Hitchins Schwartz and David Joseph Brick

Stressing Out the ER: A Role of the Unfolded Protein Response in Prion-Related Disorders

Journal: Current Molecular Medicine
Volume: 6,Issue: 1
Page: 37-43
Authors: Claudio A. Hetz and Claudio Soto

Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties

Journal: Current Alzheimer Research
Volume: 4,Issue: 5
Page: 522-536
Authors: Cornelis J. Van der Schyf, Silvia Mandel, Werner J. Geldenhuys, Tamar Amit, Yael Avramovich, Hailin Zheng, Mati Fridkin, Shunit Gal, Orly Weinreb, Orit Bar Am, Yotam Sagi and Moussa B.H. Youdim

Environment, Physical Activity, and Neurogenesis: Implications for Prevention and Treatment of Alzhemiers Disease

Journal: Current Alzheimer Research
Volume: 3,Issue: 1
Page: 49-54
Authors: Teresita L. Briones

Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases

Journal: Current Drug Targets
Volume: 13,Issue: 2
Page: 272-284
Authors: Rong-Rong Tao, Yue-Long Ji, Ying-Mei Lu, Kohji Fukunaga and Feng Han

Therapeutic Potential in Alzheimer Disease

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 1
Page: 1605-1610
Authors: A. D. Cash, G. Perry and M. A. Smith

Neuroprotective Effects of Quercetin: From Chemistry to Medicine

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 8
Page: 964-975
Authors: Davide Barreca, Ersilia Bellocco, Grazia D'Onofrio, Seyed Fazel Nabavi, Maria Daglia, Luca Rastrelli and Seyed Mohammad Nabavi

NADPH Oxidase and Neurodegeneration

Journal: Current Neuropharmacology
Volume: 10,Issue: 4
Page: 321-327
Authors: Marina S. Hernandes and Luiz R. G. Britto

Oxidative Stress Mechanisms and Potential Therapeutic Modalities in Alzheimer Disease

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1,Issue: 1
Page: 19-23
Authors: Adam D. Cash, Mark A. Smith and George Perry

Natural Product Inhibitors of Hsp90: Potential Leads for Drug Discovery

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 140-152
Authors: M. W. Amolins and B. S.J. Blagg

DNA Repair in Premature Aging Disorders and Neurodegeneration

Journal: Current Aging Science
Volume: 3,Issue: 1
Page: 3-19
Authors: Fabio Coppede and Lucia Migliore

Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimers Disease, Parkinsons Disease, and Amyotrophic Lateral Sclerosis

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 2
Page: 95-107
Authors: Vincenzo Di Matteo and Ennio Esposito

A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models

Journal: Current Alzheimer Research
Volume: 3,Issue: 5
Page: 505-513
Authors: Ina Tesseur and Tony Wyss-Coray

Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed β-Sheet Hypothesis

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 3
Page: 3267-3279
Authors: Yoshitaka Nagai and H. Akiko Popiel

Ubiquitin-Proteasome Pathway Components as Therapeutic Targets for CNS Maladies

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 2
Page: 3807-3828
Authors: S. C. Upadhya and A. N. Hegde

Use of Human Umbilical Cord Blood (HUCB) Cells to Repair the Damaged Brain

Journal: Current Neurovascular Research
Volume: 1,Issue: 3
Page: 269-281
Authors: Mary B. Newman, Dwaine F. Emerich, Cesario V. Borlongan, Cyndy Davis Sanberg and Paul R. Sanberg

Inhibition of Ataxia Telangiectasia-p53-E2F-1 Pathway in Neurons as a Target for the Prevention of Neuronal Apoptosis

Journal: Current Drug Metabolism
Volume: 8,Issue: 7
Page: 709-715
Authors: Antoni Camins, Ester Verdaguer, Jaume Folch, Carlos Beas-Zarate, Anna Maria Canudas and Merce Pallas

Current limitations in the treatment Parkinson s and Alzheimer s diseases: state-of-the-art and future perspective of polymeric carriers.

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 0
Page: 1-16
Authors: Chiara Tonda-Turo, Nicola Origlia, Clara Mattu, Alice Accorroni and Valeria Chiono*

Reserve Mechanisms in Neurodegenerative Diseases: From Bench to Bedside and Back Again

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 6112-6118
Authors: B. Borroni, E. Premi, M. Bozzali and A. Padovani

Inhibiting Caspase-6 Activation and Catalytic Activity for Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 14,Issue: 3
Page: 319-325
Authors: John A. Flygare and Michelle R. Arkin

Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 5
Page: 429-442
Authors: Antonio Cuadrado and Ana I. Rojo

Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 9,Issue: 2
Page: 101-109
Authors: Federica Titta, Martina Iannaccone, Antonio Martin and Vittorio Gentile

Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease

Journal: Current Alzheimer Research
Volume: 13,Issue: 6
Page: 654-662
Authors: Carlo Wilke, Frank Gillardon, Christian Deuschle, Evelyn Dubois, Markus A. Hobert, Jennifer Müller vom Hagen, Stefanie Krüger, Saskia Biskup, Cornelis Blauwendraat, Michael Hruscha, Stephan A. Kaeser, Peter Heutink, Walter Maetzler and Matthis Synofzik

Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 1517-1531
Authors: Agnieszka Jazwa and Antonio Cuadrado

Rationally Designed Multi-Targeted Agents Against Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 1
Page: 1662-1672
Authors: W. J. Geldenhuys and C. J. Van der Schyf

Inflammation in Parkinsons Diseases and Other Neurodegenerative Diseases: Cause and Therapeutic Implications

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 1
Page: 1925-1928
Authors: H. Wilms, L. Zecca, P. Rosenstiel, J. Sievers, G. Deuschl and R. Lucius


DNA Double Strand Breaks: A Common Theme in Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 13,Issue: 1
Page: 1208-1218
Authors: Daniela Merlo, Cristiana Mollinari, Mauro Racaniello, Enrico Garaci and Alessio Cardinale

NAD Metabolism and Functions: A Common Therapeutic Target for Neoplastic, Metabolic and Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 2918-2929
Authors: Giuseppina Di Stefano, Marcella Manerba and Marina Vettraino

Editorial (Hot Topic: Model System Caenorhabditis elegans and Neurodegenerative Disease Research)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 8
Page: 955-956
Authors: Aamir Nazir

A Short Review of Diffusion Models and their Possibilities to Enhance Imaging Biomarkers for Neurodegenerative Diseases

Journal: Current Medical Imaging Reviews
Volume: 10,Issue: 4
Page: 281-289
Authors: Farhad Nadi, Mandava Rajeswari and Mohammad Fermi Pasha

A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 6
Page: 726-740
Authors: Deepak Kumar Kaushik and Anirban Basu

L-Type Voltage-Dependent Calcium Channels As Therapeutic Targets for Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 2
Page: 4816-4827
Authors: T. Yagami, H. Kohma and Y. Yamamoto

Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 2
Page: 2830-2838
Authors: Irene Paterniti, Emanuela Esposito and Salvatore Cuzzocrea

Liver Growth Factor as a Tissue Regenerating Factor in Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 9,Issue: 3
Page: 173-180
Authors: Rafael Gonzalo-Gobernado, Lucia Calatrava-Ferreras, Juan Perucho, Diana Reimers, MarIa J. Casarejos, Antonio S. Herranz, Adriano Jimenez-Escrig, Juan J. Diaz-Gil and Eulalia Bazan

Phosphodiesterase: An Interface Connecting Cognitive Deficits to Neuropsychiatric and Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 3
Page: 303-316
Authors: Zhen-Zhen Wang, Yi Zhang, Han-Ting Zhang and Yun-Feng Li

Age-Related Sleep Changes and its Implication in Neurodegenerative Diseases

Journal: Current Aging Science
Volume: 9,Issue: 1
Page: 26-33
Authors: Elena A. Lyashenko, Michael G. Poluektov, Oleg S. Levin and Polina V. Pchelina

Scope of Lipid Nanoparticles in Neuroscience: Impact on the Treatment of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 2
Page: 3120-3133
Authors: Segura-Uribe Julia J, Ciprés-Flores Fabiola Jimena, Farfán-García Eunice Dalet, Trujillo-Ferrara José Guadalupe and Soriano-Ursúa Marvin Antonio*

Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 5
Page: 667-668
Authors: Ana Raquel Esteves

Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases

Journal: Current Protein & Peptide Science
Volume: 18,Issue: 0
Page: 1-18
Authors: Munazza Tamkeen Fatima*, Zeyaul Islam, Ejaj Ahmad and Parveen Salahuddin

Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species

Journal: Current Neuropharmacology
Volume: 10,Issue: 4
Page: 289-302
Authors: Peter Kovacic and Ratnasamy Somanathan

Phosphorylation-Dephosphorylation Imbalance of Cytoskeletal Associated Proteins in Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1,Issue: 2
Page: 219-230
Authors: Gloria Benitez-King, Leonardo Ortiz-Lopez, Sandra Morales-Mulia, Graciela Jimenez-Rubio, Gerardo Ramirez-Rodriguez and Isaura Meza

Brain Slices as Models for Neurodegenerative Disease and Screening Platforms to Identify Novel Therapeutics

Journal: Current Neuropharmacology
Volume: 5,Issue: 1
Page: 19-33
Authors: Seongeun Cho, Andrew Wood and Mark R. Bowlby

The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases

Journal: Current Neuropharmacology
Volume: 11,Issue: 3
Page: 276-297
Authors: Mauro Cataldi

Editorial (Thematic Selection: Strategies of Current Drugs and Alternative Treatments for Neurodegenerative Diseases)

Journal: Current Neuropharmacology
Volume: 14,Issue: 4
Page: 301-301
Authors: Xiao-Ping Wang and Hong-Zhuan Chen

Development of Calorie Restriction Mimetics as Therapeutics for Obesity, Diabetes, Inflammatory and Neurodegenerative Diseases

Journal: Current Genomics
Volume: 11,Issue: 8
Page: 562-567
Authors: Takuya Chiba, Tomoshi Tsuchiya, Toshimitsu Komatsu, Ryoichi Mori, Hiroko Hayashi and Isao Shimokawa

Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases

Journal: Current Protein & Peptide Science
Volume: 18,Issue: 7
Page: 746-757
Authors: Hui-Gwan Goo, Hyangshuk Rhim and Seongman Kang*

Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application

Journal: Current Molecular Pharmacology
Volume: 10,Issue: 2
Page: 115-140
Authors: Xiaodan Jiao, Niloufar Ashtari, Maryam Rahimi-Balaei, Qi Min Chen, Ilnaz Badbezanchi, Shahla Shojaei, Adel Marzban, Nima Mirzaei, Seunghyuk Chung, Teng Guan, Jiasi Li, Jerry Vriend, Shahram Ejtemaei Mehr, Jiming Kong and Hassan Marzban*

Editorial [Hot Topic: Neurodegenerative Diseases (Guest Editor: Santosh R. DMello)]

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 1
Page: i-i
Authors: Santosh R. D'Mello

The Neuroprotective Role of Vesicular Monoamine Transporter 2 in Neurodegenerative Diseases

Journal: Medicinal Chemistry
Volume: 11,Issue: 2
Page: 104-108
Authors: Burak Yulug, Lutfu Hanoglu and Ertugrul Kilic

Can Environmentally Relevant Levels of Aluminium Promote the Onset and Progression of Neurodegenerative Diseases?

Journal: Current Inorganic Chemistry
Volume: 2,Issue: 1
Page: 40-45
Authors: Stephen C. Bondy

The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 7,Issue: 3
Page: 218-229
Authors: Gururaj Joshi and Jeffrey A. Johnson

The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis

Journal: Current Alzheimer Research
Volume: 13,Issue: 1
Page: 1219-1231
Authors: Paola Riva, Antonia Ratti and Marco Venturin

Editorial (Thematic Issue: Peptides as a Novel Therapeutic Approach for Neurodegenerative Diseases)

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 2
Page: 2573-2574
Authors: Zakir Khan

Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 5
Page: 615-626
Authors: Wiep Scheper and Jeroen J.M. Hoozemans

Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 13,Issue: 2
Page: 93-98
Authors: Mohammed Akbar, Musthafa M. Essa, Byoung-Joon Song and Mohammed A.S. Khan

Oxidative Stress and Neurodegenerative Diseases: Looking for a Therapeutic Solution Inspired on Benzopyran Chemistry

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 5
Page: 432-445
Authors: Alexandra Gaspar, Nuno Milhazes, Lourdes Santana, Eugenio Uriarte, Fernanda Borges and Maria Joao Matos

Cognitive Stimulation: The Evidence Base for its Application in Neurodegenerative Disease

Journal: Current Alzheimer Research
Volume: 11,Issue: 5
Page: 469-483
Authors: Matteo De Marco, Michael F. Shanks and Annalena Venneri

The Role of ?-Synuclein in Neurodegenerative Diseases: From Molecular Pathways in Disease to Therapeutic Approaches

Journal: Current Alzheimer Research
Volume: 10,Issue: 6
Page: 559-568
Authors: Karima M. Al-Mansoori, Mohamed Y. Hasan, Abdulmonem Al-Hayani and Omar M.A. El-Agnaf

Retromer's Role in Endosomal Trafficking and Impaired Function in Neurodegenerative Diseases

Journal: Current Protein & Peptide Science
Volume: 18,Issue: 7
Page: 687-701
Authors: Jordan Follett, Andrea Bugarcic, Brett M. Collins and Rohan D. Teasdale*

Lysosomal Potassium Channels: Potential Roles in Lysosomal Function and Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17,Issue: 0
Page: 1-6
Authors: Xinghua Feng*, Zhuangzhuang Zhao, Qian Li and Zhiyong Tan

Radiotracers for Amyloid Imaging in Neurodegenerative Disease: State-of-the-Art and Novel Concepts

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 0
Page: 1-9
Authors: Angelina Cistaro*, Pierpaolo Alongi, Federico Caobelli and Laura Cassalia

Induction of Molecular Chaperones as a Therapeutic Strategy for the Polyglutamine Diseases

Journal: Current Pharmaceutical Biotechnology
Volume: 11,Issue: 2
Page: 188-197
Authors: Yoshitaka Nagai, Nobuhiro Fujikake, H. Akiko Popiel and Keiji Wada

Microglial Activation and its Implications in the Brain Diseases

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 1
Page: 1189-1197
Authors: S. Thameem Dheen, Charanjit Kaur and Eng-Ang Ling

Novel Pharmacological Targets for Controlling Dendrite Branching and Growth During Neuronal Development

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 100-106
Authors: Jose R. Fernandez and Bonnie L. Firestein

Targeting Autophagy in the Brain: A Promising Approach?

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 158-168
Authors: R.X. Santos, S. Cardoso, S. Correia, C. Carvalho, M.S. Santos and P.I. Moreira

New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 5
Page: 731-752
Authors:

Medicinal Plants as Protective Strategies Against Parkinson's Disease

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 2
Page: 4180-4188
Authors: Natalia Areiza Mazo, Valentina Echeverria*, Ricardo Cabezas, Marco Avila-Rodriguez, Vadim V. Tarasov, Nagendra S. Yarla, Gjumrakch Aliev and George E. Barreto

Treatment of Insulin Resistance in the Neurodegeneration

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 9,Issue: 1
Page: 54-63
Authors: Manuela Stefanelli, Antonio Martocchia, Elisabetta Adele De Marinis, Giulia Maria Falaschi, Gloria Romano, Maddalena Rufo and Paolo Falaschi

Monoamino Oxidase A: An Interesting Pharmacological Target for the Development of Multi-Target QSAR

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 947-958
Authors: Enrique Molina, Eduardo Sobarzo-Sanchez, Alejandro Speck-Planche, Maria Joao Matos, Eugenio Uriarte, Lourdes Santana, Matilde Yanez and Francisco Orallo

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 2
Page: 5051-5064
Authors: Luis M. Valor, Jose Viosca, Jose P. Lopez-Atalaya and Angel Barco

Changes in Rat 50-kHz Ultrasonic Vocalizations During Dopamine Denervation and Aging: Relevance to Neurodegeneration

Journal: Current Neuropharmacology
Volume: 13,Issue: 2
Page: 211-219
Authors: Aaron M. Johnson, Laura M. Grant, Timothy Schallert and Michelle R. Ciucci

Histone Deacetylation and Motor Neuron Degeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 3
Page: 279-284
Authors: S. Schmalbach and S. Petri

Stem Cells: An Overview of the Current Status of Therapies for Central and Peripheral Nervous System Diseases

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 7
Page: 595-608
Authors: A. Orlacchio, G. Bernardi and S. Martino

Pituitary Adenylate Cyclase Activating Polypeptide in Animal Models of Neurodegenerative Disorders - Implications for Huntington and Parkinsons Diseases

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 4
Page: 311-315
Authors: D. Reglodi, A. Tamas and A. Somogyvari-Vigh

Coenzyme Q10 and Neurological Diseases: An Update

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 6
Page: 378-382
Authors: Michelangelo Mancuso, Anna Choub, Massimiliano Filosto, Lucia Petrozzi, Gianfranco Cafforio, Gabriele Siciliano and Luigi Murri

Memory-Enhancing Drugs: A Molecular Perspective

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9,Issue: 7
Page: 769-781
Authors: Barbara Monti and Antonio Contestabile

Dual Effects of Antioxidants in Neurodegeneration: Direct Neuroprotection against Oxidative Stress and Indirect Protection via Suppression of Gliamediated Inflammation

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 2
Page: 3521-3533
Authors: Jia-Yi Wang, Li- Li Wen, Ya-Ni Huang, Yen-Tsun Chen and Min-Chi Ku

New Therapeutic Strategy for Parkinsons and Alzheimers Disease

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 2
Page: 2764-2774
Authors: E. Esposito and S. Cuzzocrea

Emerging Role for ?B-Crystallin as a Therapeutic Agent: Pros and Cons

Journal: Current Molecular Medicine
Volume: 15,Issue: 1
Page: 47-61
Authors: V.S. Reddy and G.B. Reddy

Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 5,Issue: 2
Page: 101-109
Authors: Merce Pallas, Anna M. Canudas, Ester Verdaguer, Clemens Allgaier, Susana Garcia de Arriba, Daniel Alvira, Francesc X. Sureda and Antoni Camins

Effects of Resveratrol and Other Polyphenols on the Most Common Brain Age-Related Diseases

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 3
Page: 4245-4266
Authors: Fiorella Sarubbo, David Moranta, Victor J. Asensio, Antonio Miralles and Susana Esteban*

Cyclophilin D as a Drug Target

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1485-1506
Authors: Peter C. Waldmeier, Kaspar Zimmermann, Ting Qian, Marina Tintelnot-Blomley and John J. Lemasters

Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection

Journal: Current Molecular Pharmacology
Volume: 2,Issue: 1
Page: 95-109
Authors: Barbara Monti, Elisabetta Polazzi and Antonio Contestabile

Neuroprotective Effects of Estrogens: Cross-Talk Between Estrogen and Intracellular Insulin Signalling

Journal: Infectious Disorders - Drug Targets
Volume: 8,Issue: 1
Page: 65-67
Authors: Celestino Gonzalez, Fernando Diaz and Ana Alonso

Herbal Compounds with Special Reference to Gastrodin as Potential Therapeutic Agents for Microglia Mediated Neuroinflammation

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 0
Page: 1-17
Authors: Juan-Juan Li , Shun-Jin Liu , Xiao-Yu Liu and Eng-Ang Ling*



Journal: Medicinal Chemistry
Volume: 8,Issue: 1
Page: 102-111
Authors: Lukasz Ciesla

Regulation Of In Vitro Fibril Formation Of Synuclein Mutant Proteins By Hsp104p

Journal: Protein & Peptide Letters
Volume: 10,Issue: 5
Page: 491-495
Authors: Byungmoon Kong, Young Kee Chae and Kyunghee Lee

Prion Chemical Biology: On the Road to Therapeutics?

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 2441-2464
Authors: Beining Chen, Mark Thompson, Jennifer Louth and Kai Guo

Study of Protein Amyloid-Like Aggregates by Solid-State Circular Dichroism Spectroscopy

Journal: Current Protein & Peptide Science
Volume: 18,Issue: 1
Page: 100-103
Authors: Hong-Yu Hu, Lei-Lei Jiang and Jun-Ye Hong

Endocannabinoid Transporter Inhibitors

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 2,Issue: 2
Page: 129-141
Authors: Maria L. Lopez-Rodriguez, Alma Viso, Silvia Ortega-Gutierrez, Javier Fernandez-Ruiz and Jose A. Ramos

Electrochemical Biosensors for Superoxide Anion

Journal: Current Analytical Chemistry
Volume: 2,Issue: 1
Page: 51-58
Authors: Yang Tian, Lanqun Mao and Takeo Ohsaka

Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 2
Page: 171-180
Authors: Quan Liu, Fang Xie, Raj Rolston, Paula I. Moreira, Akihiko Nunomura, Xiongwei Zhu, Mark A. Smith and George Perry

Amyloids, Aggregates and Neuronal Inclusions: Good or Bad News for Neurons?

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3,Issue: 4
Page: 293-298
Authors: Hyoung-gon Lee, Xiongwei Zhu, Robert B. Petersen, George Perry and Mark A. Smith

The Multiple Pharmaceutical Potential of Curcumin in Parkinson's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 2
Page: 369-373
Authors: Hong-Fang Ji and Liang Shen

The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 95-109
Authors: Olivia Bibollet-Bahena, Qiao-Ling Cui and Guillermina Almazan

α-Synuclein Aggregation

Journal: Protein & Peptide Letters
Volume: 11,Issue: 3
Page: 271-279
Authors: Angela M. Bodles and G. Brent Irvine

Caspases: Structure-Guided Design of Drugs to Control Cell Death

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 1154-1162
Authors: Irene T. Weber, Bin Fang and Johnson Agniswamy

Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 6
Page: 727-740
Authors: Nahuai Badiola, Marc Suarez-Calvet and Alberto Lleo

Ceramide Involvement in Apoptosis and Apoptotic Diseases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6,Issue: 6
Page: 699-709
Authors: Karin Thevissen, Isabelle E.J.A. Francois, Joris Winderickx, Christophe Pannecouque and Bruno P.A. Cammue

Glaucoma Disease: A Survey

Journal: Current Medical Imaging Reviews
Volume: 11,Issue: 4
Page: 272-283
Authors: Saleha Masood, Muhammad Sharif, Mudassar Raza, Mussarat Yasmin, Muhammad Iqbal and Muhammad Y. Javed

Inhibitors of c-jun-N-Terminal Kinase (JNK)

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 8
Page: 755-766
Authors: Philip LoGrasso and Theodore Kamenecka

Metal Protein Attenuating Compounds (MPACs): An Emerging Approach for the Treatment of Neurodegenerative Disorders

Journal: Current Bioactive Compounds
Volume: 4,Issue: 2
Page: 57-67
Authors: Prashant S. Kharkar and Aloke K. Dutta

Damaged Proteins Bearing L-Isoaspartyl Residues and Aging: A Dynamic Equilibrium Between Generation of Isomerized Forms and Repair by PIMT

Journal: Current Aging Science
Volume: 4,Issue: 1
Page: 8-18
Authors: Richard R. Desrosiers and Irvens Fanelus

Induced Adaptive Resistance to Nitrooxidative Stress in the CNS: Therapeutic Implications

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 281-291
Authors: Amy Bishop, Renea Gooch and James Anderson

Establishment of Cell-Based Neuroglobin Promoter Reporter Assay for Neuroprotective Compounds Screening

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 5
Page: 629-639
Authors: Ning Liu, Zhanyang Yu, Xiumei Gao, Yun S. Song, Jing Yuan, Yu Xun, Tingting Wang, Feng Yan, Shishan Yuan, Jian Zhang, Shuanglin Xiang, Eng H. Lo and Xiaoying Wang

Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 5,Issue: 2
Page: 109-117
Authors: Christian Holscher

Are Circulating Monocytes as Microglia Orthologues Appropriate Biomarker Targets for Neuronal Diseases? (Supplementry Table)

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 4
Page: 307-330
Authors: Gerd Schmitz, Kerstin Leuthauser-Jaschinski and Evelyn Orso

Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 3418-3433
Authors: Sarika Srivastava and Marcia C. Haigis

Synergistic Effect of L-Carnosine and EGCG in the Prevention of Physiological Brain Aging

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 1
Page: 2722-2727
Authors: Sergio Davinelli, Roberto Di Marco, Renata Bracale, Alessandro Quattrone, Davide Zella and Giovanni Scapagnini

Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 2,Issue: 2
Page: 113-123
Authors: Laurent Lecanu and Vassilios Papadopoulos

Alzheimers Disease: Pathological Mechanisms and Recent Insights

Journal: Current Neuropharmacology
Volume: 9,Issue: 4
Page: 674-684
Authors: Dana M. Niedowicz, Peter T. Nelson and M. Paul Murphy

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 204-214
Authors: Tommy Seaborn, Olfa Masmoudi-Kouli, Alain Fournier, Hubert Vaudry and David Vaudry

Mixed Lineage Kinase Family, Potential Targets for Preventing Neurodegeneration

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 2,Issue: 2
Page: 143-155
Authors: Anna C. Maroney, Michael S. Saporito and Robert L. Hudkins

Emerging Methods for Structural Analysis of Protein Aggregation

Journal: Protein & Peptide Letters
Volume: 24,Issue: 4
Page: 331-339
Authors: Eshan Khan, Subodh K. Mishra and Amit Kumar

Neuroprotective Effects of Ellagitannins: A Brief Review

Journal: Current Drug Targets
Volume: 18,Issue: 1
Page: 1518-1528
Authors: Silvia Tejada, William N. Setzer, Maria Daglia, Seyed Fazel Nabavi, Antoni Sureda, Nady Braidy, Olga Gortzi and Seyed Mohammad Nabavi*

Translational Therapeutic Str ategies in Amyotrophic Lateral Sclerosis

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 2
Page: 141-150
Authors: Hoon Ryu and Robert J. Ferrante

Pharmacologic Strategies for Suppression of Lipid Peroxidation in Neurodegeneration

Journal: Current Neuropharmacology
Volume: 1,Issue: 2
Page: 125-134
Authors: K. S. Montine, D. Milatovic, M. Doherty, J. D. Morrow and T. J. Montine

Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 6
Page: 791-800
Authors: Mathuravani A. Thevandavakkam, Robert Schwarcz, Paul J. Muchowski and Flaviano Giorgini

The Role of Mitochondrial Function in Glutamate-Dependent Metabolism in Neuronal Cells

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 3865-3877
Authors: S. S. Smaili, R. P. Ureshino, L. Rodrigues, K. K. Rocha, J. T. Carvalho, K. T. Oseki, C. Bincoletto, G. S. Lopes and H. Hirata

Recent Advances on the Possible Neuroprotective Activities of Epstein- Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System

Journal: Current Neuropharmacology
Volume: 8,Issue: 3
Page: 268-275
Authors: Alicia Wynne, Rupinder K. Kanwar, Rajiv Khanna and Jagat R. Kanwar

The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 3
Page: 267-281
Authors: Freek L. van Muiswinkel and H. Bea Kuiperij

New Insight into 2-Methoxyestradiol- a Possible Physiological Link between Neurodegeneration and Cancer Cell Death

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 1
Page: 1513-1527
Authors: Magdalena Gorska, Alicja Kuban-Jankowska, Jaroslaw Slawek and Michal Wozniak

Disease-Specific iPS Cell Models in Neuroscience

Journal: Current Molecular Medicine
Volume: 13,Issue: 5
Page: 832-841
Authors: M. Peitz, J. Jungverdorben and O. Brustle

Dynamical Properties of Steric Zipper Polymorphs Formed by a IAPPDerived Peptide

Journal: Protein & Peptide Letters
Volume: 19,Issue: 8
Page: 846-851
Authors: Francesca Stanzione, Alfonso De Simone, Luciana Esposito and Luigi Vitagliano

Mechanisms of Neuroprotection by Polyphenols

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 5,Issue: 4
Page: 307-318
Authors: J. G. Frade, N. R. Ferreira, R. M. Barbosa and J. Laranjinha

Pharmacological Intervention at Ionotropic Glutamate Receptor Complexes

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 2
Page: 3583-3596
Authors: Rosa Planells-Cases, Juan Lerma and Antonio Ferrer-Montiel

Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 6
Page: 807-812
Authors: Daniele De Filippis, Mariateresa Cipriano, Giuseppe Esposito, Caterina Scuderi, Luca Steardo and Teresa Iuvone

Metabolic Dysfunction in Alzheimers Disease and Related Neurodegenerative Disorders

Journal: Current Alzheimer Research
Volume: 9,Issue: 1
Page: 5-17
Authors: Huan Cai, Wei-na Cong, Sunggoan Ji, Sarah Rothman, Stuart Maudsley and Bronwen Martin

The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 2
Page: 2456-2470
Authors: Marjelo Mines, Yun Ding and Guo-Huang Fan

Role of Nitric Oxide and Calpain Activation in Neuronal Death and Survival

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 4
Page: 319-324
Authors: I. M. Araujo and C. M. Carvalho

Ubiquitin Enzymes, Ubiquitin and Proteasome Activity in Blood Mononuclear Cells of MCI, Alzheimer and Parkinson Patients

Journal: Current Alzheimer Research
Volume: 7,Issue: 6
Page: 549-555
Authors: C. Ullrich, R. Mlekusch, A. Kuschnig, J. Marksteiner and C. Humpel

Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure- Activity Relationships of a Neuroprotective Peptide

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 3
Page: 4462-4480
Authors: S. Bourgault, D. Vaudry, A. Dejda, N. D. Doan, H. Vaudry and A. Fournier

Natural Polyphenols in the Treatment of Alzheimer s Disease

Journal: Current Drug Targets
Volume: 19,Issue: 8
Page: 927-937
Authors: Syed-Badrul Syarifah-Noratiqah, Isa Naina-Mohamed*, Mohamed S. Zulfarina and H.M.S Qodriyah

Identification of Potent Caspase-3 Inhibitors for Treatment of Multi- Neurodegenerative Diseases Using Pharmacophore Modeling and Docking Approaches

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 8
Page: 1346-1353
Authors: Khurshid Ahmad, Vishal M. Balaramnavar, Mohammad H. Baig, Ashwini K. Srivastava, Saif Khan and Mohammad A. Kamal

Adult Hippocampal Neurogenesis, Aging and Neurodegenerative Diseases: Possible Strategies to Prevent Cognitive Impairment

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 2175-2192
Authors: Carmen Vivar

Protein Folding and Misfolding, Endoplasmic Reticulum Stress in Neurodegenerative Diseases: in Trace of Novel Drug Targets

Journal: Current Protein & Peptide Science
Volume: 17,Issue: 2
Page: 169-182
Authors: Botond Penke, Ferenc Bogár and Lívia Fülöp

Cell Clocks and Neuronal Networks: Neuron Ticking and Synchronization in Aging and Aging-Related Neurodegenerative Disease

Journal: Current Alzheimer Research
Volume: 10,Issue: 6
Page: 597-608
Authors: Marta Bonaconsa, Valeria Colavito, Fabien Pifferi, Fabienne Aujard, Esther Schenker, Sophie Dix, Gigliola Grassi-Zucconi, Marina Bentivoglio and Giuseppe Bertini

Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 11,Issue: 1
Page: 20-36
Authors: Adriano Mollica, Azzurra Stefanucci, Roberto Costante and Francesco Pinnen

Reorganizing Metals: the Use of Chelating Compounds as Potential Therapies for Metal-Related Neurodegenerative Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 543-552
Authors: Alison C. Badrick and Christopher E. Jones

Tryptamine Induces Axonopathy and Mitochondriopathy Mimicking Neurodegenerative Diseases via Tryptophanyl-tRNA Deficiency

Journal: Current Alzheimer Research
Volume: 10,Issue: 9
Page: 987-1004
Authors: Elena L. Paley, George Perry and Olga Sokolova

Editorial [Hot Topic: Advances and Perspectives on Stem Cell Therapy for Human Neurodegenerative Diseases (Guest Editor: Liang-Wei Chen)]

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 4
Page: 417-418
Authors: Liang-Wei Chen

Hydrophobic Plant Antioxidants. Preparation of Nanoparticles and their Application for Prevention of Neurodegenerative Diseases. Review and Experimental Data

Journal: Current Topics in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 2520-2528
Authors: Vladimir Muronetz, Regina Asryants, Pavel Semenyuk, Elena Schmalhausen and Luciano Saso

Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 8,Issue: 2
Page: 161-168
Authors: Martina Iannaccone, Enrica Serretiello, Giulia De Vivo, Antonio Martin, Alessandro Stefanile, Federica Titta and Vittorio Gentile

Islet-Brain (IB)/JNK-Interacting Proteins (JIPs): Future Targets for the Treatment of Neurodegenerative Diseases?

Journal: Current Neurovascular Research
Volume: 1,Issue: 2
Page: 111-127
Authors: Nathalie Moulin and Christian Widmann

Neuronal High-Affinity Sodium-Dependent Glutamate Transporters (EAATs): Targets for the Development of Novel Therapeutics Against Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 8
Page: 599-625
Authors: Giuseppe Campiani, Caterina Fattorusso, Meri De Angelis, Bruno Catalanotti, Stefania Butini, Roberto Fattorusso, Isabella Fiorini, Vito Nacci and Ettore Novellino

Computational Chemistry Study of Natural Alkaloids and Homemade Databank to Predict Inhibitory Potential Against Key Enzymes in Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 2926-2934
Authors: Vitor Prates Lorenzo, Mateus Feitosa Alves, Luciana Scotti, Socrates Golzio dos Santos, Margareth de Fatima Formiga Melo Diniz and Marcus Tullius Scotti*

Glaucoma: Validated and Facile In Vivo Experimental Models of a Chronic Neurodegenerative Disease for Drug Development

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 5,Issue: 1
Page: 43-49
Authors: Marcelo Rudzinski and H. Uri Saragovi

The Journey From Metabolic Profiling to Biomarkers: The Potential of NMR Spectroscopy Based Metabolomics in Neurodegenerative Disease Research

Journal: Current Metabolomics
Volume: 1,Issue: 2
Page: 160-179
Authors: Philippine C. Geiszler, Dorothee P. Auer and Clare A. Daykin

Preface [Hot Topic: Amyloidogenic Proteins and Peptides Involved in Human Neurodegenerative Diseases (Guest Editor: Brian m. Austen)]

Journal: Protein & Peptide Letters
Volume: 11,Issue: 3
Page: i-i
Authors: Brian M. Austen

Partnerships Between Philanthropy, Government and Investors are Needed to Advance Drug Discovery for Neurodegenerative Diseases

Journal: Current Alzheimer Research
Volume: 3,Issue: 3
Page: 175-176
Authors: Lorenzo M Refolo and Howard M Fillit

Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 2239-2252
Authors: Luciana Scotti and Marcus Tullius Scotti

Patents Relating to the Application of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell and Whole Marrow Transplantation for Neurodegenerative Diseases: A Review

Journal: Recent Patents on Regenerative Medicine
Volume: 2,Issue: 2
Page: 125-136
Authors: Helen Nightingale, Claire M. Rice, Kevin Kemp, Derek Sheader, Jonathan Witherick, Neil J. Scolding and Alastair Wilkins

Editorial [Hot topic: Central and Peripheral Metabolic Changes in Neurodegenerative Diseases (Guest Editor: Ana Cristina Rego)]

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 1192-1192
Authors: Ana Cristina Rego

Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 8,Issue: 4
Page: 277-284
Authors: Shuei Sugama, Takato Takenouchi, Byung P. Cho, Tong H. Joh, Makoto Hashimoto and Hiroshi Kitani

The Neuroprotective Role of Repetitive Transcranial Magnetic Stimulation (rTMS) for Neurodegenerative Diseases: A Short Review on Experimental Studies

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 1
Page: 1269-1273
Authors: Burak Yulug, Lütfü Hanoglu, Ertugrul Kilic, Burcu Polat and Wolf Rüdiger Schabitz

Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimers Disease

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 6
Page: 699-704
Authors: P. Hajieva and C. Behl

Immunopathogenesis of Neurodegenerative Diseases: Current Therapeutic Models of Neuroprotection with Special Reference to Natural Products

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 34-42
Authors: T. Magrone, G. Marzulli and E. Jirillo

Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 9,Issue: 2
Page: 76-84
Authors: Martina Iannaccone, Federica Titta, Enrica Serretiello, Marco Monfregola and Vittorio Gentile

BDNF Serum Concentrations Show No Relationship with Diagnostic Group or Medication Status in Neurodegenerative Disease

Journal: Current Alzheimer Research
Volume: 9,Issue: 7
Page: 815-821
Authors: Josh D. Woolley, Eric V. Strobl, Wendy B. Shelly, Anna M. Karydas, R. N. Robin Ketelle, Owen M. Wolkowitz, Bruce L. Miller and Katherine P. Rankin

Editorial [Hot topic: New Therapeutic Strategies for Treatment of Neurodegenerative Diseases (Executive Editor: Aleksey G. Kazantsev)]

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 3
Page: 3917-3918
Authors: Aleksey G. Kazantsev

Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis ofCeliac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 1
Page: 1895-1902
Authors: A. Martin, G. Romito, I. Pepe, G. De Vivo, M. R. Merola, A. Limatola and V. Gentile

Transcriptomics Study of Neurodegenerative Disease: Emphasis on Synaptic Dysfunction Mechanism in Alzheimer's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 7
Page: 1202-1212
Authors: Sajjad Karim, Zeenat Mirza, Shakeel A. Ansari, Mahmood Rasool, Zafar Iqbal, Sayed S. Sohrab, Mohammad A. Kamal, Adel M. Abuzenadah and Mohammed H. Al-Qahtani

Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 3
Page: 244-256
Authors: Johannes M. van Noort, Marianna Bugiani and Sandra Amor*

Editorial (Thematic Issue: Current Advances in Biochemistry, Medicinal Chemistry and Drug Development Strategies for Age-Related Neurodegenerative Diseases)

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 2115-2115
Authors: Sandro Arguelles-Castilla

Commentary: Intravenous Immunoglobulin (IVIG) Therapy for Patients with Langerhans Cell Histiocytosis (LCH)-Related Neurodegenerative Diseases of the CNS

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 688-690
Authors: Shinsaku Imashuku

Editorial [Hot topic: Transgenic Animal Models of Neurodegenerative Diseases (Guest Editor: Stephen D. Skaper)]

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 384-385
Authors: Stephen D. Skaper

Editorial [Hot Topic: Innate Immune Responses in CNS Neurodegenerative Diseases (Guest Editors: Hans van Noort and Sandra Amor)]

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 1
Page: 2-3
Authors: Hans van Noort and Sandra Amor

HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy

Journal: Current Neurovascular Research
Volume: 5,Issue: 2
Page: 143-152
Authors: Zhiping Hu and Ting Li

Polymeric Systems as Nanodevices for siRNA Delivery

Journal: Current Gene Therapy
Volume: 13,Issue: 5
Page: 358-369
Authors: Marcio J. Tiera, Qin Shi, Hellen Franciane Gonçalves Barbosa and Julio C. Fernandes

Nicotinamide and its Pharmacological Properties for Clinical Therapy

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1,Issue: 1
Page: 43-52
Authors: J. Yang and J. D. Adams

Computational Studies on the Prion Protein

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 2419-2431
Authors: Giulia Rossetti, Salvatore Bongarzone and Paolo Carloni

Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways

Journal: Current Signal Transduction Therapy
Volume: 1,Issue: 2
Page: 133-146
Authors: Ulrich L.M. Eisel, Knut Biber and Paul G.M. Luiten

Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 7
Page: 933-936
Authors: Simonetta Clemente

Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 5
Page: 303-313
Authors: L. F. Alguacil and C. Perez-Garcia

Function and Chemotypes of Human Hsp70 Chaperones

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 2812-2828
Authors: Liza Shrestha and Jason C. Young

Oxidative Stress Induced Functional and Structural Modifications of High Molecular Mass Goat Brain Cystatin

Journal: Protein & Peptide Letters
Volume: 15,Issue: 1
Page: 20-26
Authors: Bilqees Bano and Sadia Sumbul

FKBP Ligands as Novel Therapeutics for Neurological Disorders

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 1,Issue: 4
Page: 377-397
Authors: C. Christner, T. Herdegen and G. Fischer



Journal: Current Alzheimer Research
Volume: 5,Issue: 4
Page: 396-405
Authors: Jens Pahnke, Olaf Wolkenhauer, Markus Krohn and Lary C. Walker

Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 1
Page: 1025-1035
Authors: Catalina Abad and James A. Waschek

Resveratrol: New Avenues for a Natural Compound in Neuroprotection

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 3
Page: 6726-6731
Authors: Mercè Pallàs, David Porquet, Alberto Vicente and Coral Sanfeliu

Cell-Penetrating Peptide Technology to Deliver Chaperones and Associated Factors in Diseases and Basic Research

Journal: Current Pharmaceutical Biotechnology
Volume: 11,Issue: 2
Page: 167-174
Authors: Gunnar P.H. Dietz

Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors

Journal: Current Drug Targets
Volume: 16,Issue: 1
Page: 1048-1056
Authors: Massimiliano Tognolini and Alessio Lodola

Purine-Scaffold Hsp90 Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 1436-1446
Authors: Tony Taldone and Gabriela Chiosis

Targeting Epigenetics in Nervous System Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 1
Page: 126-141
Authors: Ruihan Zhang, Junyan Lu, Xiangqian Kong, Lu Jin and Cheng Luo

Cognitive Impairment and Dementia in Patients with Parkinson Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 903-912
Authors: James B. Leverenz, Joseph F. Quinn, Cyrus Zabetian, Jing Zhang, Kathleen S. Montine and Thomas J. Montine

Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 1
Page: 11-19
Authors: Ammar Al-Chalabi and Vineeta B. Tripathi

Neuroprotection by Natural Polyphenols: Molecular Mechanisms

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 10,Issue: 4
Page: 269-277
Authors: Maria del Rosario Campos-Esparza and Monica Adriana Torres-Ramos

Davunetide: Peptide Therapeutic in Neurological Disorders

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 2
Page: 2591-2598
Authors: Iddo Magen and Illana Gozes

Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine

Journal: Current Drug Delivery
Volume: 4,Issue: 3
Page: 211-224
Authors: Rishi Paliwal, Shivani Rai, Bhuvaneshwar Vaidya, Sunil Mahor, Prem N. Gupta, Amit Rawat and S.P. Vyas

Probing Multidrug Resistance P-glycoprotein Transporter Activity with SPECT Radiopharmaceuticals

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1834-1845
Authors: David Piwnica-Worms and Vijay Sharma

The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 7
Page: 1060-1069
Authors: Jie Li, Yonghong Gao, Xiaomeng Ren, Yanda Li, Lijun Wu, Xinyu Yang, Jie Wang, Hongcai Shang, Xingjiang Xiong* and Yanwei Xing*

Major Developments in the Design of Inhibitors along the Kynurenine Pathway

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 2
Page: 2471-2495
Authors: Kelly R. Jacobs, Gloria Castellano-Gonzalez , Gilles J. Guillemin * and David B. Lovejoy *

Dopamine: Agonists and Neurodegenerative Disorders

Journal: Current Drug Targets
Volume: 18,Issue: 0
Page: 1-13
Authors: Saba Khanam and Yasir Hasan Siddique*

High Throughput Screening for Neurodegeneration and Complex Disease Phenotypes

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 11,Issue: 3
Page: 238-248
Authors: Hemant Varma, Donald C. Lo and Brent R. Stockwell

The APOE Genotype: Modification of Therapeutic Responses in Alzheimers Disease

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 1
Page: 114-120
Authors: Angela J. Hanson, Suzanne Craft and William A. Banks

Aβ Monomers, Oligomers and Fibrils: Structural Features

Journal: Current Bioactive Compounds
Volume: 7,Issue: 3
Page: 198-213
Authors: Cristina Airoldi, Erika Sironi, Barbara La Ferla, Francisco Cardona and Francesco Nicotra

TGF-β Pathway as a Potential Target in Neurodegeneration and Alzheimers

Journal: Current Alzheimer Research
Volume: 3,Issue: 3
Page: 191-195
Authors: Tony Wyss-Coray

Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 3
Page: 340-348
Authors: Anne Penttinen, Jofre Tenorio-Laranga, Anssi Siikanen, Markus Morawski, Steffen Roßner and J. Arturo Garcia-Horsman

Pharmacological Properties of Indazole Derivatives: Recent Developments

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 1
Page: 869-878
Authors: Hugo Cerecetto, Alejandra Gerpe, Mercedes Gonzalez, Vicente J. Aran and Carmen O. de Ocariz

New Perspective on the Dual Functions of Indirubins in Cancer Therapy and Neuroprotection

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 9
Page: 1213-1219
Authors: Ying Wang, Pui Man Hoi, Judy Yuet-Wa Chan and Simon M.-Y. Lee

Bio-Activities and Syntheses Developments of Triptolides

Journal: Mini-Reviews in Organic Chemistry
Volume: 9,Issue: 2
Page: 151-162
Authors: Shi-Wu Chen, Ni-Ni Zhou and Chong Li

Roles of p75NTR in Maintaining Brain Hemostasis and the Implications for p75NTR-targeted Therapies

Journal: Current Alzheimer Research
Volume: 14,Issue: 5
Page: 554-561
Authors: Changyue Gao, Lili Zhang, Dayu Sun, Jingcheng Li, Xiuqing Yao, Huadong Zhou and Yanjiang Wang

Medicinal Chemistry of Sirtuin Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 1
Page: 1936-1946
Authors: L. Chen

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis

Journal: Current Neuropharmacology
Volume: 14,Issue: 4
Page: 314-321
Authors: Haiyan Lu, Wei Dong Le, Ya-Ying Xie and Xiao-Ping Wang

Astrocyte-Neuron Interaction at Tripartite Synapses

Journal: Current Drug Targets
Volume: 14,Issue: 1
Page: 1220-1224
Authors: Alberto Pérez-Alvarez and Alfonso Araque

Immunological Approaches to Prevent Neuronal Apoptosis During Neuroinflammation

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 4,Issue: 4
Page: 367-381
Authors: F. J. Murphy, K. E. Keating, D. Sheehan and I. Hayes

Inhibition of Ceramide Metabolism Key Enzymes and its Implication in Cell Physiology and Pathology

Journal: Current Enzyme Inhibition
Volume: 7,Issue: 4
Page: 191-204
Authors: Antonio Gomez-Munoz, Alberto Ouro, Lide Arana, Io-Guane Rivera, Marta Ordonez, Patricia Gangoiti and Miguel Trueba

Sirtuin Modulators: Targets for Metabolic Diseases and Beyond

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 1533-1544
Authors: B. G. Szczepankiewicz and P. Y. Ng

Endogenous Regulation of Neural Stem Cells in the Adult Mammalian Brain

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 110-118
Authors: Valerie Coronas

Estrogen and Cytokines Production - The Possible Cause of Gender Differences in Neurological Diseases

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 8
Page: 1017-1030
Authors: A. Czlonkowska, A. Ciesielska, G. Gromadzka and I. Kurkowska-Jastrzebska

Drosophila melanogaster in the Study of Human Neurodegeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 504-523
Authors: Frank Hirth

The Endocannabinoid System and Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 2
Page: 2326-2336
Authors: David Baker and Gareth Pryce

Inhibition of Brain Phospholipase A2 by Antimalarial Drugs: Implications for Neuroprotection in Neurological Disorders

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 2,Issue: 5
Page: 379-392
Authors: Akhlaq A. Farooqui, Wei-Yi Ong, Mei-Lin Go and Lloyd A. Horrocks

The Potential Role of the Endocannabinoid System in the Control of Multiple Scleorsis

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4,Issue: 3
Page: 195-202
Authors: David Baker and Gareth Pryce

The Controversial Role of Adenosine A2A Receptor Antagonists as Neuro-protective Agents

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4,Issue: 1
Page: 35-45
Authors: Patrizia Popoli, David Blum, Annita Pintor, Maria Teresa Tebano, Claudio Frank, Marco Gianfriddo, Maria Rosaria Domenici, Serge N. Schiffmann and Felicita Pedata

Immune-Inflammatory Responses and Oxidative Stress in Alzheimers Disease: Therapeutic Implications

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 6
Page: 684-691
Authors: D. Di Bona, G. Scapagnini, G. Candore, L. Castiglia, G. Colonna-Romano, G. Duro, D. Nuzzo, F. Iemolo, D. Lio, M. Pellicano, V. Scafidi, C. Caruso and S. Vasto

Translational Multimodality Neuroimaging

Journal: Current Drug Targets
Volume: 18,Issue: 9
Page: 1039-1050
Authors: Sushil Sharma*

Chemical Biology: Past, Present and Future

Journal: Current Chemical Biology
Volume: 2,Issue: 3
Page: 278-311
Authors: Bhupinder Singh Sekhon

In Vivo and In Vitro Molecular Imaging Techniques to Clarify the Mechanism of Oxidative Stress Related to Brain Aging and Neuro-degenerative Diseases

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4,Issue: 1
Page: 61-69
Authors: Toru Sasaki

Discovery of Neurogenic, Alzheimers Disease Therapeutics

Journal: Current Alzheimer Research
Volume: 3,Issue: 1
Page: 55-62
Authors: Judith Kelleher-Andersson

Neuropathological Correlates of Cerebral Multimorbidity

Journal: Current Alzheimer Research
Volume: 10,Issue: 6
Page: 569-577
Authors: Johannes Attems and Kurt Jellinger

Small Molecule Trk Receptor Agonists and Other Neurotrophic Factor Mimetics

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 1
Page: 59-80
Authors: Scott J. Pollack and Sarah J. Harper

Cell Microencapsulation Implants into the Central Nervous System

Journal: Recent Patents on Nanomedicine
Volume: 1,Issue: 1
Page: 60-67
Authors: Carlos Spuch and Carmen Navarro

Dosage and Passage Dependent Neuroprotective Effects of Exosomes Derived from Rat Bone Marrow Mesenchymal Stem Cells: An In Vitro Analysis

Journal: Current Gene Therapy
Volume: 17,Issue: 5
Page: 379-390
Authors: Chaitra Venugopal, Christopher Shamir, Sivapriya Senthilkumar, Janitri Venkatachala Babu, Peedikayil Kurien Sonu, Kusum Jain Nishtha, Kiranmai S Rai, Shobha K and Anandh Dhanushkodi*

In the Rush for Green Gold: Can Green Tea Delay Age-Progressive Brain Neurodegeneration?

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 7,Issue: 3
Page: 205-217
Authors: Silvia A. Mandel and Moussa B.H. Youdim

Immunophilin Dysfunction and Neuropathology

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 3
Page: 5398-5407
Authors: H. J. Park, J. A. Rosado, P. C. Redondo and Y. S. Cho

Nanotheranostics in Evidence Based Personalized Medicine

Journal: Current Drug Targets
Volume: 15,Issue: 1
Page: 915-930
Authors: Sushil Sharma

Mitochondria Play a Central Role in Estrogen-Induced Neuroprotection

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 1
Page: 69-83
Authors: James W. Simpkins, Jian Wang, Xiaofei Wang, Evelyn Perez, Laszlo Prokai and James A. Dykens

Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimers Disease: The Role of the ER-MT Cross-Talk

Journal: Current Alzheimer Research
Volume: 12,Issue: 7
Page: 655-672
Authors: Katalin Volgyi, Gábor Juhász, Zsolt Kovacs and Botond Penke

Neuronal Death and Survival Under Oxidative Stress in Alzheimer and Parkinson Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 6
Page: 411-423
Authors: A. Nunomura, P. I. Moreira, H. G. Lee, X. Zhu, R. J. Castellani, M. A. Smith and G. Perry

Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders

Journal: Current Gene Therapy
Volume: 8,Issue: 6
Page: 461-473
Authors: Cecilia Lundberg, Tomas Bjorklund, Thomas Carlsson, Johan Jakobsson, Philippe Hantraye, Nicole Deglon and Deniz Kirik

Pharmacological Aspects of (-)-Deprenyl

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 1
Page: 2017-2031
Authors: K. Magyar, M. Palfi, T. Tabi, H. Kalasz, B. Szende and E. Szoko

Potential Application of Centrifuges to Protect the CNS in Space and on Earth

Journal: Current Alzheimer Research
Volume: 15,Issue: 0
Page: 1-8
Authors: Makoto Hashimoto*, Gilbert Ho, Yuka Shimizu, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Jianshe Wei and Yoshiki Takamatsu

Natural or Plant Products for the Treatment of Neurological Disorders: Current Knowledge

Journal: Current Drug Metabolism
Volume: 19,Issue: 5
Page: 424-428
Authors: Mohammad Khalid Parvez*

Disease Modifying Approaches for Alzheimers Pathology

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 1
Page: 1943-1954
Authors: Marcin Sadowski and Thomas Wisniewski

A Dual Activity of ROS and Oxidative Stress on Adult Neurogenesis and Alzheimers Disease

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 16-21
Authors: Philippe Taupin

The Clinical Applications of Curcumin: Current State and the Future

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 1
Page: 2011-2031
Authors: Xia Fan, Chun Zhang, Dong-bo Liu, Jun Yan and Hua-ping Liang

Recent Developments of Melatonin Related Antioxidant Compounds

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 9,Issue: 6
Page: 409-419
Authors: Sibel Suzen

SUMOylation Modulates CFTR Biogenesis: Is the Pathway Druggable?

Journal: Current Drug Targets
Volume: 16,Issue: 9
Page: 965-975
Authors: Annette Ahner and Raymond A. Frizzell

Epigenetics in Alzheimers Disease: a Focus on DNA Modifications

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 3398-3412
Authors: Natacha Coppieters and Mike Dragunow

The Pathophysiology of Heme in the Brain

Journal: Current Alzheimer Research
Volume: 13,Issue: 2
Page: 174-184
Authors: Raffaella Gozzelino

Inhibitors of Mammalian Central Nervous System Selective Amino Acid Transporters

Journal: Current Medicinal Chemistry
Volume: 7,Issue: 2
Page: 199-209
Authors: Richard E. Armer

Heat Shock Proteins, Substrate Specificity and Modulation of Function

Journal: Protein & Peptide Letters
Volume: 13,Issue: 7
Page: 699-705
Authors: Yusuf Tutar

Mechanisms of Tau Self-Aggregation and Neurotoxicity

Journal: Current Alzheimer Research
Volume: 8,Issue: 6
Page: 608-614
Authors: G. Farias, A. Cornejo, J. Jimenez, L. Guzman and R. B. Maccioni

Transcription Factors as Therapeutic Targets in CNS Disorders

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 4,Issue: 3
Page: 190-199
Authors: Michael J. Kane and Bruce A. Citron

Targeting IAP (Inhibitor of Apoptosis) Proteins for Therapeutic Intervention in Tumors

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 2
Page: 110-117
Authors: Domagoj Vucic

Serine Proteinase Inhibitors in the Skin: Role in Homeostasis and Disease

Journal: Current Protein & Peptide Science
Volume: 6,Issue: 3
Page: 241-254
Authors: Hans-Jurgen Magert, Katrin Drogemuller and Michael Raghunath

New Insights into the Roles of Endolysosomal Cathepsins in the Pathogenesis of Alzheimers Disease: Cathepsin Inhibitors as Potential Therapeutics

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 3
Page: 270-277
Authors: Azizul Haque, Naren L. Banik and Swapan K. Ray

Hunting for Peptide Substrates of Prolyl Oligopeptidase: Classical Versus Non-Classical Bioactive Peptides

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 3
Page: 319-326
Authors: Jofre Tenorio-Laranga, Pekka T. Mannisto and J. Arturo Garcia-Horsman

Role of Caspases in Activation-Induced Cell Death of Neuroglia

Journal: Current Enzyme Inhibition
Volume: 1,Issue: 1
Page: 43-50
Authors: Kyoungho Suk

Amyloid Forming Proteases: Therapeutic Targets for Alzheimers Disease

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 2
Page: 2521-2531
Authors: Frauke Schimmoller, Jeffrey N. Higaki and Barbara Cordell

Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease

Journal: Current Neuropharmacology
Volume: 8,Issue: 3
Page: 211-217
Authors: Hongwen He, Weiguo Dong and Fang Huang

Modulation of the Ceramide Level, A Novel Therapeutic Concept

Journal: Current Drug Targets
Volume: 1,Issue: 2
Page: 185-205
Authors: R. Claus, S. Russwurm, M. Meisner, R. Kinscherf and H. P. Deigner

Modulation of Endoplasmic Reticulum Stress: An Opportunity to Prevent Neurodegeneration?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 4
Page: 518-533
Authors: Ana I. Placido, Claudia M.F. Pereira, Ana I. Duarte, Emanuel Candeias, Sonia C. Correia, Cristina Carvalho, Susana Cardoso, Catarina R. Oliveira and Paula I. Moreira

Parkinson Disease: From Cellular and Animal Models to Genomics

Journal: Current Genomics
Volume: 6,Issue: 4
Page: 241-250
Authors: Ignacio Marin and Jorge Vallejo

Non-viral Gene Delivery and Therapeutics Targeting to Brain

Journal: Current Nanoscience
Volume: 7,Issue: 1
Page: 55-70
Authors: Yang Liu, Rongqin Huang and Chen Jiang

Approaches to Palliative Therapies for Alzheimers Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 6
Page: 553-568
Authors: Albert J. Robichaud

Small Molecule Neurotrophin Receptor Ligands: Novel Strategies for Targeting Alzheimers Disease Mechanisms

Journal: Current Alzheimer Research
Volume: 4,Issue: 5
Page: 503-506
Authors: Frank M. Longo, Tao Yang, Juliet K. Knowles, Youmei Xie, Laura A. Moore and Stephen M. Massa

Matter of Life and Death: the Pharmacological Approaches Targeting Apoptosis in Brain Diseases

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 215-229
Authors: Virve Cavallucci and Marcello D'Amelio

Fetuin-A: A Multifunctional Protein

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5,Issue: 2
Page: 124-146
Authors: Katsuhito Mori, Masanori Emoto and Masaaki Inaba

Potential Application of Dietary Polyphenols from Red Wine to Attaining Healthy Ageing

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 1
Page: 1780-1796
Authors: T. Magrone and E. Jirillo

NMR Metabolomics Analysis of Parkinsons Disease

Journal: Current Metabolomics
Volume: 1,Issue: 3
Page: 191-209
Authors: Shulei Lei and Robert Powers

Neuroprotective Activities of Marine Natural Products from Marine Sponges

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 4
Page: 360-382
Authors: Mousa Alghazwi, Yen Qi Kan, Wei Zhang, Wei Ping Gai and Xiao-Xin Yan

Recent Evidence of the Regulatory Role of PPARs in Neural Stem Cells and Their Underlying Mechanisms for Neuroprotective Effects

Journal: Current Stem Cell Research & Therapy
Volume: 11,Issue: 3
Page: 188-196
Authors: Jing Wang, Yun Shen, Yiming Zhang, Rui Zhang, Xiaoshan Tang, Li Fang and Yuanzhi Xu

Microglial Activation in Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 6,Issue: 6
Page: 554-563
Authors: Johannes C.M. Schlachetzki and Michael Hull

The Principle and the Potential Approach to ROS-dependent Cytotoxicity by Non-pharmaceutical Therapies: Optimal Use of Medical Gases with Antioxidant Properties

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 2
Page: 2253-2263
Authors: Mami Noda, Kyota Fujita, Chih-Hung Lee and Tohru Yoshioka

The Role of Tau Phosphorylation in the Pathogenesis of Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 3,Issue: 5
Page: 449-463
Authors: Kaihong Mi and Gail V.W. Johnson

Cytokines in HIV-Infection - Inflammatory Damage or Therapeutic Potential?

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 115-130
Authors: Gabriele Arendt and Thorsten Nolting

Gene Therapy in Cerebrovascular Diseases

Journal: Current Gene Therapy
Volume: 7,Issue: 6
Page: 421-433
Authors: Rodney Allanigue Gabriel and Guo-Yuan Yang

SOD1 Aggregation and ALS: Role of Metallation States and Disulfide Status

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 2
Page: 2560-2572
Authors: Yuewei Sheng, Madhuri Chattopadhyay, Julian Whitelegge and Joan Selverstone Valentine



Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 7
Page: 988-994
Authors: Christopher S. Beevers, Hongyu Zhou and Shile Huang

Crosstalk Between Calpain and Calcineurin in Excitotoxic Neurodegeneration; Therapeutic Targets for the Treatment of Excitotoxic Neurodegeneration

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 5,Issue: 3
Page: 207-216
Authors: Hai-Yan Wu, Hideki Matsui and Kazuhito Tomizawa

Naturally Occurring Regulators of Histone Acetylation/Deacetylation

Journal: Current Nutrition & Food Science
Volume: 6,Issue: 1
Page: 78-99
Authors: Florence Folmer, Barbora Orlikova, Michael Schnekenburger, Mario Dicato and Marc Diederich

Genomic and Proteomic Analyses of the Methionine Sulfoxide Reductase A Knockout Mouse

Journal: Current Proteomics
Volume: 5,Issue: 2
Page: 96-103
Authors: Derek B. Oien, Xinkun Wang and Jackob Moskovitz

Cell Transplantation: A Future Therapy for Narcolepsy?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 4
Page: 309-314
Authors: Oscar Arias-Carrion and Eric Murillo-Rodriguez

Development of BACE1 Inhibitors for Alzheimers Disease

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 1
Page: 1811-1829
Authors: Tao Guo and Doug W. Hobbs

Pin1: A New Outlook in Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 8,Issue: 6
Page: 615-622
Authors: E. Lonati, M. Masserini and A. Bulbarelli

Celastrol and Terpenes as Anti-Infective Agents

Journal: Anti-Infective Agents in Medicinal Chemistry
Volume: 7,Issue: 2
Page: 97-100
Authors: Ngan Hon Lee and John W. Ho

PET Studies of Brain Monoamine Transporters

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 1
Page: 1611-1623
Authors: Aki Laakso and Jarmo Hietala

Tau Oligomerization: A Role for Tau Aggregation Intermediates Linked to Neurodegeneration

Journal: Current Alzheimer Research
Volume: 5,Issue: 6
Page: 591-598
Authors: N. Sahara, S. Maeda and A. Takashima

In Silico Methods to Assist Drug Developers in Acetylcholinesterase Inhibitor Design

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 8
Page: 1122-1136
Authors: J. A. Bermudez-Lugo, M. C. Rosales-Hernandez, O. Deeb, J. Trujillo-Ferrara and J. Correa-Basurto

PET Radiotracers for Molecular Imaging in Dementia

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 4
Page: 215-230
Authors: Aylin Baskin, Panteleimon Giannakopoulos, Osman Ratib, Yann Seimbille, Frederic Assal, Daniela Perani and Valentina Garibotto

Cannabinoids: Between Neuroprotection and Neurotoxicity

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 6
Page: 677-684
Authors: Yosef Sarne and Raphael Mechoulam

Heat Shock Proteins; An Overview

Journal: Current Pharmaceutical Biotechnology
Volume: 11,Issue: 2
Page: 216-222
Authors: Lutfi Tutar and Yusuf Tutar

Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders

Journal: Current Gene Therapy
Volume: 17,Issue: 3
Page: 187-193
Authors: Aneesh Donde, Philip C. Wong and Liam L. Chen*

Expression and Single Nucleotide Polymorphism of Poly (ADPRibose) Polymerase-1 in Gastrointestinal Tumours: Clinical Involvement

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 2
Page: 2156-2173
Authors: Sandra M. Martín-Guerrero, Josefa León, Rosa Quiles-Perez, Laura Belmonte, David Martin-Oliva, Ángeles Ruiz-Extremera, Javier Salmerón and José Antonio Muñoz-Gámez*

MicroRNA Dysregulation in Alzheimer's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 9
Page: 1000-1009
Authors: Manish Putteeraj, Yahaya Mohamad Fairuz and Seong Lin Teoh*

Structure-based Approaches Targeting Parasite Cysteine Proteases

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 0
Page: 1-18
Authors: Rafael Pinto Vieira, Viviane Corrêa Santos and Rafaela Salgado Ferreira*



Journal: Current Alzheimer Research
Volume: 14,Issue: 1
Page: 1198-1206
Authors: Priya Gupta, Surajit Bhattacharjee, Ashish Ranjan Sharma, Garima Sharma, Sang-Soo Lee* and Chiranjib Chakraborty*

Physicochemical and Structural Studies on Shaping of β-hairpin in Proteins as a First Stage of Amyloid Formation

Journal: Current Protein & Peptide Science
Volume: 18,Issue: 1
Page: 1244-1253
Authors: Joanna Makowska*

Microglial Senescence

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 6
Page: 763-767
Authors: Wolfgang J. Streit and Qing-Shan Xue

Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 3,Issue: 4
Page: 339-349
Authors: Isaac G. Onyango and Shaharyar M. Khan

Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 1429-1438
Authors: L. Ferraro, M. C. Tomasini, S. Beggiato, R. Guerrini, S. Salvadori, K. Fuxe, L. Calza, S. Tanganelli and T. Antonelli

Vascular Endothelial Growth Factor Electro-Gene Therapy Improves Functional Outcome in a Mouse Model of ALS

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 107-111
Authors: Tatsufumi Murakami, Yuki Shimada, Yoshimi Imada, Akihiro Nakamura and Yoshihide Sunada

The Role of Immune and Inflammatory Mechanisms in ALS

Journal: Current Molecular Medicine
Volume: 11,Issue: 3
Page: 246-254
Authors: P. A. McCombe and R. D. Henderson

Prion Protein Misfolding and Brain Degeneration

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3,Issue: 2
Page: 137-147
Authors: Claudio Hetz, Sergio Benavent, Sylvain Bieler and Claudio Soto

Dopamine Receptor Agonists for Protection and Repair in Parkinsons Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 1089-1099
Authors: Giulia Ferrari-Toninelli, Sara A. Bonini, Giovanna Cenini, Giuseppina Maccarinelli, Mariagrazia Grilli, Daniela Uberti and Maurizio Memo

Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 3
Page: 351-355
Authors: Margarita E. Neganova, Sergei G. Klochkov, Ludmila N. Petrova, Elena F. Shevtsova, Svetlana V. Afanasieva, Ekaterina S. Chudinova, Vladimir P. Fisenko, Sergei O. Bachurin, George E. Barreto and Gjumrakch Aliev*

Role of Astrocytes, Soluble Factors, Cells Adhesion Molecules and Neurotrophins in Functional Synapse Formation: Implications for Human Embryonic Stem Cell Derived Neurons

Journal: Current Stem Cell Research & Therapy
Volume: 5,Issue: 3
Page: 251-260
Authors: Mahesh C. Dodla, Jennifer Mumaw and Steven L. Stice

Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 1
Page: 82-107
Authors: Robert A. Harris and Sandra Amor

Implication of Complement System and its Regulators in Alzheimers Disease

Journal: Current Neuropharmacology
Volume: 7,Issue: 1
Page: 1-8
Authors: Martin V. Kolev, Marieta M. Ruseva, Claire L. Harris, B. Paul Morgan and Rossen M. Donev

Targeting Neurotrophin Receptors in the Central Nervous System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 1
Page: 71-82
Authors: Italo Mocchetti, Milton Brown and Milton Brown

Chondroitin Sulfate, a Major Niche Substance of Neural Stem Cells, and Cell Transplantation Therapy of Neurodegeneration Combined with Niche Modification

Journal: Current Stem Cell Research & Therapy
Volume: 4,Issue: 3
Page: 200-209
Authors: Yoshiaki Sato and Atsuhiko Oohira

Inhibition of Tau Aggregation in Cell Models of Tauopathy

Journal: Current Alzheimer Research
Volume: 4,Issue: 5
Page: 544-546
Authors: Inna Khlistunova, Marcus Pickhardt, Jacek Biernat, Yipeng Wang, Eva-Maria Mandelkow and Eckhard Mandelkow

The Immunomodulating Activities of Resveratrol Glucosides in Humans

Journal: Recent Patents on Food, Nutrition & Agriculture
Volume: 3,Issue: 2
Page: 81-90
Authors: Mariapia Fuggetta and Fulvio Mattivi

Nicotinic Receptors Containing the α7 Subunit: A Model for Rational Drug Design

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 2
Page: 2921-2932
Authors: G. Sharma and S. Vijayaraghavan

Neuroprotective Effects of Lithium - Pointing out Protein Phosphatases as Drug Targets?

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3,Issue: 4
Page: 335-339
Authors: A. Mora, G. Sabio and F. Centeno

Hybrid PET Imaging in Neurologic Disease: PET/MRI Rather than PET/CT

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 3
Page: 193-201
Authors: Erik S. Musiek, Lise Borgwardt, Babak Saboury and Abass Alavi

Drugs and Foods for Chronic Subclinical Inflammation in Humans

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5,Issue: 2
Page: 149-155
Authors: Alberto Battezzati and Antonella San Romerio

Molecular and Cellular Mechanisms for Alzheimers Disease:Understanding APP Metabolism

Journal: Current Molecular Medicine
Volume: 7,Issue: 7
Page: 687-696
Authors: Yun-wu Zhang and Huaxi Xu

Molecular Mechanisms of Neurotoxicity of Pathological Prion Protein

Journal: Current Molecular Medicine
Volume: 4,Issue: 4
Page: 397-403
Authors: Joaquin Castilla, Claudio Hetz and Claudio Soto

The Anti-Inflammatory and Pharmacological Actions of Oleocanthal, a Phenolic Contained in Extra Virgin Olive Oil

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 10,Issue: 6
Page: 399-406
Authors: Lisa Lucas, Sara Cicerale and Russell Keast

The Role of Venous Abnormalities in Neurological Disease

Journal: Reviews on Recent Clinical Trials
Volume: 7,Issue: 2
Page: 100-116
Authors: E. Mark Haacke, Clive B. Beggs and Charbel Habib

The Neuroprotective Role of PEDF: Implication for the Therapy of Neurological Disorders

Journal: Current Molecular Medicine
Volume: 10,Issue: 3
Page: 259-266
Authors: T. Yabe, T. Sanagi and H. Yamada

Nanostructures for Drug Delivery to the Brain

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 3
Page: 5303-5321
Authors: L. Martin-Banderas, M. A. Holgado, J. L. Venero, J. Alvarez-Fuentes and M. Fernandez-Arevalo

Interleukin-18, From Neuroinflammation to Alzheimers Disease

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 4213-4224
Authors: Paola Bossu, Antonio Ciaramella, Francesca Salani, Diego Vanni, Ilaria Palladino, Carlo Caltagirone and Giuseppe Scapigliati

Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 8
Page: 1003-1016
Authors: Yeong Keng Yoon and Chern Ein Oon

Cytokines in the Central Nervous System: Targets for Therapeutic Intervention

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3,Issue: 4
Page: 271-280
Authors: Bared Safieh-Garabedian, John J. Haddad and Nayef E. Saade

Recent Patents Concerning Modulators of Protein Kinase C

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 7,Issue: 1
Page: 74-81
Authors: Sonia Sanchez-Bautista and Francisco E. Nicolas

Drug Target Identification for Neuronal Apoptosis Through a Genome Scale Screening

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 2
Page: 2906-2920
Authors: E.A. Tendi, R. Cunsolo, D. Bellia, R.L. Messina, S. Paratore, P. Calissano and S. Cavallaro

Mitophagy in Neurodegeneration: An Opportunity for Therapy?

Journal: Current Drug Targets
Volume: 12,Issue: 6
Page: 790-799
Authors: R. X. Santos, S. C. Correia, C. Carvalho, S. Cardoso, M. S. Santos and P. I. Moreira

The Potential Role of Glycogen Synthase Kinase 3 Inhibitors as Amyotrophic Lateral Sclerosis Pharmacological Therapy

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 2
Page: 3028-3034
Authors: V. Palomo, D. I. Perez, C. Gil and A. Martinez

Selective Agonists and Antagonists for Kainate Receptors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2,Issue: 2
Page: 177-184
Authors: Paola Conti, Marco De Amici and Carlo De Micheli

Clinical Potential of Minocycline for Schizophrenia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 4
Page: 376-381
Authors: Tsuyoshi Miyaoka

Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 4
Page: 282-287
Authors: Christian Schmeer, Alexandra Kretz and Stefan Isenmann

Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 6
Page: 479-482
Authors: Kazuhiro Honda, Paula I. Moreira, Quan Liu, Sandra L. Siedlak, Xiongwei Zhu, Mark A Smith and George Perry

Development of Neurotrophic Molecules for Treatment of Neurode-generation

Journal: Current Protein & Peptide Science
Volume: 2,Issue: 3
Page: 261-276
Authors: Zhe-yu Chen, Li Cao, Li-mei Wang, Chao Guo, Jun-Li Ye, Yan-Feng Chai and Zhi-Yong Yan

Cellular Uptake and Organ Accumulation of Amphipolar Metallocorroles with Cytoprotective and Cytotoxic Properties

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 4
Page: 380-384
Authors: Zoya Okun, Lana Kupershmidt, Moussa B. H. Youdim and Zeev Gross

Neuronal Response of Peroxisomal and Peroxisome-Related Proteins to Chronic and Acute Aβ Injury

Journal: Current Alzheimer Research
Volume: 6,Issue: 3
Page: 238-251
Authors: A. Cimini, E. Benedetti, B. D'Angelo, L. Cristiano, S. Falone, S. Di Loreto, F. Amicarelli and M. P. Ceru

Oxidative Stress in the Hypothalamus: the Importance of Calcium Signaling and Mitochondrial ROS in Body Weight Regulation

Journal: Current Neuropharmacology
Volume: 10,Issue: 4
Page: 344-353
Authors: Erika Gyengesi, George Paxinos and Zane B. Andrews

Strain Specificity and Drug Resistance in Anti-Prion Therapy

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 2397-2406
Authors: Lakshmi Miller-Vedam and Sina Ghaemmaghami

Metal-Protein Attenuating Compounds (MPACs) for the Treatment of Alzheimers Disease

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1,Issue: 1
Page: 75-82
Authors: Kevin J. Barnham, Robert A. Cherny, Roberto Cappai, Simon Melov, Colin L. Masters and Ashley I. Bush

Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 2
Page: 217-231
Authors: G. Hoffner, W. Andre, A. Vanhoutteghem, S. Soues and P. Djian

Diagnostic and Therapeutic Uses of Nanomaterials in the Brain

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 3
Page: 4100-4131
Authors: Elisa Garbayo, Ander Estella-Hermoso de Mendoza and Maria J. Blanco-Prieto

Signal Transduction Pathway Regulated by Genistein and its Therapeutic Use

Journal: Current Signal Transduction Therapy
Volume: 3,Issue: 3
Page: 231-233
Authors: Kenichi Yoshida

Glaucoma and Aging

Journal: Current Aging Science
Volume: 4,Issue: 2
Page: 110-117
Authors: Guilherme Guedes, James C. Tsai and Nils A. Loewen

Brain Diffusion Changes in Patients Diagnosed with Alzheimers Disease

Journal: Current Medical Imaging Reviews
Volume: 4,Issue: 4
Page: 226-230
Authors: Shoichi Ito

Pathophysiological Role of Pigment Epithelium-Derived Factor (PEDF) in Hepatic Disorders

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 1
Page: 1995-2000
Authors: S.-I. Yamagishi, T. Matsui, T. Kawaguchi and M. Sata

Glycosaminoglycans, Protein Aggregation and Neurodegeneration

Journal: Current Protein & Peptide Science
Volume: 12,Issue: 3
Page: 258-268
Authors: Dulce Papy-Garcia, Morin Christophe, Huynh Minh Bao, Sineriz Fernando, Sissoeff Ludmilla, Sepulveda Diaz Julia Elisa and Raisman-Vozari Rita

Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 4
Page: 396-415
Authors: Valentina Zuliani, Manoj K. Patel, Marco Fantini and Mirko Rivara

Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier

Journal: Current Drug Metabolism
Volume: 14,Issue: 6
Page: 625-640
Authors: Martha Leonor Pinzon-Daza, Ivana Campia, Joanna Kopecka, Ruth Garzon, Dario Ghigo and Chiara Rigant

Amyloid Beta Protein as a Marker or Risk Factor of Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 4,Issue: 4
Page: 359-363
Authors: Pankaj D. Mehta

Design of Multivalent Ligand Targeting G-Protein-Coupled Receptors

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 6
Page: 682-718
Authors: Zhili Liu, Jing Zhang and Ao Zhang

Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 1
Page: 102-107
Authors: Margarita E. Neganova, Sergei G. Klochkov, Svetlana V. Afanasieva, Tatiana P. Serkova, Ekaterina S. Chudinova, Sergei O. Bachurin, V. Prakash Reddy, Gjumrakch Aliev and Elena F. Shevtsova

DNAJ Proteins and Protein Aggregation Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 2
Page: 2479-2490
Authors: Vaishali Kakkar, Louis C. B. Prins and Harm H. Kampinga

A New Model for Academics Based Drug Discovery

Journal: Current Alzheimer Research
Volume: 4,Issue: 5
Page: 574-576
Authors: Ross L. Stein

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimers Disease

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 2
Page: 2790-2798
Authors: Miguel Medina and Jesus Avila

Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 3
Page: 317-330
Authors: C. Ballatore, K. R. Brunden, J. Q. Trojanowski, V. M.-Y. Lee, A. B. Smith and D. M. Huryn



Journal: Current Alzheimer Research
Volume: 13,Issue: 4
Page: 343-358
Authors: José J. Rodríguez, Arthur M. Butt, Emanuela Gardenal, Vladimir Parpura and Alexei Verkhratsky

Small Molecules that Promote Neurogenesis in vitro

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 3,Issue: 3
Page: 200-208
Authors: Gilbert M. Rishton

The Role of Hesperidin in Cell Signal Transduction Pathway for the Prevention or Treatment of Cancer

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 3
Page: 3462-3471
Authors: A. Ahmadi, A. Shadboorestan, S.F. Nabavi, W.N. Setzer and S.M. Nabavi

Graphene-Based Nanomaterials: Potential Tools for Neurorepair

Journal: Current Pharmaceutical Design
Volume: 24,Issue: 1
Page: 56-61
Authors: Qing Wang, Yan-Hua Li, Wei-Jia Jiang, Jian-Guo Zhao, Bao-Guo Xiao, Guang-Xian Zhang* and Cun-Gen Ma*

Alzheimer s Disease and Parkinson s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

Journal: Current Pharmaceutical Design
Volume: 24,Issue: 1
Page: 22-45
Authors: Adriana Trompetero, Aldemar Gordillo, Mora Carolina del Pilar, Velasquillo María Cristina and Rosa Helena Bustos Cruz*

PPARs in Neurodegenerative and Neuroinflammatory Pathways

Journal: Current Alzheimer Research
Volume: 15,Issue: 4
Page: 336-344
Authors:

The Mitochondrial Unfolded Protein Response: Role in Cellular Homeostasis and Disease

Journal: Current Molecular Medicine
Volume: 17,Issue: 9
Page: 587-597
Authors: I. De, N. Dogra and S. Singh*


Conclusive Article: Sorting the Good from the Bad: The Different Approaches to Predict Cognitive Properties of New Symptomatic Drug Candidates for Neurodegenerative Diseases in Early Development

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 7
Page: 837-838
Authors: Julie Deguil, Alexandra Auffret, Esther Schenker, Fabienne Aujard, Yves Lamberty, David Bartrès-Faz, María T. Herrero, Olivier Blin, Joëlle Micallef, Jill C. Richardson and Régis Bordet



Commentary

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 383-383
Authors: Frank Hirth

Ion Channels on Microglia: Therapeutic Targets for Neuroprotection

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 1
Page: 44-56
Authors: Stephen D. Skaper

What Does Systems Biology Mean for Drug Development?

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 1
Page: 1520-1528
Authors: Andre Schrattenholz and Vukic Soskic

3D MI-DRAGON: New Model for the Reconstruction of US FDA Drug- Target Network and Theoretical-Experimental Studies of Inhibitors of Rasagiline Derivatives for AChE

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 1843-1865
Authors: Francisco Prado-Prado, Xerardo Garcia-Mera, Manuel Escobar, Nerea Alonso, Olga Caamano, Matilde Yanez and Humberto Gonzalez-Diaz

γ-Secretase Modulation and its Promise for Alzheimers Disease: a Rationale for Drug Discovery

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 34-37
Authors: Dirk Beher

Recent Developments in Therapeutic Approaches for Lysosomal Storage Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 6,Issue: 1
Page: 1-19
Authors: Lorena Urbanelli, Alessandro Magini, Alice Polchi, Mario Polidoro and Carla Emiliani

Wasp Venom Toxins as a Potential Therapeutic Agent

Journal: Protein & Peptide Letters
Volume: 23,Issue: 8
Page: 688-698
Authors: Yashad Dongol, Bhadrapara L. Dhananjaya, Rakesh K. Shrestha and Gopi Aryal

The Impact of Small Heat Shock Proteins (HspBs) in Alzheimer’s and Other Neurological Diseases

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 4050-4062
Authors: Nikola Golenhofen and Britta Bartelt-Kirbach

Mood, Memory and Movement: An Age-Related Neurodegenerative Complex?

Journal: Current Aging Science
Volume: 1,Issue: 2
Page: 133-139
Authors: Ann-Charlotte Granholm, Heather Boger and Marina E. Emborg

Synthesis and Structure-Activity Relationships of 4,10-Dihydro-4-oxo-4HImidazo[ 1,2-a]Indeno[1,2-e]Pyrazine Derivatives: Highly Potent and Selective AMPA Receptor Antagonists with In Vivo Activity

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4,Issue: 2
Page: 123-140
Authors: Jean-Marie Stutzmann, Marc Vuilhorgne and Serge Mignani

Role of Microfluidics in Blood-Brain Barrier Permeability Cell Culture Modeling: Relevance to CNS Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 3
Page: 301-309
Authors: Alexander L. Rusanov, Natalia G. Luzgina, George E. Barreto and Gjumrakch Aliev

Relevance of Mutations in Tau for Understanding the Tauopathies

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3,Issue: 4
Page: 341-348
Authors: Michel Goedert

Flavonoids in Human Health: From Structure to Biological Activity

Journal: Current Nutrition & Food Science
Volume: 5,Issue: 4
Page: 225-237
Authors: Djebbar Atmani, Nassima Chaher, Dina Atmani, Meriem Berboucha, Nadjet Debbache and Hania Boudaoud

Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker

Journal: Current Molecular Medicine
Volume: 9,Issue: 9
Page: 1095-1107
Authors: M. Mancuso, D. Orsucci, F. Coppede, C. Nesti, A. Choub and G. Siciliano

Natural and Synthetic Inhibitors of Caspases: Targets for Novel Drugs

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3,Issue: 4
Page: 333-340
Authors: Brigitte Onteniente

Estrogen Activates Classical and Alternative Mechanisms to Orchestrate Neuroprotection

Journal: Current Neurovascular Research
Volume: 2,Issue: 4
Page: 287-301
Authors: R. Marin, B. Guerra, R. Alonso, C. M. Ramirez and M. Diaz

The Fate of Exogenous Human HSP70 Introduced into Animal Cells by Different Means

Journal: Current Drug Delivery
Volume: 12,Issue: 5
Page: 524-532
Authors: Marina Yurinskaya, Olga G. Zatsepina, Maxim G. Vinokurov, Natalia V. Bobkova, David G. Garbuz, Alexei V. Morozov, Dina A. Kulikova, Vladimir A. Mitkevich, Alexander A. Makarov, Sergei Yu. Funikov and Michael B. Evgen’ev

Therapeutic Potential of Hepatocyte Growth Factor for Treating Neurological Diseases

Journal: Current Drug Therapy
Volume: 6,Issue: 3
Page: 197-206
Authors: Keiichi Kadoyama, Kaori Kadoyama, Hiroshi Funakoshi, Toshikazu Nakamura and Toshiyuki Sakaeda

Programmed Axon Death, Synaptic Dysfunction and the Ubiquitin Proteasome System

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3,Issue: 3
Page: 227-238
Authors: M. P. Coleman and R. R. Ribchester

Anti-Inflammatory Drugs in Psychiatry

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 8,Issue: 4
Page: 266-276
Authors: Mark Berthold-Losleben, Sabine Heitmann and Hubertus Himmerich

The Peripheral Benzodiazepine Receptor: A Promising Therapeutic Drug Target

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1563-1572
Authors: Sylvaine Galiegue, Norbert Tinel and Pierre Casellas

Classical and Hologram QSAR Studies on a Series of Tacrine Derivatives as Butyrylcholinesterase Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 2
Page: 106-113
Authors: M. S. Castilho, R. V. C. Guido and A. D. Andricopulo

New Hope for the Diagnosis and Therapy of Alzheimers Disease

Journal: Protein & Peptide Letters
Volume: 14,Issue: 4
Page: 389-393
Authors: Bernd Kastenholz

Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntingtons Disease - from Clinical Features to the Bench

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 1218-1236
Authors: Tatiana R. Rosenstock, Ana I. Duarte and A. Cristina Rego

NAD Biosynthesis in Humans - Enzymes, Metabolites and Therapeutic Aspects

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 2907-2917
Authors: Christian Dölle, Renate Hvidsten Skoge, Magali R. VanLinden and Mathias Ziegler

In Vitro and Ex Vivo Model Systems to Measure ABC Transporter Activity at the Blood-Brain Barrier

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 3
Page: 5768-5773
Authors: Nienke M. de Wit, Gijs Kooij and Helga E. de Vries

Noscapine and its Analogs as Chemotherapeutic Agent: Current updates

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 174-188
Authors: Vartika Tomar, Shrikant Kukreti, Satya Prakash, Jitender Madan and Ramesh Chandra

Molecular Dynamics and Regulation of Butyrylcholinesterase Cholinergic Activity by RNA Binding Proteins

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 8
Page: 1366-1377
Authors: Iqra Sohail and Sajid Rashid

Recent Patents on Proteasome Inhibitors of Natural Origin

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 12,Issue: 1
Page: 4-15
Authors: Daniela Correia da Silva, Paula B. Andrade, Vera Ribeiro, Patricia Valentao and David M. Pereira

Clinical Studies in Stem Cells Transplantation for Stroke: A Review

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 1
Page: 29-34
Authors: Anna Bersano, Elena Ballabio, Silvia Lanfranconi, Giorgio B. Boncoraglio, Stefania Corti, Federica Locatelli, Pierluigi Baron, Nereo Bresolin, Eugenio Parati and Livia Candelise

Genomic and Molecular Characterization of Alzheimer Disease

Journal: Current Psychiatry Reviews
Volume: 6,Issue: 2
Page: 104-113
Authors: Tih-Shih Lee, Sze-Ming Chua, Philip Ly and Weihong Song

CuAAC Click Chemistry Accelerates the Discovery of Novel Chemical Scaffolds as Promising Protein Tyrosine Phosphatases Inhibitors

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 1
Page: 2399-2405
Authors: X. -P. He, J. Xie, Y. Tang, J. Li and G. -R. Chen

Natural Protective Amyloids

Journal: Current Protein & Peptide Science
Volume: 9,Issue: 3
Page: 291-309
Authors: Vassiliki A. Iconomidou and Stavros J. Hamodrakas

Old Friends in New Constellations - the Hematopoetic Growth Factors G-CSF, GMCSF, and EPO for the Treatment of Neurological Diseases

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 1
Page: 1407-1411
Authors: M. H. Maurer, W.-R. Schabitz and A. Schneider

Recent Trends in High Throughput Analysis and Antioxidant Potential Screening for Phenolics

Journal: Current Pharmaceutical Analysis
Volume: 4,Issue: 3
Page: 137-150
Authors: Paula B. Andrade, David M. Pereira, Federico Ferreres and Patricia Valentao

Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis

Journal: Current Stem Cell Research & Therapy
Volume: 4,Issue: 3
Page: 178-199
Authors: Jason R. Thonhoff, Luis Ojeda and Ping Wu

Mechanisms of Control of Neuron Survival by the Endocannabinoid System

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 2
Page: 2279-2288
Authors: Ismael Galve-Roperh, Tania Aguado, Javier Palazuelos and Manuel Guzman

Antioxidants in Health, Disease and Aging

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 2
Page: 192-207
Authors: Mark E. Obrenovich, Yi Li, Kalpana Parvathaneni, Bharat B. Yendluri, Hector H. Palacios, Jerzy Leszek and Gjumrakch Aliev

Adult Neurogenesis, Neural Stem Cells and Alzheimers Disease: Developments, Limitations, Problems and Promises

Journal: Current Alzheimer Research
Volume: 6,Issue: 6
Page: 461-470
Authors: Philippe Taupin

Miglustat: Substrate Reduction Therapy for Lysosomal Storage Disorders Associated with Primary Central Nervous System Involvement

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1,Issue: 1
Page: 77-82
Authors: Gregory M. Pastores

Gangliosides Potentially Inhibit Extracellular Nucleotide Metabolism

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 1
Page: 2233-2239
Authors: Miki Hara-Yokoyama

Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children

Journal: Current Pediatric Reviews
Volume: 3,Issue: 3
Page: 207-213
Authors: Raili Riikonen

Dynamic Crosstalk between GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription and Human Disease (Supplementary Material)

Journal: Current Signal Transduction Therapy
Volume: 5,Issue: 1
Page: 25-40
Authors: Shino Shimoji, Kyoungsook Park and Gerald W. Hart

Neural Stem Cells: From Neurobiology to Clinical Applications

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 1
Page: 20-28
Authors: Christian Andressen

Cytochrome P450 in Neurological Disease

Journal: Current Drug Metabolism
Volume: 5,Issue: 3
Page: 225-234
Authors: M. Liu, P. D. Hurn and N. J. Alkayed

Tetracyclines and Pulmonary Inflammation

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7,Issue: 4
Page: 232-236
Authors: S. Rempe, J. M. Hayden, R. A. Robbins and J. C. Hoyt

Endocannabinoids in Neuroimmunology and Stress

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 6
Page: 657-665
Authors: Erica J. Carrier, Sachin Patel and Cecilia J. Hillard

Binding of the PET Radiotracer [18F]BF227 Does not Reflect the Presence of Alpha-Synuclein Aggregates in Transgenic Mice

Journal: Current Alzheimer Research
Volume: 11,Issue: 1
Page: 955-960
Authors: Elise Levigoureux, Sophie Lancelot, Caroline Bouillot, Fabien Chauveau, Mathieu Verdurand, Jeremy Verchere, Thierry Billard, Thierry Baron and Luc Zimmer

NSAID Use and the Risk of Parkinsons Disease

Journal: Current Drug Safety
Volume: 1,Issue: 3
Page: 223-225
Authors: Mahyar Etminan and Samy Suissa

Evaluation of Glial Cell Line-Derived Neurotrophic Factors as Therapeutics: Pharmacogenomic and Pharmacoproteomic Studies

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 11,Issue: 1
Page: 76-85
Authors: Seyeon Park

TRP Channels: New Potential Therapeutic Approaches in CNS Neuropathies

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 2
Page: 274-293
Authors: Maria Beatrice Morelli, Consuelo Amantini, Sonia Liberati, Matteo Santoni and Massimo Nabissi

Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss

Journal: Current Neuropharmacology
Volume: 14,Issue: 8
Page: 831-839
Authors: Joanna Kadłubowska, Lucia Malaguarnera, Piotr Wąż and Katarzyna Zorena

Pharmacophore Based 3D-QSAR Modeling and Molecular Docking of Leucettines as Potent Dyrk1A Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 10,Issue: 8
Page: 719-726
Authors: Anu Bahl, Prashant Joshi, Sandip B. Bharate and Harish Chopra

Epigenetic and Disease Targets by Polyphenols

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 3
Page: 6156-6185
Authors: Min-Hsiung Pan, Ching-Shu Lai, Jia-Ching Wu and Chi-Tang Ho

Protein Oxidation and Proteolytic Signalling in Aging

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 1
Page: 3040-3051
Authors: Christiane Ott and Tilman Grune

Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 3
Page: 302-315
Authors: Takakuni Maki, Kazuhide Hayakawa, Loc-Duyen D. Pham, Changhong Xing, Eng H. Lo and Ken Arai

Targeting Rho GTPases by Peptidic Structures

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 2
Page: 2481-2487
Authors: Filippo Marchioni and Yi Zheng

Current Therapeutic Options for Alzheimers Disease

Journal: Current Genomics
Volume: 8,Issue: 8
Page: 550-558
Authors: Alberto Lleo

HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study

Journal: Current Drug Targets
Volume: 17,Issue: 1
Page: 1610-1625
Authors: Federica Chiappori, Luciano Milanesi and Ivan Merelli

Transgenic Mouse Models of Tauopathy in Drug Discovery

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 403-428
Authors: W. Noble, D.P. Hanger and J.-M. Gallo

Multifunctional Ligands in Medicinal Inorganic Chemistry- Current Trends and Future Directions

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 3
Page: 122-144
Authors: Linus Chiang, Michael R. Jones, Cara L. Ferreira and Tim Storr

Ligand and Structure-Based Pharmacophore Modeling for the Discovery of Potential Human HNMT Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 1
Page: 17-29
Authors: Pavadai Elumalai, Hsuan-Liang Liu, Zheng-Li Zhou, Jian-Hua Zhao, Wilson Chen, Chih-Kuang Chuang, Wei-Bor Tsai and Yih Ho

A Review of Natural and Synthetic Antioxidants Important for Health and Longevity

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 2
Page: 3262-3288
Authors: M. Wojcik, I. Burzynska-Pedziwiatr and L. A. Wozniak

Interferon-γ-Induced Neurotoxicity of Human Astrocytes

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 2
Page: 251-256
Authors: Sadayuki Hashioka, Edith G. McGeer, Tsuyoshi Miyaoka, Rei Wake, Jun Horiguchi and Patrick L. McGeer

Recent Patents in Cell Therapy for Amyotrophic Lateral Sclerosis

Journal: Recent Patents on Regenerative Medicine
Volume: 5,Issue: 1
Page: 10-19
Authors: Eithan D. Haim, Stephanie N. Williams, Paul R. Sanberg and Svitlana N. Garbuzova-Davis

Stem Cells as In Vitro Models of Disease

Journal: Current Stem Cell Research & Therapy
Volume: 2,Issue: 4
Page: 280-292
Authors: Pilar Ruiz-Lozano and Prithi Rajan

Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes

Journal: Current Signal Transduction Therapy
Volume: 5,Issue: 1
Page: 74-91
Authors: Tracey M. Gloster and David J. Vocadlo

The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 6
Page: 698-717
Authors: C. Lanni, S. Stanga, M. Racchi and S. Govoni

n-3 Fatty Acid-Derived Lipid Mediators in the Brain: New Weapons Against Oxidative Stress and Inflammation

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 4
Page: 532-543
Authors: A. A. Farooqui

Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 9
Page: 1615-1626
Authors: Julio C. Tobon-Velasco, Elvis Cuevas and Mónica A. Torres-Ramos

Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 3
Page: 3862-3882
Authors: Mariateresa Cristani, Antonio Speciale, Antonella Saija, Sebastiano Gangemi, Paola Lucia Minciullo and Francesco Cimino

Therapeutic Use of Agonists of the Nuclear Receptor PPARγ in Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 4,Issue: 2
Page: 159-164
Authors: Gary Landreth



Journal: Current Neuropharmacology
Volume: 14,Issue: 2
Page: 177-190
Authors: A. Giulietti, A. Vignini, L. Nanetti, L. Mazzanti, R. Di Primio and E. Salvolini

Alzheimers Disease and Non-Steroidal Anti-Inflammatory Drugs: Old Therapeutic Tools with Novel Mechanisms of Action?

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 5,Issue: 2
Page: 111-117
Authors: Domenico Pratico

Structural Polymorphism of Amyloid Oligomers and Fibrils Underlies Different Fibrillization Pathways: Immunogenicity and Cytotoxicity

Journal: Current Protein & Peptide Science
Volume: 11,Issue: 5
Page: 343-354
Authors: Massimo Stefani

Anti-Inflammatory Properties of Antipsychotics Via Microglia Modulations: Are Antipsychotics a ‘Fire Extinguisher’ in the Brain of Schizophrenia?

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 7
Page: 565-574
Authors: T. A. Kato, A. Monji, Y. Mizoguchi, S. Hashioka, H. Horikawa, Y. Seki, M. Kasai, H. Utsumi and S. Kanba

Neurochemistry Changes Associated with Mutations in Familial Parkinsons Disease

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 3
Page: 4378-4391
Authors: M. M. Siddique and E. K. Tan

Transglutaminases as Targets for Pharmacological Inhibition

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 3
Page: 279-292
Authors: Jolanta M. Wodzinska

Emerging Restorative Treatments for Parkinsons Disease: Manipulation and Inducement of Dopaminergic Neurons from Adult Stem Cells

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 4
Page: 509-516
Authors: Junpeng Zhao and Qunyuan Xu

Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 1
Page: 74-95
Authors: G. Leonarduzzi, G. Testa, B. Sottero, P. Gamba and G. Poli

Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 2
Page: 4053-4093
Authors: Wendy Xolalpa, Patricia Perez-Galan, Manuel S. Rodríguez and Gael Roue

Neuroproteomics: Are We Biased in Our Representation of Molecular Targets Associated with Specific Domains? Implications in Biomarker Discovery

Journal: Current Proteomics
Volume: 10,Issue: 1
Page: 56-66
Authors: Krishnakumar N. Menon, Adhwyth Haridasan, Tessy Xavier, Rameshwari Kundargi and Sreepriya Nair

Neural Stem Cell Transplantation and CNS Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 8
Page: 881-886
Authors: Rodolfo Gonzalez, Milton H. Hamblin and Jean-Pyo Lee

Targeted Nucleic Acid Delivery to Mitochondria

Journal: Current Gene Therapy
Volume: 9,Issue: 6
Page: 475-486
Authors: Bhuvaneshwar Vaidya, Neeraj Mishra, Devyani Dube, Shailja Tiwari and Suresh P. Vyas

Tau Protein Phosphorylation as a Therapeutic Target in Alzheimers Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 2,Issue: 4
Page: 395-415
Authors: Lit-fui Lau, Joel B. Schachter, Patricia A. Seymour and Mark A. Sanner

p75NTR as a Therapeutic Target for Neuropsychiatric Diseases

Journal: Current Molecular Pharmacology
Volume: 2,Issue: 1
Page: 70-76
Authors: Takashi Fujii and Hiroshi Kunugi

Free Radicals in Diseases and Potential Role of Phytoconstituents-A Cause with Emerging Importance

Journal: Current Chemical Biology
Volume: 5,Issue: 3
Page: 197-212
Authors: Sukhes Mukherjee and J. B. Gogoi

Recent Developments of the PET Imaging Agents for Metabotropic Glutamate Receptor Subtype 5

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 1800-1805
Authors: Meixiang Yu

Nanotechnology in Disease Diagnostic Techniques

Journal: Current Drug Metabolism
Volume: 16,Issue: 8
Page: 645-661
Authors: Reema Savaliya, Darshini Shah, Ragini Singh, Ashutosh Kumar, Rishi Shanker, Alok Dhawan and Sanjay Singh

Mutated Genes in Juvenile and Variant Late Infantile Neuronal Ceroid Lipofuscinoses Encode Lysosomal Proteins

Journal: Current Molecular Medicine
Volume: 2,Issue: 5
Page: 439-444
Authors: Jouni Vesa and Leena Peltonen

LRP/LR as an Alternative Promising Target in Therapy of Prion Diseases, Alzheimers Disease and Cancer

Journal: Infectious Disorders - Drug Targets
Volume: 9,Issue: 1
Page: 69-80
Authors: Karen Vana, Chantal Zuber, Heike Pflanz, Dominika Kolodziejczak, Georgeta Zemora, Ann-Katrin Bergmann and Stefan Weiss

Therapeutic Opportunities for Trophic Factors in Brain Inflammation

Journal: Current Pharmaceutical Analysis
Volume: 3,Issue: 1
Page: 7-15
Authors: Beatriz Moreno and Pablo Villoslada

Preventive and Therapeutic Role of Muscle Contraction Against Chronic Diseases

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 3
Page: 4686-4699
Authors: Domenico Di Raimondo, Gaia Musiari, Giuseppe Miceli, Valentina Arnao and Antonio Pinto

Erythropoietin: Cytoprotection in Vascular and Neuronal Cells

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 3,Issue: 2
Page: 141-154
Authors: Zhao Zhong Chong, Jing-Qiong Kang and Kenneth Maiese

Maternal Fish Oil Supplementation: The Prodrom of Synaptic Protection in Alzheimers Disease

Journal: Current Nutrition & Food Science
Volume: 6,Issue: 4
Page: 233-239
Authors: Massimo F.L. Pomponi, Massimiliano Pomponi and Giovanni Gambassi

Alzheimers Disease: An Overview of Current and Emerging Therapeutic Strategies

Journal: Current Topics in Medicinal Chemistry
Volume: 2,Issue: 4
Page: 343-352
Authors: J. Steven Jacobsen

The Neurotrophins and Their Role in Alzheimers Disease

Journal: Current Neuropharmacology
Volume: 9,Issue: 4
Page: 559-573
Authors: Shelley J. Allen, Judy J. Watson and David Dawbarn

Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 491-503
Authors: M. Peviani, I. Caron, C. Pizzasegola, F. Gensano, M. Tortarolo and C. Bendotti

Screening Neuroprotective Agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation Induced PC12 Injury Models: A Review

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 103-110
Authors: Xiuping Chen, Jiajie Guo, Jiaolin Bao, Wenshan Xu, Yanjuan Huang and Yitao Wang

Evidence for Complex Binding Profiles and Species Differences at the Translocator Protein (TSPO) (18 kDa)

Journal: Current Molecular Medicine
Volume: 12,Issue: 4
Page: 488-493
Authors: A. M. Scarf, C. Luus, E. Da Pozzo, S. Selleri, C. Guarino, C. Martini, L. M. Ittner and M. Kassiou

The Putative Neuroprotective Role of Neuropeptide Y in the Central Nervous System

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 4
Page: 331-347
Authors: A. P. Silva, S. Xapelli, E. Grouzmann and C. Cavadas

Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 1
Page: 1832-1845
Authors: A. Napolitano, P. Manini and M. d'Ischia

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 3
Page: 4936-4947
Authors: Ikuko Miyazaki* and Masato Asanuma

The Emerging Role of Helicobacter Pylori-Induced Metabolic Gastrointestinal Dysmotility and Neurodegeneration

Journal: Current Molecular Medicine
Volume: 17,Issue: 6
Page: 389-404
Authors: J. Kountouras*, M. Boziki, S.A. Polyzos, P. Katsinelos, E. Gavalas, C. Zeglinas, D. Tzivras, I. Romiopoulos, N. Giorgakis, K. Anastasiadou, E. Vardaka, C. Kountouras, E. Kazakos, E. Giartza-Taxidou, G. Deretzi, E. Dardiotis, G. Kotronis and M. Doulberis

A Structural View of αB-crystallin Assembly and Amyloid Aggregation

Journal: Protein & Peptide Letters
Volume: 24,Issue: 4
Page: 315-321
Authors: Zhenying Liu, Shengnan Zhang, Dan Li and Cong Liu

Solid-State Structure of Abeta (Aβ) in Alzheimer's Disease

Journal: Protein & Peptide Letters
Volume: 24,Issue: 4
Page: 322-330
Authors: Jun-Xia Lu, Xing-Qi Dong and Jian-Jun Zhang

Neurodegenerative Disorders Treatment: The MicroRNA Role

Journal: Current Gene Therapy
Volume: 17,Issue: 5
Page: 327-363
Authors: Barbara Ridolfi and Hanin Abdel-Haq*

Potential Application of 5-Aryl-Substituted 2-Amino-benzamide Type of HDAC1/2- Selective Inhibitors to Pharmaceuticals

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 0
Page: 1-11
Authors: Shinichi Uesato*, Yoshiyuki Hirata and Tsutomu Sasaki

Alzheimer's Disease and NQO1: Is there a Link?

Journal: Current Alzheimer Research
Volume: 15,Issue: 1
Page: 56-66
Authors: Jamuna Chhetri*, Anna E. King and Nuri Gueven

The Protective Effects of Extra Virgin Olive Oil on Immune-mediated Inflammatory Responses

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 18,Issue: 1
Page: 23-35
Authors: Rosa Casas, Ramon Estruch and Emilio Sacanella*

Rexinoids as Therapeutics for Alzheimer s Disease: Role of APOE

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 6
Page: 708-720
Authors: Kevin P. Koster, Conor Smith, Ana C. Valencia-Olvera, Gregory R.J. Thatcher, Leon M. Tai and Mary Jo LaDu

Epigenetic Modulation Using Small Molecules - Targeting Histone Acetyltransferases in Disease

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 3
Page: 4121-4150
Authors: Andre Richters and Angela N. Koehler*

An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 3
Page: 3749-3773
Authors: Enrico Zanforlin, Giuseppe Zagotto* and Giovanni Ribaudo

Biohybrid Membrane Systems for Testing Molecules and Stem Cell Therapy in Neuronal Tissue Engineering

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 2
Page: 3858-3870
Authors: Sabrina Morelli*, Antonella Piscioneri*, Simona Salerno, Enrico Drioli and Loredana De Bartolo

The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 0
Page: 1-9
Authors: Junichi Matsumoto, Tessandra Stewart, William A. Banks and Jing Zhang*

Interactions of VDAC with Proteins Involved in Neurodegenerative Aggregation: An Opportunity for Advancement on Therapeutic Molecules

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 0
Page: 1-18
Authors: Andrea Magri* and Angela Messina*

Pathophysiological Role of Mitochondrial Potassium Channels and their Modulation by Drugs

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 0
Page: 1-14
Authors: Valentina Citi, Vincenzo Calderone, Alma Martelli, Maria Cristina Breschi and Lara Testai*

Implications of PEGylation of Carbon Nanotubes for Central Nervous System Bioavailability

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 9
Page: 983-989
Authors: Gisele Eva Bruch, Marcos F. Cordeiro, Livia S. Gomides, Carolina Peixoto, Arthur P. Cordeiro, Lidiane Dal Bosco, Adelina P. Santos and Daniela M. Barros*

Epigenetic Regulation of Memory-Therapeutic Potential for Disorders

Journal: Current Neuropharmacology
Volume: 15,Issue: 8
Page: 1208-1221
Authors: Padmanabh Singh, Sweta Srivas and M. K. Thakur *

Benefits of Caloric Restriction on Brain Aging and Related Pathological States: Understanding Mechanisms to Devise Novel Therapies

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 3
Page: 350-361
Authors: Antonio Contestabile

Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 3
Page: 285-296
Authors: N. Ticozzi, A. Ratti and V. Silani

Curcumin: A Potential Neuroprotective Agent in Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 91-99
Authors: R. B. Mythri and M. M. Srinivas Bharath

The Neuroprotective Effect of Ginkgo biloba Leaf Extract and its Possible Mechanism

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7,Issue: 4
Page: 230-235
Authors: Ying T. Mak, Maria S.M. Wai and David T. Yew

Chemokines and Brain Functions

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4,Issue: 3
Page: 387-399
Authors: Ghazal Banisadr, William Rostene, Patrick Kitabgi and Stephane Melik Parsadaniantz

Amyotrophic Lateral Sclerosis: From Research to Therapeutic Attempts and Therapeutic Perspectives

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 3
Page: 5655-5665
Authors: A. Contestabile

Natural Animal Models of Neurodegenerative Protein Misfolding Diseases

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 8
Page: 1148-1158
Authors: Ines Moreno-Gonzalez and Claudio Soto

Exogenous Progesterone: A Potential Therapeutic Candidate in CNS Injury and Neurodegeneration

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 1
Page: 1418-1425
Authors: Zhiying Hu, Yan Li, Marong Fang, Maria S.M. Wai and David T. Yew

Approaches to Mitochondrial Gene Therapy

Journal: Current Gene Therapy
Volume: 4,Issue: 3
Page: 317-328
Authors: Gerard G.M. D'Souza and Volkmar Weissig

Cyclin-Dependent Kinase Inhibitors: Cancer Killers to Neuronal Guardians

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 5
Page: 367-379
Authors: E. A. Monaco III and M. L. Vallano



Journal: Current Pharmaceutical Design
Volume: 19,Issue: 1
Page: 2807-2818
Authors: Magdalena Kusaczuk and Marzanna Cechowska-Pasko

Molecular Biomarkers for Amyotrophic Lateral Sclerosis

Journal: Current Bioinformatics
Volume: 8,Issue: 1
Page: 87-92
Authors: Chi-Shin Hwang, Chia-Hung Hsieh, Guan-Ting Liu, Si-Yi Chen, Johnannes Scheng-Ming Tschen and Hao-Teng Chang

Tau Pathology and Future Therapeutics

Journal: Current Alzheimer Research
Volume: 7,Issue: 8
Page: 685-696
Authors: I. Gozes

Oligomers on the Brain: the Emerging Role of Soluble Protein Aggregates in Neurodegeneration.

Journal: Protein & Peptide Letters
Volume: 11,Issue: 3
Page: 213-228
Authors: Dominic M. Walsh and Dennis J. Selkoe



Journal: Current Enzyme Inhibition
Volume: 10,Issue: 2
Page: 81-93
Authors: Anuradha Pandey, Pooja Makhija, Prakash G. Chandak and Anil B. Gaikwad

Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?

Journal: Current Neuropharmacology
Volume: 12,Issue: 6
Page: 475-489
Authors: Ana R. Nunes, Marco G. Alves, Paula I. Moreira, Pedro F. Oliveira and Branca M. Silva

Neuroprotective Effects of Lutein in the Retina

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 51-56
Authors: Yoko Ozawa, Mariko Sasaki, Noriko Takahashi, Mamoru Kamoshita, Seiji Miyake and Kazuo Tsubota

Therapeutic Strategies in Parkinsons Disease

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2,Issue: 2
Page: 135-147
Authors: Muchukunte M.S. Bharath

Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 6
Page: 764-778
Authors: Julia Costa, Catarina Gomes and Mamede de Carvalho

Innovative Strategies in In Vivo Apoptosis Imaging

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 2
Page: 187-194
Authors: Johann Schoenberger, Johann Bauer, Jutta Moosbauer, Christoph Eilles and Daniela Grimm

Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific

Journal: Current Drug Metabolism
Volume: 9,Issue: 8
Page: 686-696
Authors: Elisabetta Aldieri, Chiara Riganti, Manuela Polimeni, Elena Gazzano, Cristina Lussiana, Ivana Campia and Dario Ghigo

Potentiality of Small Interfering RNAs (siRNA) as Recent Therapeutic Targets for Gene-Silencing

Journal: Current Drug Targets
Volume: 8,Issue: 3
Page: 469-482
Authors: Chiranjib Chakraborty

Reactive Oxygen and Nitrogen Species in Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 1,Issue: 2
Page: 111-119
Authors: Mutay Aslan and Tomris Ozben

Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 1
Page: 2921-2942
Authors: S. Schenone, C. Brullo, F. Musumeci, M. Biava, F. Falchi and M. Botta

Assays for Identification of Hsp90 Inhibitors and Biochemical Methods for Discriminating their Mechanism of Action

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 1462-1478
Authors: Robert L. Matts and Jacob R. Manjarrez

The Role of the Endocannabinoid System in Alzheimers Disease: Facts and Hypotheses

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 2
Page: 2299-2305
Authors: Tiziana Bisogno and Vincenzo Di Marzo

SPECT Radiopharmaceuticals for Dementia

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 4
Page: 192-207
Authors: Claudio Guidotti, Daniela Farioli, Maria Chiara Gaeta, Elisabetta Giovannini, Patrizia Lazzeri, Martina Meniconi and Andrea Ciarmiello

Cofilin/Actin Rod Formation by Dysregulation of Cofilin-1 Activity as a Central Initial Step in Neurodegeneration

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 393-400
Authors: Patricia Schonhofen, Liana Marengo de Medeiros, Carolina Piletti Chatain, Ivi Juliana Bristot and Fabio Klamt

Impact of Various Factors on Pharmacokinetics of Bioactive Polyphenols: An Overview

Journal: Current Drug Metabolism
Volume: 15,Issue: 1
Page: 62-76
Authors: Laura Rubio, Alba Macia and Maria-Jose Motilva

Neurotrophic Factors for the Investigation and Treatment of Movement Disorders

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1,Issue: 3
Page: 225-238
Authors: J. Garcia de Yebenes and M. P. Sanchez

Histone Deacetylase Inhibitors In Inflammatory Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 3
Page: 309-319
Authors: Maria A. Halili, Melanie R. Andrews, Matthew J. Sweet and David P. Fairlie

Mitochondria as Targets for Neuronal Protection Against Excitotoxicity: A Role for Phenolic Compounds?

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7,Issue: 3
Page: 205-222
Authors: Bruno A. Silva, Paulo J. Oliveira, Alberto C.P. Dias and Joao O. Malva

RNA Interference as a Tool for Alzheimers Disease Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 1166-1176
Authors: Antonio Orlacchio, Giorgio Bernardi, Aldo Orlacchio and Sabata Martino

Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection

Journal: Current Stem Cell Research & Therapy
Volume: 6,Issue: 1
Page: 63-68
Authors: Ibrahim Kassis, Adi Vaknin-Dembinsky and Dimitrios Karussis

Molecular Structure of Ionotropic Glutamate Receptors

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 2
Page: 2608-2635
Authors: A.A. Kaczor and D. Matosiuk

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors

Journal: Current Molecular Medicine
Volume: 12,Issue: 2
Page: 126-137
Authors: C. Tian, R.J. Ambroz, L. Sun, Y. Wang, K. Ma, Q. Chen, B. Zhu and J.C. Zheng

Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase

Journal: Current Drug Targets
Volume: 7,Issue: 1
Page: 1377-1388
Authors: Lisa Kockeritz, Bradley Doble, Satish Patel and James R. Woodgett

Small Molecule Modulation of p75 Neurotrophin Receptor Functions

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 1
Page: 63-70
Authors: Frank M. Longo, Frank M. Longo, Stephen M. Massa and Stephen M. Massa

Therapeutic Targets in Prostaglandin E2 Signaling for Neurologic Disease

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 1
Page: 1863-1869
Authors: P. J. Cimino, C. Dirk Keene, Richard M. Breyer, Kathleen S. Montine and Thomas J. Montine

Lentiviral Vector-Based Models of Amyloid Pathology: From Cells to Animals

Journal: Current Alzheimer Research
Volume: 2,Issue: 2
Page: 239-247
Authors: Laura Shaughnessy, Mary Beth Thomas, John Wakefield, Beth Chamblin, Ayyappan Nair, Frank Koentgen and Ram Ramabhadran

Nutritional Antioxidants and Adaptive Cell Responses: An Update

Journal: Current Molecular Medicine
Volume: 11,Issue: 9
Page: 770-789
Authors: A. Speciale, J. Chirafisi, A. Saija and F. Cimino

Functional Roles of Synaptic and Extrasynaptic NMDA Receptors in Physiological and Pathological Neuronal Activities

Journal: Current Drug Targets
Volume: 13,Issue: 2
Page: 207-221
Authors: Sheng-Tian Li and Jue-Gang Ju

Molecular Mechanisms of Inflammation. Anti-Inflammatory Benefits of Virgin Olive Oil and the Phenolic Compound Oleocanthal

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 8
Page: 754-768
Authors: Lisa Lucas, Aaron Russell and Russell Keast

Progress in the Development of Selective Nitric Oxide Synthase (NOS) Inhibitors

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 3
Page: 177-200
Authors: L. Saleron, V. Sorrenti, C. Di Giacomo, G. Romeo and M. A. Siracusa

RAGE and its Ligands in Retinal Disease

Journal: Current Molecular Medicine
Volume: 7,Issue: 8
Page: 758-765
Authors: Gaetano R. Barile and Ann M. Schmidt

Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 1
Page: 969-972
Authors: Hideyuki Hyogo and Sho-ichi Yamagishi

Recent Inventions on Receptor Tyrosine Kinase RET Modulation

Journal: Recent Patents on Biotechnology
Volume: 2,Issue: 1
Page: 47-54
Authors: Adrian Goldman and Jaana M. Jurvansuu

Does the MK2-dependent Production of TNF? Regulate mGluR-dependent Synaptic Plasticity?

Journal: Current Neuropharmacology
Volume: 14,Issue: 5
Page: 474-480
Authors: Ellen L. Hogg, Jürgen Müller and Sônia A.L. Corrêa

Glutamate Transporters as Drug Targets

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 2
Page: 211-220
Authors: Eiichi Hinoi, Takeshi Takarada, Yuriko Tsuchihashi and Yukio Yoneda

Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 1,Issue: 1
Page: 39-46
Authors: Masayoshi Takeuchi, Seiji Kikuchi, Nobuyuki Sasaki, Takako Suzuki, Takayuki Watai, Mina Iwaki, Richard Bucala and Sho-ichi Yamagishi

Oxytosis: A Novel Form of Programmed Cell Death

Journal: Current Topics in Medicinal Chemistry
Volume: 1,Issue: 6
Page: 497-506
Authors: Shirlee Tan, David Schubert and Pamela Maher

Present and Future of Adeno Associated Virus Based Gene Therapy Approaches

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 6,Issue: 1
Page: 47-66
Authors: Saida Ortolano, Carlos Spuch and Carmen Navarro

Pathology of Multiple Sclerosis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 5
Page: 506-517
Authors: Markus Kipp, Paul van der Valk and Sandra Amor

Psychiatric Disorders Associated with FXTAS

Journal: Current Psychiatry Reviews
Volume: 9,Issue: 1
Page: 59-64
Authors: Andreea L. Seritan, Melina Ortigas, Stefan Seritan, James A. Bourgeois and Randi J. Hagerman

Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 2,Issue: 1
Page: 57-78
Authors: Istvan Tarnawa, Hedvig Bolcskei and Pal Kocsis

Food-Derived Advanced Glycation end Products (AGEs): A Novel Therapeutic Target for Various Disorders

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 2
Page: 2832-2836
Authors: Sho-ichi Yamagishi, Seiji Ueda and Seiya Okuda

Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 3474-3479
Authors: Jia Yao and Roberta Diaz Brinton

Clinical Applications of Non-Antimicrobial Actions of Tetracyclines in Inflammatory Diseases

Journal: Current Drug Therapy
Volume: 6,Issue: 4
Page: 233-239
Authors: Aleksandra Kladna and Hassan Y. Aboul-Enein

Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients

Journal: Current Alzheimer Research
Volume: 1,Issue: 2
Page: 103-109
Authors: Carmen Galbusera, Maurizio Facheris, Fulvio Magni, Gloria Galimberti, Gessica Sala, Lucia Tremolada, Valeria Isella, Franca Rosa Guerini, Ildebrando Appollonio, Marzia Galli-Kienle and Carlo Ferrarese

Molecular Targeting Regulation of Proliferation and Differentiation of the Bone Marrow-Derived Mesenchymal Stem Cells or Mesenchymal Stromal Cells

Journal: Current Drug Targets
Volume: 13,Issue: 4
Page: 561-571
Authors: Bei-Yu Chen, Xi Wang, Liang-Wei Chen and Zhuo-Jing Luo

Chaperone Therapy: New Molecular Therapy for Protein Misfolding Diseases with Brain Dysfunction

Journal: Current Bioinformatics
Volume: 11,Issue: 4
Page: 421-429
Authors: Yoshiyuki Suzuki, Kousaku Ohno and Aya Narita

Proteins of the Esterase Family: Patents for Some Proteins in Search of Metabolic Functions

Journal: Recent Patents on Biomarkers
Volume: 1,Issue: 3
Page: 205-212
Authors: GumpenY R. Sridhar

Old and New Drug Targets in Diabetic Retinopathy: From Biochemical Changes to Inflammation and Neurodegeneration

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 4
Page: 421-434
Authors: E. C. Leal, A. R. Santiago and A. F. Ambrosio

Melatonin Redox Activity. Its Potential Clinical Applications in Neurodegenerative Disorders

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 163-169
Authors: Elzbieta Miller, Agnieszka Morel, Luciano Saso and Joanna Saluk

The Role of Glucose in the Pathogenesis of Alzheimers Disease Revisited:What Does it Tell us About the Therapeutic use of Lithium?

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6,Issue: 3
Page: 175-192
Authors: Anna Strunecka and Paul Grof

Glial Reaction in Parkinsons Diseases: Inflammatory Activation Signaling of Glia as a Potential Therapeutic Target

Journal: Current Signal Transduction Therapy
Volume: 2,Issue: 1
Page: 77-90
Authors: Dong-Kug Choi and Kyoungho Suk

Induction of Serine Racemase Expression and D-Serine Release from Microglia by Secreted Amyloid Precursor Protein (sAPP)

Journal: Current Alzheimer Research
Volume: 4,Issue: 3
Page: 243-251
Authors: Shengzhou Wu, Anthony S. Basile and Steven W. Barger

Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 1
Page: 1942-1959
Authors: B.C. Cheah, S. Vucic, A. V. Krishnan and M.C. Kiernan

Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer

Journal: Current Drug Targets
Volume: 14,Issue: 6
Page: 653-661
Authors: Alessandra Donadini, Camillo Rosano, Lamberto Felli and Marco Ponassi



Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 1797-1806
Authors: Levente Szalardy, Denes Zadori, Jozsef Toldi, Ferenc Fulop, Peter Klivenyi and Laszlo Vecsei

The Concept of Protein Mosaics: Physiological Role and Relevance for Prion Disease

Journal: Current Proteomics
Volume: 3,Issue: 3
Page: 171-179
Authors: Luigi Francesco Agnati, Susanna Genedani, Chiara Carone, Giuseppina Leo and Kjell Fuxe

Immunomodulatory Properties of Antibiotics

Journal: Current Molecular Pharmacology
Volume: 1,Issue: 1
Page: 68-79
Authors: R. Nau and S. C. Tauber

Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 1
Page: 2324-2342
Authors: S. K. Palaninathan


Antioxidative Properties of Flavonoids

Journal: Current Organic Chemistry
Volume: 15,Issue: 1
Page: 2616-2626
Authors: Thomas C.F. Bodewes, Joanna Luttikhold, Mireille F.M. van Stijn, Marliek Visser, Klaske van Norren, Mechteld A.R. Vermeulen and Paul A.M. van Leeuwen

Variability in the Effects of Nicotine on Different Regions of the Brain: Changes in the Concentration of Superoxide Dismutase Isoforms

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 1
Page: 10-22
Authors: Adolfo Toledano, Maria-Isabel Alvarez and Adolfo Toledano-Díaz

The Contribution of Nitric Oxide and Carbon Monoxide to Neuronal Function and Development

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7,Issue: 2
Page: 85-96
Authors: Rodrigo R. Resende, Marcella Faria and Henning Ulrich


New Issues for Copper-64: from Precursor to Innovative Pet Tracers in Clinical Oncology

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 3
Page: 117-123
Authors: Laura Evangelista, Mansi Luigi and Giuseppe Lucio Cascini

Omega-3 Fatty Acids and their Role in Central Nervous System - A Review

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 8
Page: 816-831
Authors: Tomasz Wysoczański, Ewa Sokoła-Wysoczańska, Jolanta Pękala, Stanisław Lochyński, Katarzyna Czyż, Robert Bodkowski, Grzegorz Herbinger, Bożena Patkowska-Sokoła and Tadeusz Librowski

Metabotropic Glutamate Receptors in the Trafficking of Ionotropic Glutamate and GABAA Receptors at Central Synapses

Journal: Current Neuropharmacology
Volume: 4,Issue: 1
Page: 77-86
Authors: Min-Yi Xiao, Bengt Gustafsson and Yin-Ping Niu

Molecular Dynamics Simulations of Intrinsically Disordered Proteins in Human Diseases

Journal: Current Computer-Aided Drug Design
Volume: 5,Issue: 4
Page: 280-287
Authors: Jihua Wang, Zanxia Cao and Shuqiang Li

Neurodegeneration in Diabetic Retina and Its Potential Drug Targets

Journal: Current Neuropharmacology
Volume: 12,Issue: 4
Page: 380-386
Authors: Mohammad Shamsul Ola and Abdullah S. Alhomida

Proteasome Inhibitors Therapeutic Strategies for Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4,Issue: 1
Page: 73-82
Authors: Annamaria D'Alessandro, Luisa Pieroni, Maurizio Ronci, Simona D'Aguanno, Giorgio Federici and Andrea Urbani

GPE and GPE Analogues as Promising Neuroprotective Agents

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 13-23
Authors: I. Cacciatore, C. Cornacchia, L. Baldassarre, E. Fornasari, A. Mollica, A. Stefanucci and F. Pinnen

Relationship Between Non-Genomic Actions of Estrogens and Insulin Resistace

Journal: Infectious Disorders - Drug Targets
Volume: 8,Issue: 1
Page: 48-51
Authors: Ana Alonso and Celestino Gonzalez

Molecular Cytogenetics and Cytogenomics of Brain Diseases

Journal: Current Genomics
Volume: 9,Issue: 7
Page: 452-465
Authors: I. Y. Iourov, S. G. Vorsanova and Y. B. Yurov

Inflammation: A Multidimensional Insight on Natural Anti-Inflammatory Therapeutic Compounds

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 3
Page: 3775-3800
Authors: Khalid Bashir Dar, Aashiq Hussain Bhat, Shajrul Amin, Akbar Masood, Mohammad Afzal Zargar and Showkat Ahmad Ganie

Galantamine-based Hybrid Molecules with Acetylcholinesterase, Butyrylcholinesterase and ?-Secretase Inhibition Activities

Journal: Current Alzheimer Research
Volume: 9,Issue: 5
Page: 600-605
Authors: L. Vezenkov, J. Sevalle, D. Danalev, T. Ivanov, A. Bakalova, M. Georgieva and F. Checler

Growth Factors as Therapeutics for Diabetic Neuropathy

Journal: Current Drug Targets
Volume: 9,Issue: 1
Page: 47-59
Authors: Nigel A. Calcutt, Corinne G. Jolivalt and Paul Fernyhough

Applications of Human Umbilical Cord Blood Cells in Central Nervous System Regeneration

Journal: Current Stem Cell Research & Therapy
Volume: 5,Issue: 1
Page: 17-22
Authors: Antonio S. Herranz, Rafael Gonzalo-Gobernado, Diana Reimers, Maria J. Asensio, Macarena Rodriguez-Serrano and Eulalia Bazan

JNK Signalling: A Possible Target to Prevent Neurodegeneration

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 1
Page: 1875-1886
Authors: Tiziana Borsello and Gianluigi Forloni

Oxidative Stress-Induced Necrotic Cell Death via Mitochondira-Dependent Burst of Reactive Oxygen Species

Journal: Current Neurovascular Research
Volume: 6,Issue: 4
Page: 213-222
Authors: Kyungsun Choi, Jinho Kim, Gyung W. Kim and Chulhee Choi

Small Molecules and Future Regenerative Medicine

Journal: Current Topics in Medicinal Chemistry
Volume: 5,Issue: 4
Page: 383-395
Authors: Sheng Ding and Peter G. Schultz

Transcriptional Dysregulation: A Therapeutic Target for Polyglutamine Diseases

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 5,Issue: 2
Page: 119-127
Authors: Jonathan Cornett, Meyer Friedman, Shi-Hua Li and Xiao-Jiang Li

Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 5
Page: 651-660
Authors: Liyun Wang, Wayne Chadwick, Sung-Soo Park, Yu Zhou, Nathan Silver, Bronwen Martin and Stuart Maudsley

Omega-3 Polyunsaturated Fatty Acids in Alzheimers Disease: Key Questions and Partial Answers

Journal: Current Alzheimer Research
Volume: 8,Issue: 5
Page: 470-478
Authors: F. Calon

Selenium in the Prevention and Treatment of Hepatocellular Carcinoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 4
Page: 338-345
Authors: Altaf S. Darvesh and Anupam Bishayee

Involvement of Immune Response in the Pathogenesis of Amyotrophic Lateral Sclerosis: A Therapeutic Opportunity?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 3
Page: 325-330
Authors: A. Calvo, C. Moglia, M. Balma and A. Chio

Pin1: A New Genetic Link between Alzheimers Disease, Cancer and Aging

Journal: Current Aging Science
Volume: 3,Issue: 3
Page: 158-165
Authors: Jane A. Driver and Kun Ping Lu

Reactivity-Based Drug Discovery Using Vitamin B6-Derived Pharmacophores

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 5
Page: 519-528
Authors: Georg T. Wondrak

Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 2116-2138
Authors: Caio Henrique Mazucanti, Joao Victor Cabral-Costa, Andrea Rodrigues Vasconcelos, Diana Zukas Andreotti, Cristoforo Scavone and Elisa Mitiko Kawamoto

Functional Genomics Approach for Identification of Molecular Processes Underlying Neurodegenerative Disorders in Prion Diseases

Journal: Current Genomics
Volume: 13,Issue: 5
Page: 369-378
Authors: Urmila Basu, Le Luo Guan and Stephen S. Moore

Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1,Issue: 3
Page: 233-252
Authors: Joanna Bandorowicz-Pikula

Mushrooms as a Source of Anti-Inflammatory Agents

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 125-141
Authors: Ana Garcia-Lafuentea, Carlos Moro, Ana Villares, Eva Guillamon, Mauricio A. Rostagno, Matilde D'Arrigo and Jose Alfredo Martinez

Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review

Journal: Drug Delivery Letters
Volume: 1,Issue: 1
Page: 13-23
Authors: Andreas M. Grabrucker, Magali Rowan and Craig C. Garner

One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 15,Issue: 3
Page: 171-185
Authors: Matteo A. Russo, Luigi Sansone, Ilaria Carnevale, Federica Limana, Alessandra Runci, Lucia Polletta, Giulietta A. Perrone, Elena De Santis and Marco Tafani

Perspectives on Therapeutic Target for Multiple System Atrophy

Journal: Recent Patents on Regenerative Medicine
Volume: 2,Issue: 1
Page: 30-36
Authors: Ikuru Yazawa

Neuropharmacological Mechanisms Underlying the Neuroprotective Effects of Methylphenidate

Journal: Current Neuropharmacology
Volume: 6,Issue: 4
Page: 379-385
Authors: T. J. Volz

Cerium Oxide Nanoparticles Trigger Neuronal Survival in a Human Alzheimer Disease Model By Modulating BDNF Pathway

Journal: Current Nanoscience
Volume: 5,Issue: 2
Page: 167-176
Authors: Barbara D'Angelo, Sandro Santucci, Elisabetta Benedetti, Silvia Di Loreto, R. A. Phani, Stefano Falone, Fernanda Amicarelli, Maria Paola Ceru and Annamaria Cimini

Protein Oxidative Modification in the Aging Organism and the Role of the Ubiquitin Proteasomal System

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 4007-4022
Authors: Marc Kastle and Tilman Grune

Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 3
Page: 4247-4256
Authors: Wei-Yi Ong, Suku-Maran Shalini and Luca Costantino

The Mediterranean Diet and Gastrointestinal Cancers Risk

Journal: Recent Patents on Food, Nutrition & Agriculture
Volume: 6,Issue: 1
Page: 23-26
Authors: Qianxin Wang, Jianpeng Hao, Quanlin Guan and Wenzhen Yuan

Recent Advances on α-Synuclein Cell Biology: Functions and Dysfunctions

Journal: Current Molecular Medicine
Volume: 3,Issue: 1
Page: 17-24
Authors: C. Alves da Costa

Alzheimer Disease: What Role for Leptin and Insulin?

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 271-279
Authors: Sami Dridi, D. Dominguez and J. Buyse

Discovery of a Novel HDAC2 Inhibitor by a Scaffold-Merging Hybrid Query

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 18,Issue: 7
Page: 693-700
Authors: Nikita Basant, Xionghao Lin, Terry-Elinor Reid, Pradeep K. Karla and Xiang S. Wang

Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 100-108
Authors: Antonella De Jaco, Laura Bernardini, Jessica Rosati and Ada Maria Tata*

Tau Oligomers as Potential Targets for Immunotherapy for Alzheimers Disease and Tauopathies

Journal: Current Alzheimer Research
Volume: 8,Issue: 6
Page: 659-665
Authors: C. A. Lasagna-Reeves, D. L. Castillo-Carranza, G. R. Jackson and R. Kayed

Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1,Issue: 1
Page: 15-28
Authors: V. Weissig, S. V. Boddapati, G. G.M. D'Souza and S. M. Cheng

Non-Primate EIAV-Based Lentiviral Vectors as Gene Delivery System for Motor Neuron Diseases

Journal: Current Gene Therapy
Volume: 4,Issue: 3
Page: 277-286
Authors: M. Azzouz and N. Mazarakis

Endoplasmic Reticulum Stress and Atherosclerosis

Journal: Current Hypertension Reviews
Volume: 6,Issue: 1
Page: 66-71
Authors: Huiping Zhou, Lixin Sun, Jian Xiao, Luyong Zhang, Xiaokun Li, Elaine Studer, William M. Pandak and Phillip B. Hylemon

Pharmacophore and 3D-QSAR Characterization of Thieno[3,2-d] pyrimidine-6-carboxamides as SIRT-2 Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 15,Issue: 6
Page: 661-670
Authors: Neetu Agrawal*, Kamal Shah and Pradeep Mishra

Phosphodiesterase 10 Inhibitors - Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 0
Page: 1-27
Authors: Agnieszka Zagorska*, Anna Partyka, Adam Bucki , Alicja Gawalska , Anna Czopek and Maciej Pawlowski

Relationship between CNS and Immunology, in Relation to Psychology

Journal: Current Drug Metabolism
Volume: 19,Issue: 0
Page: 1-9
Authors: Ghulam Md Ashraf*, Asim Azhar, Ashraf Ali, Mohd Rehan, Qamar Zia, Mohammad Owais, Athanasios Alexiou, Ahmar Rauf, Magdah Ganash and Muhammad Amjad Kamal

Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration

Journal: Current Drug Targets
Volume: 19,Issue: 8
Page: 973-985
Authors: Fariba Khodagholi, Fatemeh Shaerzadeh* and Fateme Montazeri


The Role of Adenosine in Alzheimers Disease

Journal: Current Neuropharmacology
Volume: 7,Issue: 3
Page: 207-216
Authors: Anisur Rahman

MAPKs and Their Inhibitors in Neuronal Differentiation

Journal: Current Enzyme Inhibition
Volume: 3,Issue: 4
Page: 298-308
Authors: Mariarosario Miloso, Giovanni Tredici and Mariarosaria Miloso

Signal Transduction by the Cytoplasmic Domain of NEUREGULIN-1 and its Roles During Neuronal Aging

Journal: Current Signal Transduction Therapy
Volume: 2,Issue: 3
Page: 240-245
Authors: Jianxin Bao

MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings

Journal: Current Alzheimer Research
Volume: 7,Issue: 4
Page: 287-294
Authors: M. Pagani, B. Dessi, S. Morbelli, A. Brugnolo, D. Salmaso, A. Piccini, D. Mazzei, G. Villavecchia, S.A. Larsson, G. Rodriguez and F. Nobili

Astrocytes: Adhesion Molecules and Immunomodulation

Journal: Current Drug Targets
Volume: 17,Issue: 1
Page: 1871-1881
Authors: Shane Liddelow and Daniel Hoyer

Multi-Target-Directed Ligands in Alzheimers Disease Treatment

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 3
Page: 4949-4975
Authors: M. Bajda, N. Guzior, M. Ignasik and B. Malawska

Gene-Nutrient Interactions in One-Carbon Metabolism

Journal: Current Drug Metabolism
Volume: 6,Issue: 1
Page: 37-46
Authors: Simonetta Friso and Sang-Woon Choi

Wnt Signalling is a Relevant Pathway Contributing to Amyloid Beta-Peptide-Mediated Neuropathology in Alzheimers Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 6
Page: 720-726
Authors: Odete A.B. da Cruz e Silva, Ana Gabriela Henriques, Sara Catarina Timoteo Santos Domingues and Edgar F. da Cruz e Silva



Journal: Current Alzheimer Research
Volume: 13,Issue: 9
Page: 964-972
Authors: Cinzia Severini, Carla Petrella and Pietro Calissano

Myeloperoxidase Inhibitors as Potential Drugs

Journal: Current Drug Metabolism
Volume: 16,Issue: 3
Page: 168-190
Authors: Tamara Lazarevic-Pasti, Andreja Leskovac and Vesna Vasic

Recent Advances in Prion Chemotherapeutics

Journal: Infectious Disorders - Drug Targets
Volume: 9,Issue: 1
Page: 81-91
Authors: Valerie L. Sim and Byron Caughey

Oxidative Stress Modulation Through Habitual Physical Activity

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 3648-3680
Authors: Andrea Boccatonda, Romina Tripaldi, Giovanni Davì and Francesca Santilli

Role of FK506 Binding Proteins in Neurodegenerative Disorders

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 3
Page: 5380-5397
Authors: S. Chattopadhaya, A. Harikishore and H. S. Yoon

Structural and Functional Determinants of γ-Secretase, an Intramembrane Protease Implicated in Alzheimers Disease

Journal: Current Genomics
Volume: 8,Issue: 8
Page: 531-549
Authors: Patrick C. Fraering

Genetic Studies in Relation to Kuru: An Overview

Journal: Current Molecular Medicine
Volume: 4,Issue: 4
Page: 375-384
Authors: L. G. Goldfarb, L. Cervenakova and D. C. Gajdusek

What Animal Models Have Taught us About Adenosine Receptor Function

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 7,Issue: 4
Page: 328-340
Authors: Joana Esteves Coelho, Hai-Ying Shen, Kenneth Roy Goldstein and Jiang-Fan Chen

Oxidative RNA Damage and Neurodegeneration

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 2
Page: 2968-2975
Authors: A. Nunomura, P. I. Moreira, A. Takeda, M. A. Smith and G. Perry

Functional Connectivity in a Rat Model of Alzheimer's Disease During a Working Memory Task

Journal: Current Alzheimer Research
Volume: 11,Issue: 1
Page: 981-991
Authors: Tiaotiao Liu, Wenwen Bai, Hu Yi, Tao Tan, Jing Wei, Ju Wang and Xin Tian

Low Molecular Weight Compounds with Transition Metals as Free Radical Scavengers and Novel Therapeutic Agents

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 8,Issue: 3
Page: 128-146
Authors: Andrea Bencini, Paola Failli, Barbara Valtancoli and Daniele Bani

Concepts for Biologically Active Peptides

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 3390-3400
Authors: Abba J. Kastin and Weihong Pan

Modelling and Treating Amyotrophic Lateral Sclerosis through Induced- Pluripotent Stem Cells Technology

Journal: Current Stem Cell Research & Therapy
Volume: 11,Issue: 4
Page: 301-312
Authors: Delphine Bohl, Roland Pochet, Dinko Mitrecic and Charles Nicaise

Neurorescue Activity, APP Regulation and Amyloid-β Peptide Reduction by Novel Multi-Functional Brain Permeable Iron- Chelating- Antioxidants,M-30 and Green Tea Polyphenol, EGCG

Journal: Current Alzheimer Research
Volume: 4,Issue: 4
Page: 403-411
Authors: Yael Avramovich-Tirosh, Lydia Reznichenko, Tamar Amit, Hailin Zheng, Mati Fridkin, Orly Weinreb, Silvia Mandel and Moussa B.H. Youdim

Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB

Journal: Current Neurovascular Research
Volume: 3,Issue: 3
Page: 187-201
Authors: Faqi Li, Zhao Zhong Chong and Kenneth Maiese



Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 913-948
Authors: Mario Di Napoli

Molecular Mechanisms and Pathophysiology of Necrotic Cell Death

Journal: Current Molecular Medicine
Volume: 8,Issue: 3
Page: 207-220
Authors: Nele Vanlangenakker, Tom Vanden Berghe, Dmitri V. Krysko, Nele Festjens and Peter Vandenabeele

MRI Abnormalities Associated with Mild Cognitive Impairments of Vascular (VMCI) Versus Neurodegenerative (NMCI) Types Prodromal for Vascular and Alzheimers Dementias

Journal: Current Alzheimer Research
Volume: 2,Issue: 5
Page: 579-585
Authors: John S. Meyer, Juebin Huang and Munir Chowdhury

Possible Use of Autologous Stem Cell Therapies for Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 2,Issue: 3
Page: 367-376
Authors: Kiminobu Sugaya

Microglia-Neuron Interaction in Inflammatory and Degenerative Diseases: Role of Cholinergic and Noradrenergic Systems

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 6
Page: 388-397
Authors: L. Minghetti, D. Carnevale and R. De Simone

PET Imaging of MRP1 Function in the Living Brain: Method Development and Future Perspectives

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1810-1819
Authors: T. Okamura, T. Kikuchi and T. Irie



Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 3
Page: 429-439
Authors: Sajjad Karim, Zeenat Mirza, Mohammad A. Kamal, Adel M. Abuzenadah, Esam I. Azhar, Mohammed H. Al-Qahtani and Sayed S. Sohrab

PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 1
Page: 1519-1536
Authors: Aren van Waarde, Willem Vaalburg, Petra Doze, Fokko J. Bosker and Philip H. Elsinga

Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 6
Page: 562-573
Authors: Manfred Jung, Robert C. Neugebauer and Wolfgang Sippl

Antioxidant Therapy: Current Status and Future Prospects

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 2
Page: 3871-3888
Authors: O. Firuzi, R. Miri, M. Tavakkoli and L. Saso

Role of Kynurenines in the Central and Peripherial Nervous Systems

Journal: Current Neurovascular Research
Volume: 2,Issue: 3
Page: 249-260
Authors: Hajnalka Nemeth, Jozsef Toldi and Laszlo Vecsei

Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors

Journal: Current Neuropharmacology
Volume: 15,Issue: 4
Page: 495-518
Authors: Stefano Cobianchi*, Ariadna Arbat-Plana, Víctor M. Lopez-Alvarez and Xavier Navarro

Curcumin and Liver Cancer: A Review

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 1
Page: 218-228
Authors: Altaf S. Darvesh, Bharat B. Aggarwal and Anupam Bishayee

Uridine Function in the Central Nervous System

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 8
Page: 1058-1067
Authors: Arpad Dobolyi, Gabor Juhasz, Zsolt Kovacs and Julianna Kardos

Polymeric Nanocarriers and Nanoreactors: A Survey of Possible Therapeutic Applications

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 2622-2643
Authors: Ozana Onaca-Fischer, Juan Liu, Mark Inglin and Cornelia G. Palivan

P2Y Receptors: Focus on Structural, Pharmacological and Functional Aspects in the Brain

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 2
Page: 2429-2455
Authors: W. Fischer and U. Krugel

Acetylcholinesterase-Amyloid-β-peptide Interaction: Effect of Congo Red and the Role of the Wnt Pathway

Journal: Current Alzheimer Research
Volume: 2,Issue: 3
Page: 301-306
Authors: Nibaldo C. Inestrosa, Alejandra Alvarez, Margarita C. Dinamarca, Tomas Perez-Acle and Marcela Colombres

Group VI Phospholipases A2: Homeostatic Phospholipases with Significant Potential as Targets for Novel Therapeutics

Journal: Current Drug Targets
Volume: 9,Issue: 8
Page: 683-697
Authors: W. P. Wilkins III and S. E. Barbour



Journal: Current Alzheimer Research
Volume: 5,Issue: 3
Page: 319-341
Authors: F. Rahimi, A. Shanmugam and G. Bitan

Small Non-Coding RNAs as Novel Therapeutics

Journal: Current Molecular Medicine
Volume: 10,Issue: 4
Page: 361-368
Authors: M. Rossbach

The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors

Journal: Current Cancer Drug Targets
Volume: 3,Issue: 5
Page: 349-358
Authors: Luke Whitesell, Rochelle Bagatell and Ryan Falsey

The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 7,Issue: 4
Page: 250-273
Authors: Imtiaz M. Shah and Mario Di Napoli

The Proteasome in Health and Disease

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 6
Page: 1010-1028
Authors: Elzbieta Jankowska, Julia Stoj, Przemyslaw Karpowicz, Pawel A. Osmulski and Maria Gaczynska

Neuroprotection Abilities of Cytosolic Phospholipase A2 Inhibitors in Kainic acid-induced Neurodegeneration

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4,Issue: 1
Page: 85-96
Authors: Akhlaq A. Farooqui, Wei-Yi Ong and Lloyd A. Horrocks

Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 3
Page: 297-304
Authors: E. Bogaert, C. d'Ydewalle and L. Van Den Bosch

Myeloperoxidase: The Good, the Bad, and the Ugly

Journal: Current Immunology Reviews
Volume: 6,Issue: 2
Page: 123-129
Authors: Doris L. Lefkowitz, James Mone and Stanley S. Lefkowitz

GSK-3 Inhibitors: Recent Developments and Therapeutic Potential

Journal: Current Signal Transduction Therapy
Volume: 3,Issue: 3
Page: 195-205
Authors: Shinsuke Kaku, Shigeyuki Chaki and Makoto Muramatsu

Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition

Journal: Medicinal Chemistry
Volume: 14,Issue: 1
Page: 74-85
Authors: Nehal A. Khan, Imtiaz Khan, Syed M.A. Abid, Sumera Zaib, Aliya Ibrar, Hina Andleeb, Shahid Hameed* and Jamshed Iqbal*

Antioxidant Nanoplatforms for Dermal Delivery: Melatonin

Journal: Current Drug Metabolism
Volume: 18,Issue: 5
Page: 437-453
Authors: Aroha Sanchez Milan, Ana Cristina Calpena Campmany and Beatriz Clares Naveros*

Glaucoma: Hot Topics in Pharmacology

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 4
Page: 596-607
Authors: Shiama I. Balendra, Parth Arvind Shah, Mishank Jain, Andrzej Grzybowski and Maria F. Cordeiro

Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems

Journal: Current Gene Therapy
Volume: 17,Issue: 2
Page: 170-183
Authors: Prachi Bangde*, Sonal Atale, Anomitra Dey, Ashish Pandit, Prajakta Dandekar* and Ratnesh Jain*


Computational Modeling of Small Molecule Inhibitors of Mitochondrial Fusion

Journal: Current Bioinformatics
Volume: 12,Issue: 6
Page: 509-516
Authors: Sonam Arora, Salma Jamal, Sonam Gaba, Yasha Hasija and Vinod Scaria*

Anti-Inflammatory Activity of Novel 12-N-methylcytisine Derivatives

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 112-122
Authors: Inna P. Tsypysheva, Sophia S. Borisevich*, Liana F. Zainullina, Nina S. Makara, Alena V. Koval`skaya, Polina R. Petrova, Sergey L. Khursan, Yulia V. Vakhitova and Felix S. Zarudii

Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 0
Page: 1-23
Authors: Roberto Russo, Claudia Cristiano, Carmen Avagliano, Carmen De Caro, Giovanna La Rana, Giuseppina Mattace Raso, Roberto Berni Canani, Rosaria Meli and Antonio Calignano

VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 0
Page: 1-12
Authors: Varda Shoshan-Barmatz*, Yakov Krelin and Quan Chen

The Panomics Approach in Neurodegenerative Disorders

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 0
Page: 1-9
Authors: Balazs Szatmari, Peter Balicza, Gyorgy Nemeth and Judit Mária Molnár*

Clinical Evaluation of the Effect of Blueberries Consumption on Chronic Diseases, Illness Prevention and Health Promotion

Journal: The Natural Products Journal
Volume: 7,Issue: 0
Page: 1-9
Authors: Eleni Pavlidou, Constantinos Giaginis*, Aristeidis Fasoulas and Dimitris Petridis

Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia

Journal: Current Alzheimer Research
Volume: 14,Issue: 3
Page: 240-254
Authors: Christian Knöchel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Dominik Kraft, David Prvulovic, Andre F. Carvalho, Andreas Reif and Viola Oertel-Knochel

The Application of Aptasensors for the Aging Diseases Diagnosis

Journal: Current Immunology Reviews
Volume: 13,Issue: 0
Page: 1-9
Authors: Bing He, Yinxia Chao, Eng Lee Tan and Peng Li*

Hyperhomocysteinaemia: A Critical Review of Old and New Aspects

Journal: Current Drug Metabolism
Volume: 8,Issue: 1
Page: 17-31
Authors: Wolfgang Herrmann, Markus Herrmann and Rima Obeid

Microwave Assisted Synthesis of Chalcogenides

Journal: Current Microwave Chemistry
Volume: 4,Issue: 1
Page: 25-35
Authors: Sabir Ahammed, Debasish Kundu, Nirmalya Mukherjee and Brindaban C. Ranu

Inflammasome as a New Therapeutic Target for Diabetic Complications

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 10,Issue: 1
Page: 56-62
Authors: Caroline M.O. Volpe, Paula M.F. Anjos and José A. Nogueira-Machado

Cytoprotection by Melatonin, Precursors and Metabolites in an In Vitro Model of Neurotoxicity Induced by Okadaic Acid

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 4
Page: 316-321
Authors: I. Tunez, R. Drucker-Colin, M. C. Munoz and P. Montilla

The Role of Phosphorylation in Synucleinopathies: Focus on Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 471-481
Authors: Nadia Cavallarin, Mattia Vicario and Alessandro Negro

The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimers Disease

Journal: Current Genomics
Volume: 8,Issue: 8
Page: 509-530
Authors: R. Vassar and S. L. Cole

Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntingtons Disease Phenotype

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 4
Page: 486-499
Authors: Yvona Mazurova, Ivana Guncova, Ivan Latr and Emil Rudolf

Molecules from Nature: Modulating the Expression of Estrogen Receptor Genes in Breast Cancer Cells

Journal: Current Bioactive Compounds
Volume: 2,Issue: 2
Page: 143-150
Authors: Mahmud T. Hassan Khan and Arjumand Ather

Calcium Homeostasis Following Traumatic Neuronal Injury

Journal: Current Neurovascular Research
Volume: 1,Issue: 2
Page: 151-171
Authors: John T. Weber

Cyclooxygenase-2 in Synaptic Signaling

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 1
Page: 1443-1451
Authors: Hongwei Yang and Chu Chen

Multiple Hsp70 Isoforms in the Eukaryotic Cytosol: Mere Redundancy or Functional Specificity?

Journal: Current Genomics
Volume: 9,Issue: 5
Page: 338-348
Authors: Mehdi Kabani and Celine N. Martineau

The Pharmaceutical Potential of Histone Deacetylase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 2
Page: 2584-2620
Authors: Greetje Elaut, Vera Rogiers and Tamara Vanhaecke

Galectin-1 as a Potential Therapeutic Agent for Amyotrophic Lateral Sclerosis

Journal: Current Drug Targets
Volume: 6,Issue: 4
Page: 407-418
Authors: T. Kato, C.- H. Ren, M. Wada and T. Kawanami

Understanding the Structural Basis for Inhibition of Cyclin-Dependent Kinases. New Pieces in the Molecular Puzzle

Journal: Current Drug Targets
Volume: 18,Issue: 9
Page: 1104-1111
Authors: Nayara M. Bernhardt Levin, Val Oliveira Pintro, Mauricio Boff de Avila, Bruna Boldrini de Mattos and Walter Filgueira De Azevedo Jr.*

Lithium and its Neuroprotective and Neurotrophic Effects: Potential Treatment for Post-Ischemic Stroke Sequelae

Journal: Current Drug Targets
Volume: 12,Issue: 2
Page: 243-255
Authors: A. B. Gold, N. Herrmann and K. L. Lanctot

Transgenic Mouse Models of Parkinsons Disease and Huntingtons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 455-470
Authors: Stephen D. Skaper and Pietro Giusti

Cognitive Dysfunction in FMR1 Premutation Carriers

Journal: Current Psychiatry Reviews
Volume: 9,Issue: 1
Page: 78-84
Authors: Andreea Seritan, Jennifer Cogswell and Jim Grigsby

Oxygen, Reactive Oxygen Species and Tissue Damage

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 1
Page: 1611-1626
Authors: Carlo M. Bergamini, Stefania Gambetti, Alessia Dondi and Carlo Cervellati

Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy

Journal: Current Gene Therapy
Volume: 7,Issue: 2
Page: 109-120
Authors: Thomas Carlsson, Tomas Bjorklund and Deniz Kirik

Repetitive Transcranial Magnetic Stimulation for ALS

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 3
Page: 331-334
Authors: M. Dileone, P. Profice, F. Pilato, F. Ranieri, F. Capone, G. Musumeci, L. Florio, R. Di Iorio and V. Di Lazzaro

RNAi for the Treatment of Prion Disease: A Window for Intervention in Neurodegeneration?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 5
Page: 342-352
Authors: Melanie D. White and Giovanna R. Mallucci

Modulation of Sirtuins: New Targets for Antiageing

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 3,Issue: 1
Page: 61-69
Authors: Merce Pallas, Esther Verdaguer, Marta Tajes, Javier Gutierrez-Cuesta and Antoni Camins

Structure-Function Implications in Alzheimers Disease: Effect of Aβ Oligomers at Central Synapses

Journal: Current Alzheimer Research
Volume: 5,Issue: 3
Page: 233-243
Authors: Waldo Cerpa, Margarita C. Dinamarca and Nibaldo C. Inestrosa

Lights and Shadows on Monoamine Oxidase Inhibition in Neuroprotective Pharmacological Therapies

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 2
Page: 2788-2796
Authors: Claudia Binda, Erika M. Milczek, Daniele Bonivento, Jin Wang, Andrea Mattevi and Dale E. Edmondson

The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 6
Page: 512-523
Authors: L. W. Chen, K. K.L. Yung, Y. S. Chan, D. K.Y. Shum and J. P. Bolam

Practical Aspects of microRNA Target Prediction

Journal: Current Molecular Medicine
Volume: 11,Issue: 2
Page: 93-109
Authors: T. M. Witkos, E. Koscianska and W. J. Krzyzosiak

Immunophilins in Nervous System Degeneration and Regeneration

Journal: Current Topics in Medicinal Chemistry
Volume: 3,Issue: 1
Page: 1376-1382
Authors: M. Avramut and C. L. Achim

Creutzfeldt-Jakob, Parkinson, Lewy Body Dementia and Alzheimer Diseases: From Diagnosis to Therapy

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 2-11
Authors: Ingrid Dupiereux, Willy Zorzi, Isabelle Quadrio, Armand Perret-Liaudet, Gabor G. Kovacs, Ernst Heinen and Benaissa Elmoualij

Metal Complexes of Biologically Active Ligands as Potential Antioxidants

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 4508-4539
Authors: Irena Kostova and Stefan Balkansky

Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 2
Page: 2803-2821
Authors: Marco Fidaleo, Francesca Fanelli, Maria Paola Ceru and Sandra Moreno

Mitochondria as Therapeutic Targets of Estrogen Action in the Central Nervous System

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3,Issue: 4
Page: 297-313
Authors: Jon Nilsen and Roberta Diaz Brinton

Changes in Immune and Endocrine Systems in Scrapie-Infected Animals

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 1,Issue: 2
Page: 171-183
Authors: X. Ye, A. C. Scallet and R. I. Carp

Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 2
Page: 156-167
Authors: Hiroshi Funakoshi and Toshikazu Nakamura

Oxidative Stress in Neurodegeneration: Mechanisms and Therapeutic Perspectives

Journal: Current Topics in Medicinal Chemistry
Volume: 1,Issue: 6
Page: 553-568
Authors: Antonio Contestabile

Ubiquitin-Protein Ligases - Novel Therapeutic Targets?

Journal: Current Protein & Peptide Science
Volume: 5,Issue: 3
Page: 163-176
Authors: Philip A. Robinson and Helen C. Ardley

Huntingtons Disease: New Frontiers for Molecular and Cell Therapy

Journal: Current Drug Targets
Volume: 6,Issue: 1
Page: 43-56
Authors: Mariarosa A.B. Melone, Francesco P. Jori and Gianfranco Peluso

Drugs with Estrogen-like Potency and Brain Activity Potential Therapeutic Application for the CNS

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 1
Page: 1287-1312
Authors: M. Cyr, F. Calon, M. Morissette, M. Grandbois, S. Callier and T. Di Paolo

Molecular Mechanisms Underlying Specificity of Excitotoxic Signaling in Neurons

Journal: Current Molecular Medicine
Volume: 4,Issue: 2
Page: 137-147
Authors: Michelle M. Aarts and Michael Tymianski

Low Levels of High Density Lipoprotein Increase the Severity of Cerebral White Matter Changes:Implications for Prevention and Treatment of Cerebrovascular Diseases

Journal: Current Alzheimer Research
Volume: 7,Issue: 6
Page: 534-539
Authors: M. Crisby, L. Bronge and L.-O. Wahlund

Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent

Journal: Current Alzheimer Research
Volume: 4,Issue: 5
Page: 510-517
Authors: Jun Ming Wang, Ronald W. Irwin, Lifei Liu, Shuhua Chen and Roberta Diaz Brinton

Acetylcholinesterase Imaging: Its Use in Therapy Evaluation and Drug Design

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 1
Page: 1505-1517
Authors: Hitoshi Shinotoh, Kiyoshi Fukushi, Shin-ichiro Nagatsuka and Toshiaki Irie

Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 3
Page: 3662-3672
Authors: Sathnur Pushpakumar, Sourav Kundu and Utpal Sen

Iron Leads to Memory Impairment that is Associated with a Decrease in Acetylcholinesterase Pathways

Journal: Current Neurovascular Research
Volume: 7,Issue: 1
Page: 15-22
Authors: Vinicius Pieta Perez, Maria Noemia Martins de Lima, Rosane Souza da Silva, Arethuza Silva Dornelles, Gustavo Vedana, Mauricio Reis Bogo, Carla Denise Bonan and Nadja Schroder


Iptakalim Hydrochloride and Neuronal Protection

Journal: Current Neuropharmacology
Volume: 3,Issue: 3
Page: 249-256
Authors: Jie Wu, Makoto Wakui, Hai Wang and Gang Hu

Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?

Journal: Current Pediatric Reviews
Volume: 2,Issue: 2
Page: 143-153
Authors: Virginia C.N. Wong and Brian H.Y. Chung

Novel In Situ Activity Assays for the Quantitative Molecular Analysis of Neurodegenerative Processes in the Retina

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 3
Page: 3478-3493
Authors: P.A.R. Ekstrom, M. Ueffing, E. Zrenner and F. Paquet-Durand

Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 3
Page: 4215-4226
Authors: N. Baby, R. Patnala, Eng-Ang Ling and S.T. Dheen

Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 5
Page: 410-423
Authors: Takashi Muramatsu

β-Amyloid, Neuronal Death and Alzheimers Disease

Journal: Current Molecular Medicine
Volume: 1,Issue: 6
Page: 733-737
Authors: J. Carter and C. F. Lippa

Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease

Journal: Current Alzheimer Research
Volume: 14,Issue: 1
Page: 104-111
Authors: Allal Boutajangout, Abdulwahab Noorwali, Hazem Atta and Thomas Wisniewski

Resveratrol: A Therapeutic Promise for Cardiovascular Diseases

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 2,Issue: 2
Page: 133-138
Authors: Samarjit Das and Dipak K. Das

Alzheimers Disease and n-3 Polyunsaturated Fatty Acids: Beneficial Effects and Possible Molecular Pathways Involved

Journal: Current Signal Transduction Therapy
Volume: 3,Issue: 3
Page: 152-157
Authors: Gabriella Calviello, Simona Serini and Elisabetta Piccioni

Amyloid β Peptide Levels Increase in Brain of AβPP Swedish Mice after Exposure to Chlorpyrifos

Journal: Current Alzheimer Research
Volume: 8,Issue: 7
Page: 732-740
Authors: Jose G. Salazar, Diana Ribes, Maria Cabre, Jose L. Domingo, Fernando Sanchez-Santed and Maria Teresa Colomina

Copper Chelators: Chemical Properties and Bio-medical Applications

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 3
Page: 3785-3818
Authors: M. Tegoni, D. Valensin, L. Toso and M. Remelli

Regulation of Neuronal Cell Death and Neurodegeneration by Members of the Bcl-2 Family: Therapeutic Implications

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 1
Page: 25-39
Authors: John J. Shacka and Kevin A. Roth

Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 4
Page: 449-458
Authors: L. W. Chen, F. Kuang, L. C. Wei, Y. X. Ding, K. K.L. Yung and Y. S. Chan

Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 3
Page: 3765-3788
Authors: D. Lauro, D. Pastore, B. Capuani, F. Pacifici, R. Palmirotta, P. Abete, M. Roselli, A. Bellia, M. Federici, N. Di Daniele, P. Sbraccia, F. Guadagni, R. Lauro and D. Della-Morte

NO Chimeras as Therapeutic Agents in Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 3,Issue: 3
Page: 237-245
Authors: Gregory R.J. Thatcher, Brian M. Bennett and James N. Reynolds

Association between the Polymorphisms of TLR4 and CD14 Genes and Alzheimers Disease

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 2
Page: 2672-2677
Authors: C. R. Balistreri, M. P. Grimaldi, M. Chiappelli, F. Licastro, L. Castiglia, F. Listi, S. Vasto, D. Lio, C. Caruso and G. Candore

Neuronal Generation from Somatic Stem Cells: Current Knowledge and Perspectives on the Treatment of Acquired and Degenerative Central Nervous System Disorders

Journal: Current Gene Therapy
Volume: 3,Issue: 3
Page: 247-272
Authors: S. Corti, F. Locatelli, S. Strazzer, M. Guglieri and G. P. Comi



Journal: Current Alzheimer Research
Volume: 5,Issue: 4
Page: 358-366
Authors: Stefan S. Kassner, Gabriel A. Bonaterra, Elmar Kaiser, Wulf Hildebrandt, Jurgen Metz, Johannes Schroder and Ralf Kinscherf

Cell Cycle Re-Entry in Alzheimers Disease: A Major Neuropathological Characteristic?

Journal: Current Alzheimer Research
Volume: 6,Issue: 3
Page: 205-212
Authors: J. P. Lopes, C. R. Oliveira and P. Agostinho

Assessing Activation States in Microglia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 2
Page: 174-191
Authors: Carol A. Colton and Donna M. Wilcock

Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 6,Issue: 3
Page: 222-241
Authors: Gjumrakch Aliev, Yi Li, Hector H. Palacios and Mark E. Obrenovich

Pharmacogenomics and the Treatment of Sporadic Alzheimers Disease:A Decade of Progress

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 6,Issue: 1
Page: 63-76
Authors: Judes Poirier and Serge Gauthier

New Avenue of Research: Antiepileptic Drug and Estradiol Neuroprotection in Epilepsy

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 3,Issue: 2
Page: 128-137
Authors: Libor Velisek and Jana Veliskova

East Meets West in the Search for Alzheimers Therapeutics - Novel Dimeric Inhibitors from Tacrine and Huperzine A

Journal: Current Alzheimer Research
Volume: 4,Issue: 4
Page: 386-396
Authors: W. M. Li, K. K.W. Kan, P. R. Carlier, Y. P. Pang and Y. F. Han

The Epidemiology of Adiposity and Dementia

Journal: Current Alzheimer Research
Volume: 4,Issue: 2
Page: 117-122
Authors: Rachel A. Whitmer

Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances

Journal: Current Clinical Pharmacology
Volume: 11,Issue: 2
Page: 118-127
Authors: Thekkuttuparambil A. Ajith and Puzhikunathu Vinodkumar

Can Diet and Physical Activity Limit Alzheimer's Disease Risk?

Journal: Current Alzheimer Research
Volume: 14,Issue: 1
Page: 76-93
Authors: Shraddha D. Rege, Thangiah Geetha, Tom L. Broderick and Jeganathan Ramesh Babu

Development of Nucleic Acid Drugs for Neurological Disorders

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 1621-1629
Authors: Munehisa Shimamura, Naoyuki Sato, Hironori Nakagami, Yoshiaki Taniyama and Ryuichi Morishita

Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 8,Issue: 1
Page: 67-80
Authors: Chuanyu Li, Rui Zhao, Kai Gao, Zheng Wei, Michael Yaoyao Yin, Lok Ting Lau, Dehua Chui and Albert Cheung Hoi Yu

Polyphenols Beyond Barriers: A Glimpse into the Brain

Journal: Current Neuropharmacology
Volume: 15,Issue: 4
Page: 562-594
Authors: Ines Figueira, Regina Menezes, Diana Macedo, Ines Costa and Claudia Nunes dos Santos*

The Role of Autophagy on the Survival of Dopamine Neurons

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 869-879
Authors: Ciro Isidoro, Francesca Biagioni, Filippo Sean Giorgi, Federica Fulceri, Antonio Paparelli and Francesco Fornai

Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 8
Page: 895-904
Authors: Caroline Hinton, Helma Antony, Saeed M. Hashimi, Alan Munn and Ming Q. Wei

Nitric Oxide Induced Damage and Preventive Effect of Curcumin and Quercetin on Buffalo Brain Cystatin

Journal: Current Proteomics
Volume: 9,Issue: 1
Page: 9-17
Authors: Fakhra Amin and Bilqees Bano


Human Brain Nicotinic Receptors, their Distribution and Participation in Neuropsychiatric Disorders

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 4
Page: 387-397
Authors: A. J. Graham, C. M. Martin-Ruiz, T. Teaktong, M. A. Ray and J. A. Court

Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 0
Page: 1-34
Authors: Pauraic Mc Carron , Aisling Crowley, Denis O’Shea, Malachy McCann, Orla Howe, Mary Hunt and Michael Devereux*

Erythropoietin Protects Retina Against Ceramide 2-Induced Damage in Rat

Journal: Current Molecular Medicine
Volume: 18,Issue: 0
Page: 1-8
Authors: H. Lou, D. Kang, Q. Yang, C. Lian, C. Zhang, Z. Li, H. Tian, L. Lu, G.-T. Xu*, G. Xu* and J. Zhang*

RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 0
Page: 1-20
Authors: Natalia Pessoa Rocha , Ana Cristina Simoes e Silva , Thiago Ruiz Rodrigues Prestes , Victor Feracin , Caroline Amaral Machado , Rodrigo Novaes Ferreira, Antonio Lucio Teixeira and Aline Silva de Miranda*

(±)-3,5-Bis(substitutedmethyl)pyrrolidines: Application to the Synthesis of Analogues of glycine-L-proline-L-glutamic Acid (GPE)

Journal: Current Organic Synthesis
Volume: 15,Issue: 2
Page: 230-236
Authors: Joana Ferreira da Costa, Xerardo Garcia-Mera, David Silva Poceiro and Olga Caamano*

Lipid Biomarkers in Alzheimer's Disease

Journal: Current Alzheimer Research
Volume: 15,Issue: 4
Page: 303-312
Authors: Amira Zarrouk, Meryam Debbabi, Maryem Bezine, El Mostafa Karym, Asmaa Badreddine, Olivier Rouaud, Thibault Moreau, Mustapha Cherkaoui-Malki, Mohamed El Ayeb, Boubker Nasser, Mohamed Hammami and Gerard Lizard*

Repetitive Transcranial Magnetic Stimulation Reverses A?1 42-induced Dysfunction in Gamma Oscillation during Working Memory

Journal: Current Alzheimer Research
Volume: 15,Issue: 0
Page: 1-8
Authors: Wenwen Bai, Tiaotiao Liu, Mengmeng Dou, Mi Xia, Jun Lu and Xin Tian*

Recent Patent Advances for Neurodegenerative Disorders and its Treatment

Journal: Recent Patents on Drug Delivery & Formulation
Volume: 11,Issue: 3
Page: 158-172
Authors: Bhavna Kumar* and Deepika Sharma

Dementia Etiologies and Remedies in Traditional Persian Medicine; A Review of Medicinal Plants and Phytochemistry

Journal: Current Drug Metabolism
Volume: 19,Issue: 5
Page: 414-423
Authors: Laila Shirbeigi, Behnam Dalfardi, Zohreh Abolhassanzadeh and Fatemeh Nejatbakhsh*

A New Drug Candidate (GEMSP) for Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 2
Page: 3203-3214
Authors: Arturo Mangas, Rafael Covenas, Dominique Bodet, Sebastien Duleu and Michel Geffard




Journal: Recent Patents on Drug Delivery & Formulation
Volume: 9,Issue: 1
Page: 1-64
Authors: Mark A. Babizhayev and Yegor E. Yegorov

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Journal: Current Drug Metabolism
Volume: 18,Issue: 9
Page: 868-876
Authors: Qamre Alam, Mohammad Zubair Alam, Khalid Hussain Wali Sait, Nisreen Anfinan, Abdul Wahab Noorwali, Mohammad Amjad Kamal, Mohd Sajjad Ahmad Khan and Absarul Haque*

Diabetes-Related Neurological Implications and Pharmacogenomics

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 0
Page: 1-16
Authors: Rojas Carranza Camilo Andrés, Bustos Cruz Rosa Helena*, Pino Pinzón Carmen Juliana , Ariza Marquez Yeimy Viviana, Gómez Bello Rosa Margarita and Cañadas Garre Marisa



Journal: Current Alzheimer Research
Volume: 9,Issue: 1
Page: 1142-1148
Authors: M.J. Chiu, S.Y. Yang, T.F. Chen, J.J. Chieh, T.Z. Huang, P.K. Yip, H.C. Yang, T.W. Cheng, Y.F. Chen, M.S. Hua and H.E. Horng

The Path from Anti Parkinson Drug Selegiline and Rasagiline to Multifunctional Neuroprotective Anti Alzheimer Drugs Ladostigil and M30

Journal: Current Alzheimer Research
Volume: 3,Issue: 5
Page: 541-550
Authors: Moussa B.H. Youdim

From the Editors Perspective: Rational Approaches for Radical Entities

Journal: Current Neurovascular Research
Volume: 2,Issue: 1
Page: 1-2
Authors: Kenneth Maiese

Therapeutic Potential of Neurogenesis for Prevention and Recovery from Alzheimers Disease: Allopregnanolone as a Proof of Concept Neurogenic Agent

Journal: Current Alzheimer Research
Volume: 3,Issue: 3
Page: 185-190
Authors: Roberta Diaz Brinton and Jun Ming Wang

Neurogenesis in the Adult Brain: Implications for Alzheimers Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 5
Page: 303-310
Authors: Veronica Galvan and Dale E. Bredesen

Misoprostol Reverse Hippocampal Neuron Cyclooxygenase-2 Downstream Signaling Imbalance in Aluminum-Overload Rats

Journal: Current Alzheimer Research
Volume: 13,Issue: 9
Page: 1006-1016
Authors: Yuanxin Guo, Wenjuan Lei, Jianfeng Wang, Xinyue Hu, Yuling Wei, Chaonan Ji and Junqing Yang*

The Mitochondriotropic Effects of L-carnitine and its Esters in the Central Nervous System

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3,Issue: 4
Page: 275-282
Authors: Zbigniew Binienda and Ashraf Virmani

A Path to Development or Demise ?

Journal: Current Neurovascular Research
Volume: 3,Issue: 1
Page: 1-2
Authors: Kenneth Maiese

Natural Products from Mediterranean Diet: From Anti-Inflammatory Agents to Dietary Epigenetic Modulators

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 101-124
Authors: C.A. Kontogiorgis, E.-M. Bompou, M. Ntella and W. Vanden Berghe



Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 1
Page: 1221-1221
Authors: Biswajit Mukherjee

Timing is Everything

Journal: Current Neurovascular Research
Volume: 2,Issue: 5
Page: 363-364
Authors: Kenneth Maiese

Hot topic: Editorial [Therapeutic Potential of Peptide Motifs - Part IV] (Jean Claude Herve)

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 2
Page: 3053-3055
Authors: Jean Claude Herve

Results 1 - 952 of 952